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Mesenchymal stem cells (MSCs) are increasingly being investigated as a therapeutic 
cell population for a variety of diseases. However, these therapies are limited by an 
imperfect understanding of how MSCs interact with and respond to their physical 
environment. Cell response to external stimuli is mediated by the cytoskeleton. Of the 
cytoskeletal proteins, understanding of vimentin intermediate filaments’ influence on 
MSC behavior is still lacking, despite increasing evidence that they are involved in 
many cellular processes. In this work, we investigated the influence of vimentin 
intermediate filaments in modulating MSC characteristics and behavior by using 
lentiviral shRNA transduction to decrease vimentin levels in MSCs through RNA 
interference.  
 
First, the contribution of vimentin intermediate filaments to the deformability of 
MSCs within agarose hydrogels was examined. Vimentin-deficient MSCs were found 
  
 
to be less deformable than control cell populations and this resistance to deformation 
may be due to the compensatory role of actin microfilaments. Next, to determine how 
vimentin affects the ability of MSCs to interact with various microenvironments, we 
examined cell spreading on different extracellular matrix proteins, multiple substrate 
stiffness’, and in response to fluid shear stress. An intact vimentin network was found 
to be necessary for unimpaired spreading on fibronectin, but only on stiffer substrates. 
Further, vimentin appears to be involved in resisting cell area changes in response to 
low fluid shear stress. Vimentin’s physical interaction with focal adhesions, rather 
than an impact at the transcriptional or translational level, may contribute to the cell 
spreading response observed. Finally, in the third part of this work, we examined the 
influence of vimentin on chondrogenic differentiation of MSC populations. 
Unexpectedly, we found that vimentin may not be involved in chondrogenic 
differentiation in late stage chondrogenic cultures. Instead, the culture condition-
dependent microenvironment may have a greater impact, particularly in gene 
expression of matrix degrading enzymes and the αV integrin subunit. Altogether, 
these studies indicate a role for vimentin in the MSC response to physical stimuli. 
Moreover, this work furthers the dialogue surrounding MSCs’ interaction with 
different environments, the understanding of which will be critical for the 















THE INFLUENCE OF VIMENTIN INTERMEDIATE FILAMENTS ON HUMAN 













Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 










Associate Professor Dr. Adam H. Hsieh, Chair 
Professor Dr. John P. Fisher 
Assistant Professor Dr. Giuliano Scarcelli 
Assistant Professor Dr. Kimberly Stroka 











































I would like to start by thanking my advisor, Dr. Adam Hsieh for his support and 
guidance over the course of the last few years. His mentorship has helped me become 
the researcher that I am today. I would also like to thank my committee members Drs. 
John P. Fisher, Giuliano Scarcelli, Kimberly Stroka, and Wenxia Song, as well as our 
collaborator, Dr. Diane Wagner, for all their support towards the completion of this 
work.  
 
Also, thanks to all of the undergraduate researchers who have helped me over the 
years, especially Michelle Patkin and Zachary Bolten for their tremendous help in the 
laboratory. I would also like to especially acknowledge the past and present members 
of the Orthopaedic Mechanobiology Lab, without whom this work would not have 
been possible, whether through scientific guidance or emotional support; especially, 
Lauren Resutek, Dr. Carlos Luna, and Dr. Julianne Twomey. Thank you to the BIOE 
graduate student village that has stood with me these last few years, with a smiling 
face, a joke, or a shoulder. Finally, thank you to my parents and my brother for their 
undying support, my friends for being there and much needed distractions, and 
Karthik Paco Sangaiah for all of the above. Every one of you made this possible - 
thank you!  
 
“We have but to toil awhile, endure awhile, believe always, and never turn back.”      




Table of Contents 
Acknowledgements ....................................................................................................... ii 
Table of Contents ......................................................................................................... iii 
List of Tables ............................................................................................................... vi 
List of Figures ............................................................................................................. vii 
Chapter 1: Background and Significance ..................................................................... 1 
1.1 Mesenchymal Stem Cells (MSCs) ...................................................................... 1 
1.1.1 Current Research in Treating Cartilage Disease .......................................... 1 
1.1.1.1 Articular Cartilage Tissue ..................................................................... 1 
1.1.1.2 Osteoarthritis ......................................................................................... 2 
1.1.2 Current Therapeutic Outlook for MSCs ...................................................... 3 
1.1.2.1 Cell Therapy.......................................................................................... 3 
1.1.2.2 Tissue Engineering Strategies and Goals .............................................. 6 
1.1.3 Challenges for Stem Cell-based Therapies .................................................. 7 
1.2 Behavior of Mesenchymal Stem Cells ................................................................ 8 
1.2.1 Homing and Adhesion ................................................................................. 8 
1.2.2 Differentiation - Chondrogenesis ................................................................. 8 
1.2.3 Mechanosensing and mechanical properties .............................................. 10 
1.3 Vimentin intermediate filaments....................................................................... 11 
1.3.1 Vimentin Involvement in Disease .............................................................. 14 
1.3.2 Vimentin in Cellular Mechanosensitivity and Mechanical Properties ...... 15 
1.3.3 Vimentin in Cellular Spreading and Adhesion .......................................... 16 
1.3.4 Chondrogenesis .......................................................................................... 17 
1.4 Methods for Manipulating Vimentin ................................................................ 18 
1.4.1 Disruption of the Vimentin network .......................................................... 18 
1.4.2 RNA Interference ....................................................................................... 20 
1.5 Significance and Specific Aims ........................................................................ 23 
1.5.1 Aim 1: Determine if vimentin contributes to mesenchymal stem cell 
deformability. ...................................................................................................... 24 
1.5.2 Aim 2: Evaluate vimentin’s influence on mesenchymal stem cell spreading 
in response to different microenvironmental conditions. ................................... 24 
1.5.3 Aim 3: Determine if an initially intact vimentin network is required for 
chondrogenic differentiation ............................................................................... 25 
Chapter 2: Deformability of Human Mesenchymal Stem Cells Is Dependent on 
Vimentin Intermediate Filaments ............................................................................... 26 
2.1 Introduction ....................................................................................................... 26 
2.2 Materials and Methods ...................................................................................... 29 
2.2.1 hMSC cell culture ...................................................................................... 29 
2.2.2 Lentivirus design and generation ............................................................... 29 
4.2.3 shRNA transduction ................................................................................... 30 
2.2.4 Western blotting ......................................................................................... 31 
2.2.5 Immunofluorescence imaging .................................................................... 32 
2.2.6 Cell deformation ........................................................................................ 33 
2.2.7 Cytoskeletal disruption .............................................................................. 34 
2.2.8 Statistical Analysis ..................................................................................... 34 
iv 
 
2.3 Results ............................................................................................................... 35 
2.3.1 Inducible lentiviral shRNA mediated knockdown of vimentin expression in 
hMSCs................................................................................................................. 35 
2.3.2. Vimentin knockdown reduces hMSC deformability ................................ 37 
2.3.3. Functional role of actin filaments, but not microtubules, is altered by 
vimentin knockdown ........................................................................................... 39 
2.3.4. Cytoskeletal organization and quantity in agarose embedded hMSCs ..... 40 
2.4 Discussion ......................................................................................................... 41 
2.5 Conclusion ........................................................................................................ 48 
Chapter 3: Vimentin Intermediate filaments influence Mesenchymal Stem Cell 
Spreading on Fibronectin ............................................................................................ 49 
3.1 Introduction ....................................................................................................... 49 
3.2 Materials and Methods ...................................................................................... 51 
3.2.1 hMSC Cell Culture .................................................................................... 51 
3.2.2 shRNA Transduction ................................................................................. 52 
3.2.3 Cellular Spreading ..................................................................................... 53 
3.2.4 Gene Expression ........................................................................................ 54 
3.2.5 Western Blotting ........................................................................................ 55 
3.2.6 Immunofluorescence and focal adhesion analysis ..................................... 56 
3.2.7 Statistical Analysis ..................................................................................... 56 
3.3 Results ............................................................................................................... 57 
3.3.1 Vimentin influences cell spreading on fibronectin coated surfaces ........... 57 
3.3.2 Vimentin may preferentially influence cell spreading on fibronectin-coated 
stiff substrates ..................................................................................................... 60 
3.3.3 Vimentin may provide resistance to cell area changes in response to fluid 
shear stress .......................................................................................................... 62 
3.3.4 Vimentin deficiency does not impact hMSC integrin gene expression and 
vinculin quantity ................................................................................................. 63 
3.3.5 Vimentin deficiency limits focal adhesion size in MSCs spread on 
fibronectin ........................................................................................................... 65 
3.4 Discussion ......................................................................................................... 66 
3.5 Conclusion ........................................................................................................ 71 
Chapter 4: Vimentin intermediate filaments may have a limited influence on 
chondrogenesis over extended culture periods ........................................................... 73 
4.1 Introduction ....................................................................................................... 73 
4.2 Materials and Methods ...................................................................................... 75 
4.2.1 hMSC Cell Culture .................................................................................... 75 
4.2.2 shRNA Transduction ................................................................................. 76 
4.2.3 Chondrogenic Differentiation .................................................................... 76 
4.2.4 Histology and Immunohistochemistry ....................................................... 77 
4.2.5 Gene expression ......................................................................................... 78 
4.2.6 Statistical Analysis ..................................................................................... 80 
4.3 Results and Discussion ..................................................................................... 80 
4.4 Conclusion ........................................................................................................ 89 
Chapter 5: Conclusions and Future Work ................................................................... 90 
v 
 
Appendix A: Downregulation of Vimentin Intermediate Filaments Affect Human 
Mesenchymal Stem Cell Adhesion and Formation of Cellular Projections ............. 102 
A.1 Introduction .................................................................................................... 102 
A.2 Materials and Methods ................................................................................... 105 
A.2.1 Human Mesenchymal Stem Cell Culture................................................ 105 
A.2.2 shRNA Lentivirus Generation ................................................................ 106 
A.2.3 shRNA Transduction............................................................................... 106 
A.2.4 GFP-Vimentin Transfection .................................................................... 107 
A.2.5 Surface Reflective Interference Contrast Microscopy and 
Immunofluorescence ......................................................................................... 107 
A.2.6 Immunofluorescence for F-Actin and Focal Adhesion Analysis ............ 108 
A.2.7 Cytoskeletal Disruption and Visualization ............................................. 109 
A.2.8 Cellular Cytoplasmic Projection Formation Assay and Analysis ........... 110 
A.2.9 Statistical Analysis .................................................................................. 110 
A.3 Results ............................................................................................................ 111 
A.3.1 Vimentin is involved in cell-substrate contact and might be involved in 
pseudopodia-substrate interactions in hMSCs .................................................. 111 
A.3.2 Increased actin expression and vinculin focal adhesion area play a role in 
increased cell-substrate contacts in shVim cells ............................................... 114 
A.3.3 Vimentin-rich cell protrusions resist cell retraction ................................ 117 
A.3.4 Vimentin plays a key role in the formation of cell protrusions .............. 119 
A.4 Discussion ...................................................................................................... 121 
Appendix B: Layered Alginate Constructs: A Platform for Co-culture of 
Heterogeneous Cell Populations ............................................................................... 125 
B.1 Introduction .................................................................................................... 125 
B.2 Protocol .......................................................................................................... 127 
B.2.1. Preparation for Formation of Alginate discs .......................................... 127 
B.2.2. Formation of Cell Seeded Alginate Discs .............................................. 130 
B.2.3. Layering of alginate discs ...................................................................... 132 
B.3 Representative Results: .................................................................................. 135 
B.4 Discussion ...................................................................................................... 138 






List of Tables 
Table 2.1 shRNA sequences screened for effective vimentin knockdown in hMSCs. 
Grey indicates overhang or loop shRNA .................................................. 30 
Table 3.1 Sequences of primers used for qRT-PCR ................................................... 55 




List of Figures 
Figure 1.1 MSC Clinical Trials as of 2015 (n=493). 19.1% (n=94) of trials targeting 
bone and cartilage diseases. Other targeted diseases included Neurological 
disease (17.8%, n=87), Cardiovascular disease (14.8%, n=73) and Graft 
vs. Host Disease (GVHD) (7.2%, n=35). Additional targets included lung, 
kidney, liver, hematological, and Crohn’s diseases, diabetes, and others
 1
. 4 
Figure 1.2 Schematic of knee joint and intraarticular injection of MSCs. ................... 5 
Figure 1.3 Schematic depicting MSC differentiation potential and various 
chondrogenic differentiation culture environments. Schematic adapted 
from Squillaro, et al (2016)
1
. .................................................................... 10 
Figure 1.4 Vimentin intermediate filament formation and vimentin in mesenchymal 
stem cells imaged at low and high magnifications. Scale bars 20µm and 
10µm, respectively. Vimentin = green, F-actin (phalloidin) = red, nucleus 
(DAPI) = blue. Schematic adapted from Robert, et al (2016) 
81
. ............. 13 
Figure 1.5 Acrylamide disruption of vimentin in hMSCs. Vimentin=green, F-actin 
(Phalloidin)=red A. Disruption of vimentin in hMSCs (Lonza) using 
15mM acrylamide for 4 hours. Scale Bar: 25µm. B.  Disruption of 
vimentin in hMSCs (RoosterBio) using 40mM acrylamide for 3 hours. 
Lower cell density and shorter culture time used in B in comparison to A 
and C.  Scale Bar: 50µm. C. Concentration dependency of acrylamide-
based disruption of vimentin in hMSC (Lonza) after 9 hours. Scale Bar: 
40µm. Disruption of actin seen as punctuated spots of staining instead of 
visible fibers. ............................................................................................. 20 
Figure 1.6 Schematic of shRNA-based RNAi ............................................................ 22 
Figure 2.1 Characterization of vimentin knockdown in hMSCs. a. Two lentiviral 
vectors were screened using western blots and immunostaining on Day 14. 
In Western blots, ‘+Cntl’ is a purified vimentin protein positive control for 
Vim and a 293FT HEK cell lysate for B-Act. Scale bar: 50µm. b. 
Characterization of knockdown by Western blot on days 7, 14, and 21 of 
shRNA induction. ‘+Cntl’ is purified vimentin protein for Vim and 293FT 
HEK cell lysate for B-Act. c. Observation of vimentin knockdown by 
immunostaining on days 3, 7, and 14 of shRNA induction; vimentin 
(green), F-actin (red), nucleus (blue). Scale bar: 50µm. d. Observation of 
vimentin knockdown in agarose hydrogel; vimentin (green), nucleus 
(blue). Scale bar: 50µm. e. Effect of 1µg/ml doxycycline treatment on 




Figure 2.2 Characterization of vimentin knockdown at day 14. Representative 
fluorescence images of non-transduced, shLacZ-hMSCs, and shVim-
hMSCs each labelled by immunostaining for vimentin (green) or 
phalloidin staining for F-actin (red). Scale Bar: 50µm. ......................... 37 
Figure 2.3 Cell Deformation of Vimentin-deficient hMSCs. Normalized aspect ratios 
of cells subjected to 0%, 10%, or 20% strain. a. Depiction of deformation 
and calculations. b. Deformation of control, non-transduced, hMSCs, 
shLacZ-hMSCs, shVim-hMSCs in 4% agarose hydrogels. c. Deformation 
of control, non-transduced, hMSCs, shLacZ-hMSCs, shVim-hMSCs in 
2% agarose hydrogels. d. Deformation of control, non-transduced, hMSCs 
with or without treatment with 1µg/ml doxycycline for 14 days. All data 
are expressed as mean aspect ratio ± SD. Asterisks represent statistically 
significant differences (p < 0.05). ............................................................. 38 
Figure 2.4 Effect of Cytoskeletal Disruption on Cell Deformation. Normalized aspect 
ratios of shVim-hMSCs and shLacZ-hMSCs subjected to 0%, 10%, or 
20% strain after chemical disruption of actin microfilaments or tubulin 
microtubules. a. Deformation of shLacZ-hMSCs and shVim-hMSCs after 
actin microfilament disruption b. Deformation of shLacZ-hMSCs and 
shVim-hMSCs after microtubule disruption All data are expressed as 
mean aspect ratio ± SD. Asterisks represent statistically significant 
differences (p< 0.05). ................................................................................ 40 
Figure 2.5 F-actin microfilament and Tubulin microtubule fluorescence intensity in 
shVim-hMSCs and shLacZ-hMSCs. Fluorescent intensity measurements 
of shLacZ-hMSCs and shVim-hMSCs stained for F-Actin  and tubulin. 
All data are expressed as CTCF ± s.e.m. Asterisks represent statistically 
significant differences (p < 0.05). Scale bar: 50µm. ................................. 41 
Figure 3.1 shLacZ- and shVim-hMSCs spreading and circularity after 2hrs. A. Area 
measurement of cells seeded on type I collagen and fibronectin. *p<0.01 
between shLacZ- and shVim-hMSCs seeded on the same surface. A,B,D 
p<0.01 between shLacZ-hMSCs seeded on different surfaces. x,y,z, 
p<0.01 between shVim-hMSCs seeded on different surfaces. n=140-280 
cells. B. Measurement of circularity of cells seeded on type I collagen and 
fibronectin. A,B,C p<0.01 between shLacZ-hMSCs seeded on different 
surfaces. x,y,z p<0.01 between shVim-hMSCs seeded on different 
surfaces. n=140-280 cells. ........................................................................ 58 
Figure 3.2 Cell spreading of shLacZ- and shVim-hMSCs after 24hrs. Area 
measurement of cells seeded on type I collagen and fibronectin. *p<0.01 
between shLacZ- and shVim-hMSCs seeded on the same surface. A,B 
p<0.01 between shLacZ-hMSCs seeded on different surfaces. x,y p<0.01 
between shVim-hMSCs seeded on different surfaces. n=70-155 cells..... 60 
ix 
 
Figure 3.3 Effect of varying substrate stiffness on cell spreading of shLacZ- and 
shVim-hMSCs. Top: Representative images of cells visualized using 
phase contrast microscopy. Scale bar 50µm. Bottom: Cell area 
measurement of shLacZ- and shVim-hMSCs seeded on fibronectin 
(10µg/ml) coated substrates of varying (5kPa vs. 13kPa) stiffness. 
*p<0.01, n=185-230 cells. ........................................................................ 61 
Figure 3.4 Cell spreading of shLacZ- and shVim-hMSCs in response to fluid shear 
stress. shLacZ- and shVim-hMSCs were seeded in 10ug/ml fibronectin-
coated Ibidi µ-Slide I 0.2 chamber slides subjected to reciprocal fluid flow 
for 4 hours at 1dyne/cm
2
 fluid shear stress with change in direction every 
30min. *p<0.01, n=125-280 cells. ............................................................ 62 
Figure 3.5 Gene expression and western blotting of shLacZ- and shVim-hMSCs 
cultured on tissue culture polystyrene. A. Relative gene expression levels 
(fold difference) were calculated using the exponential relationship of 2
-
ΔΔCt





) ± range and shVim-hMSC gene 
expression relative to shLacZ-hMSC gene expression.  p<0.05, n=3. B. 
Vinculin protein levels as measured by western blotting. Relative percent 
change of vinculin expression of the shVim-hMSCs relative to the 
shLacZ-hMSCs, both normalized to the GAPDH expression, mean. 
p<0.05, n=3. .............................................................................................. 64 
Figure 3.6 Vinculin focal adhesion areas. Areas of focal adhesions were quantified by 
ImageJ measurements of vinculin immunostaining fluorescence intensity 
in selected areas of shLacZ- and shVim-hMSCs seeded on fibronectin-
coated glass coverslips.  p<0.05, n=60 cells. Representative images shown 
on the left. Scale bar: 50µm. ..................................................................... 65 
Figure 4.1 IHC and Histology of Pellet Cultures. shLacZ- and shVim-hMSC pellet 
cultures stained using IHC for type II collagen, type VI collagen, and 
aggrecan and stained with safranin O for sGAGs on day 14 and day 21 of 
culture. Scale bar: 50µm. .......................................................................... 82 
Figure 4.2 IHC and Histology of Agarose Cultures. shLacZ- and shVim-hMSC 
agarose cultures stained using IHC for type II collagen, type VI collagen, 
and aggrecan and stained with safranin O for sGAGs on day 14 and day 21 
of culture. Scale bar: 50µm. ...................................................................... 83 
Figure 4.3 Gene expression of Pellet and Agarose Cultures. shLacZ- and shVim-
hMSC pellet and agarose culture assayed for gene expression at day 14 
and day 21 (n = 3-5). A. shVim-hMSC samples relative to shLacZ-hMSC 
samples for all both culture conditions and time points. B. Day 21 samples 
relative to Day 14 samples for both cell populations and culture 
conditions. C. Agarose culture samples relative to pellet culture samples 
for both cell populations and time points. *p<0.05, #p<0.01 compared to 
x 
 
stated relevant comparison. Data are shown as average values of the range 




) ± range. ............... 88 
Figure 5.1 The three aims of this dissertation. ............................................................ 90 
Figure A.1 Vimentin is involved in cell-substrate contact and might be involved in 
pseudopodia-substrate interactions in hMSCs. (A-C) Vimentin and cell-
substrate adhesion in shLacZ cell. (A) Vimentin staining in shLacZ cell.  
(B) SRIC image in shLacZ cell. (C) Vimentin and SRIC overlay of 
shLacZ cell. (D-I) Vimentin and cell-substrate adhesion for shVim cells.  
(D,G) Vimentin staining in shVim cells. (E,H) SRIC image of shVim 
cells. (F,I) Vimentin and SRIC overlay shVim cells.  (I) Zoom panel 
shows vimentin and SRIC overlay at cellular protrusion in shVim cell.  (J-
L) Vimentin at the cell edges in shLacZ cells. (M-O) Vimentin staining at 
the cell edges in shVim cells. (P-R) Vimentin and SRIC overlay.  (R) 
White arrow points to lack of vimentin staining in the cell protrusion. . 114 
Figure A.2 Increased actin expression and vinculin focal adhesion area play a role in 
increased cell-substrate contacts in shVim cells. (A) shLacZ cell showing 
vimentin, actin, and SRIC images. Vimentin is located on the periphery of 
the cell and actin does not form defined stress fibers. (B-C) shVim cell 
showing actin, vimentin, and SRIC images.  Yellow arrows indicate where 
vimentin expression does not extend into cellular projections, but where 
actin expression is increased with stress fiber formation. (D) Ratio of actin 
and vimentin fluorescence expression at the cell edge. Ashvim is actin 
fluorescence in shVim cells, AshlacZ is the actin expression in shLacZ, 
Vshvim is vimentin expression in shVim and VshlacZ is vimentin 
expression in shLacZ cells. (E) ShLacZ vinculin immunofluorescence 
staining. (F) Binary image of shLacZ vinculin. (G) Vinculin adhesions in 
shLacZ hMSC and shVim hMSC (H) shLacZ cell showing vimentin, 
vinculin and SRIC. (I) shVim cell showing vimentin, vinculin and SRIC.
................................................................................................................. 116 
Figure A.3 Vimentin projections resist cell retraction.  (A)  Live cell imaging of 
shLacZ cells treated with 0.4µm cytochalasin D at T=0 and T=1:15hr. (B) 
Live cell imaging of shLacZ GFP-vimentin cells treated with 0.4um 
cytochalasin D at T=0 and T=1:15hr.  (C) Immunofluorescence images of 
vimentin staining in shLacZ cells and shVim cells untreated (top panel) 
and cytochalasin (D) (bottom panel). ...................................................... 119 
Figure A.4. Vimentin plays a key role in the formation of cell projections (A) 
Migration of hMSCs were monitored through 3µm transwell pores using 
fluorescent microscopy.  Transwells were coated in fibronectin and SDF-1 
was included in the bottom well to stimulate cell migration through the 
pores. (B)-C Fluorescent images showing projection formation through 
transwell pores of shLacZ and shVim cells.  (D-F) Z plane projections of 
shLacZ cells stained with actin and vimentin migrating through transwell 
xi 
 
pores. (G-I) Vimentin and actin staining of a shLacZ hMSC adhered to the 
bottom side of a transwell. Green arrow (H) points to vimentin staining in 
the central area of the cell.  Red arrow (I) points to actin stress fibers on 
the periphery of the cell (J-K) Vimentin staining of shLacZ and shVim 
transmigrating through transwell pores. This panel depicts vimentin 
staining of protrusion formation through the pores to the bottom chamber. 
(L) Quantification of the average number of protrusions of shLacZ-
hMSCs vs. shVim-hMSCs. ..................................................................... 120 
Figure B.1 Schematic of layered hydrogel formation. A. Image of the stacked mold 
for the addition of 2% alginate+cell mixture with a depiction of the 
stacking order for the bottom and top mold halves. B. Schematic depicting 
procedure for layering of the gel. ............................................................ 136 
Figure B.2 Representative separation of cell populations in layered hydrogel. Model 
cell line 293FT HEK cells were either stained with live cell tracker 
CMFDA (green) or CMTPX (red). Each of these cell groups were 
embedded in 2% (w/v) alginate discs, and then halves of these discs were 
layered together. A piece was cut from the CMTPX side to identify it 
during imaging. Scale bar = 100μm. ....................................................... 137 
Figure B.3 High cell viability within layered hydrogel after layering process is 
complete. Human mesenchymal stem cells embedded in bulk and bi-
layered hydrogels were stained with live cell (green) tracker CMFDA and 
dead cells (red) were stained with Ethidium homodimer-1. Viability 
remained high for both hydrogel groups after the layering process. Scale 
bar = 100μm. ........................................................................................... 137 
Figure B.4 Significantly different trends of layered hydrogel cyclic compression 
response to cyclic compression. Hydrogels were incubated in a cell culture 
incubator for seven days and subsequently subjected to 0-10% unconfined 
cyclic compression for four hours at 1Hz. Peak stresses (± SEM) for each 
cycle were isolated and the trends over the loading period analyzed. 
Trends under unconfined cyclic compression from 0-10% strain for 






Chapter 1: Background and Significance 
1.1 Mesenchymal Stem Cells (MSCs) 
MSCs are a cell population that is increasingly being investigated for therapeutic 
applications. As strictly defined by the International Society for Cellular Therapy, 
MSCs are a bone marrow derived stromal cell population that is plastic adherent, 
positive for the cell surface markers CD105, CD90, CD73, MHC-1, negative for the 
cell surface markers MHC-II, CD11b, CD14, CD34, CD45, CD31, and can 
differentiate in vitro into osteoblasts, chondrocytes, and adipocytes 
1
. However, 
MSCs in clinical use are generally defined as self-renewing multipotent cells that can 
differentiate into cells from all skeletal tissues 
2
. These cells have also been isolated 
from a variety of other tissues 
1,2
. The desire to use MSCs for therapies can be 
attributed to the combined advantages of their differentiation potential, 
immunomodulation properties, paracrine effects, and homing capability 
1,3
. 
Therapeutically, they are thought to only remain transiently in the intended location 
due to cell death or migration, but influence damaged tissue during this time 
4
. MSCs 
are being investigated for the treatment a variety of diseases, including diseases 
affecting orthopaedic tissues such as articular cartilage.  
1.1.1 Current Research in Treating Cartilage Disease 
1.1.1.1 Articular Cartilage Tissue  
Articular cartilage is an aneural and avascular tissue with a low resident cell 
population that is found at the interface of joints. It provides a low friction surface for 
smooth joint articulation and load bearing 
5
. The tissue consists of 70-80% water, 
2 
 
with the remaining solid fraction made up of 50-75% collagen and 15-30% 
proteoglycans 
5
. Cartilage cells, chondrocytes, are responsible for maintenance of the 
tissue 
5
 and nutrients and oxygen diffuse to the cells from the synovial fluid in the 
joint 
5,6
. The cells are surrounded immediately by a pericellular matrix (PCM) 
containing a high concentration of type VI collagen 
7
. Surrounding this PCM and 
making up a large portion of the remaining tissue is type II collagen, which is about 
half of its dry weight 
5
. Other collagen types present in the tissue include types VI, 
IX, XI 
5
. Proteoglycans are large molecules trapped within the tissue’s collagen 
network and are made up of polysaccharide chains or glycosaminoglycans attached to 
protein cores. Aggrecan, the most predominant, has a hyaluronan protein core with 
varying main polysaccharide chains, primarily chondroitin or keratin sulfates 
5,7
. 
Negatively charged proteoglycans are responsible for attracting and maintaining fluid 
within the tissue. This fluid content and its rapid pressurization are responsible for 
supporting and dissipating compressive loads and allowing frictionless joint 
movement 
5,7
. Other proteoglycans include decorin, biglycan, fibromodulin, perlecan, 
versican and lumican 
5,7
.   
1.1.1.2 Osteoarthritis 
While injuries leading to cartilage defects and trauma can be damaging and have long 
lasting impacts on subsequent disease progression, osteoarthritis (OA) is a disease of 
exacerbated dysregulation. The Center for Disease Control and Prevention has 
reported that 22.7% of adults, and 49.7% of adults over the age of 65, have diagnosed 
osteoarthritis 
8
, with symptoms including pain and functional disability 
9
. OA is 
thought to be characterized by an imbalance of catabolic and anabolic regulation, 
3 
 
which is then aggravated by both normal and abnormal loading 
5,7,9
. Increases in 
collagen and aggrecan degradative enzymes, such as matrix metalloproteases (MMPs) 
and aggrecanases break down the main extracellular matrix (ECM) components 
7,9
. 
As the disease progresses, visible fissures develop in the tissue and it loses 
proteoglycans until the tissue is eroded 
5
. While it is unclear what causes the 
pathogenesis of OA, these changes to the tissue are manifested by chondrocytes. They 
lose the ability maintain the tissue in an increasingly adverse environment of 
abnormal loading and inflammation 
7,9
. As the tissue breaks down, the ECM 
5
 and the 
PCM 
10
 become less stiff than normal and even the mechanical properties of OA 
chondrocytes become impaired 
11
. 
1.1.2 Current Therapeutic Outlook for MSCs  
1.1.2.1 Cell Therapy 
As of June 2015, there were almost 500 reported clinical trials using MSCs with the 
greatest number being in the Phase I/II arena 
1
. These trials focused on a wide variety 
of diseases, with bone and cartilage diseases making up the largest percentage, around 
19%, of trials 
1






Figure 1.1 MSC Clinical Trials as of 2015 (n=493). 19.1% (n=94) of trials targeting bone 
and cartilage diseases. Other targeted diseases included Neurological disease (17.8%, 
n=87), Cardiovascular disease (14.8%, n=73) and Graft vs. Host Disease (GVHD) 
(7.2%, n=35). Additional targets included lung, kidney, liver, hematological, and 




Currently, many of the MSC therapies under investigation consist of single or 
multiple intraarticular injections of cells into the joint (Figure 1.2), with the injection 
either being soon after isolation and concentration of the collected cell population or 
after a period of ex vivo expansion, purification, and characterization of the cells 
12
. 
The injected cell dose in most studies varies from 10 million to 100 million MSCs per 
dose 
12–14
.  However, cell death or migration out of the intended location has been 
observed 
4
. For example, cells that remained in a caprine knee joint after injection 
were found to be localized to the meniscal or synovial membrane surfaces rather than 
cartilage tissue 
12,15
 (Figure 1.2). Due to such studies, it has been proposed that 
MSCs’ primary mode of therapeutic action is through coordinating regeneration via 
trophic or immunomodulatory effects, rather than through direct integration with 
degenerated or damaged cartilage tissue 
12,16




Figure 1.2 Schematic of knee joint and intraarticular injection of MSCs.  
 
As of 2016, there were 58 active clinical trials using MSCs to target OA  
4
. Thus far, 
a few trials focused on OA have shown promising results 
1–3
. Direct injection of 
autologous MSCs into osteoarthritic knee cartilage in pilot studies improved cartilage 
tissue and quality of life parameters after 6 
13
 and 12 months 
14
. A 2 year follow-up to 
the one year study demonstrated consistent results, implying a sustained benefit up to 
that point 
17
. These findings are encouraging. However, distinctive healing and 
regeneration, in conjunction with already studied quality of life parameters, remain to 
be achieved and/or measured in many studies. One strategy for improving the 
therapeutic effect of MSCs is to incorporate a biomaterial cell carrier or scaffold, 
which would serve potentially limit cell death and lengthen the time that MSCs are 







1.1.2.2 Tissue Engineering Strategies and Goals 
Tissue engineering strategies combine the use of biomaterials and/or stimulatory 
factors with cells for the treatment and regeneration of tissues. While biomaterial only 
strategies have historically been used in the treatment of cartilage, tissue engineering 
strategies using MSCs for clinical cartilage repair are still very much in their infancy. 
Use of chondrocytes, both in isolation and in conjunction with biomaterials has been 
more widely investigated and used clinically thus far 
4
. In fact, Carticel is a marketed 
autologous chondrocyte therapy used in conjunction with porcine derived collagen 
4
 . 
Comparatively, there is only one biomaterial-MSC product that is being investigated 
and is actually on the market in South Korea: Cartistem using MSCs with hyaluronic 
acid 
4,18
. While chondrocytes have been more widely studied than MSCs up until 
now, their use is limited by a low capacity for stable ex vivo expansion, limited cell 
numbers, and donor site morbidity 
4,19,20
. However, biomaterials that are being 
investigated in conjunction with chondrocytes can also be used with MSCs. A wide 
variety of biomaterials are being researched, including both natural and synthetic 
materials to be used as scaffolds or as injectables 
4,6
. These include the natural 
biomaterials fibrin, hyaluronan, agarose, alginate, and collagen as well as synthetic 
biomaterials such as poly lactic acid and polyethylene glycol 
4,6,19
. Incorporation of 
growth factors into biomaterial scaffolds for MSC therapy could also serve to tune 
their trophic behavior 
12
. While differentiation of MSCs within biomaterial scaffolds 
is common in academia, further research is needed to better understand the governing 




1.1.3 Challenges for Stem Cell-based Therapies 
As clinical research is still in the early stages, there have been many trial failures, 
either due to lack of sufficient data or limited clinical benefit 
2
. However, there have 
been promising initial results that warrant further improvement of MSC therapies. 
There are still many challenges ahead including short residence time 
4,21,22
 and 
unknown mechanisms of action for therapeutic and off target effects, especially due 
to cell source 
2,21,23
. Isolated cell populations are heterogeneous 
3,21,22
, but the 
development of standards and protocols for isolation may help provide consistent cell 
populations for evaluation 
3
. However, potential cell death, limited therapeutic matrix 
formation, mineralization present in cartilage tissue, and growth of fibrous tissue 
instead of healthy cartilage remain as hurdles 
4,22
. The combined use of cells with 
biomaterials introduces additional challenges, including development of scaffold 
materials, optimization of scaffold mechanical properties, and design of in vitro 
culture strategies. The comparative safety, benefit, ease of use, and cost of autologous 
and allogeneic MSCs are also still being evaluated 
22
. Further, uncertainty regarding 
appropriate cell dose, underdeveloped manufacturing processes, and high cost need to 
be resolved 
3,17,21,23
. The limited success in the clinic thus far may simply be an 
indication of the field’s age and potential. Better understanding of MSC source, 
properties, functions, and MSCs’ response to their physical environment is needed to 





 1.2 Behavior of Mesenchymal Stem Cells 
1.2.1 Homing and Adhesion 
Migration of MSCs to damaged tissue, and subsequent engraftment in the tissue, is an 
essential component of their therapeutic function and is an established attribute of 
MSCs 
24–26
. MSCs’ engraftment in new environments, damaged or physiological, 
depends on the characteristics of the environment itself, such as the state of the ECM. 
Adhesion and spreading of MSCs has been shown to be modulated by changes to 
substrate stiffness 
27–29
, substrate composition (e.g. ECM protein) 
28–32
, the density of 
ECM proteins on substrates 
33
, cell shape 
34,35
, and cell size 
36
, with these all affecting 
MSC differentiation. Fibronectin and type I collagen are two ECM proteins that have 
been used in research frequently to promote MSC adhesion to surfaces, as MSCs  
have shown a high affinity for attachment and spreading on them 
31,32
. Further, 
differences in cell area, especially on substrates of different stiffness’, have been 
associated with changes in MSC function and characteristics as well, such as cellular 
stiffness, differentiation potential, and branching of neurogenic MSCs 
27,34,37,38
. 
Substrate stiffness itself has also been correlated with changes in cell area and 
differentiation potential of the cells, specifically soft substrates leading to smaller 




1.2.2 Differentiation - Chondrogenesis 
Another component of MSC therapeutic function is their demonstrated capacity to 
undergo differentiation down multiple lineages, including toward osteoblasts, 
9 
 
adipocytes, myoblasts, tenocytes, chondrocytes, as well as a variety of other cell types 
1
 (Figure 1.2). Chondrogenic differentiation, as with many other lineages, is primarily 
achieved through the use of growth factors, such as those in the transforming growth 
factor-β (TGFβ) family, insulin-like growth factor (IGF) family, or some combination 
of multiple growth factors 
6,20
. The TGFβ family, including TGFβ1, 2, and 3 along 





Chondrogenic differentiation of MSCs is generally conducted in pellet cultures or 
within biomaterials and induced by growth factors of the TGFβ family (Figure 1.3). 
However, high density monolayer culture is also used to verify chondrogenic 
potential. MSC chondrogenesis within pellet cultures is used to recapitulate 
developmental condensation-like differentiation through to terminal hypertrophy 
41,42
. 
However, while MSC pellet cultures are used frequently to examine the progression 
of in vivo-like chondrogenesis, they are impractical for therapeutic use due to their 
size and hypertrophic differentiation. For regenerative or tissue engineering 
applications, growth factors and MSCs are combined within biomaterial scaffolds 
with properties that can be manipulated. These scaffolds can be designed to have an 
interconnected structure, can be biodegradable, can allow for cell attachment and/or 
tissue development, and their mechanical properties can be modulated 
5
. A wide 
variety of materials have been used successfully for chondrogenic differentiation of 






Figure 1.3 Schematic depicting MSC differentiation potential and various chondrogenic 
differentiation culture environments. Schematic adapted from Squillaro, et al (2016)
1
.  
1.2.3 Mechanosensing and mechanical properties 
MSC mechanical properties and their mechanosensitivity are tied to their capacity to 
differentiate 
51–53
. Differentiation of MSCs down different lineages has been found to 
cause changes in MSC mechanical properties 
52–56
. Changes in surface stiffness from 
stiff to soft also promote durotaxis prior to differentiation 
57
. Further, the physical 
properties of MSC environments, such as changes in substrate stiffness, have been 
found to initiate MSC differentiation along different lineages 
27
. Mechanical loading 
11 
 
also typically induces differentiation of MSCs 
51
. A variety of mechanical stimuli, 
including dynamic compression, hydrostatic pressure, osmotic pressure and fluid 
flow, in conjunction with growth factors, have been used to stimulate chondrogenic 
differentiation and the subsequent extracellular matrix deposition and tuning of 
tissue/scaffold mechanical properties 
51,58
.  Loading magnitude, frequency, and 
duration all affect the outcome of the stimulation, but dynamic compression 
43,49,50,58
 
and hydrostatic pressure 
48,58–64
 have been used most frequently to successfully 
promote ECM deposition and increase chondrogenic gene expression. Fluid flow in 
isolation has typically been shown to promote osteogenesis 
65
, but can also stimulate 
fibrocartilage ECM deposition and gene expression 
66
. Aside from effects on 
differentiation, mechanical stimuli, specifically fluid shear stress has been shown to 
potentially promote increases in proliferation and migration through calcium and 
mitogen-activated protein kinase signaling pathways 
65,67–69
. From a therapeutic 
perspective, mechanical loading of MSCs has also been shown to promote the 
secretion of various growth factors 
70
 and MSC spreading on endothelial cell layers 
71
. 
1.3 Vimentin intermediate filaments 
One tool that MSCs use to sense and respond to their physical environment is the 
cytoskeleton, which in MSCs primarily consists of actin microfilaments, 
microtubules, and vimentin intermediate filaments. Together with other proteins, the 
cytoskeleton serves to structurally support cells, allow for cell movement and 
division, assist in mechanosensing, and additionally support the trafficking of 
intracellular molecules 
52,72
. Actin microfilaments have a well-established role in cell 
shape changes, migration, and adhesion 
52,72
. Further, the disruption of actin and the 
12 
 
negative modulation of the RhoA/Rho-associated kinase (ROCK) pathway both 
promote chondrogenesis 
52,73,74
. MSC mechanical properties also appear to be 
dependent on actin microfilaments 
52,56,75,76
. Comparatively, microtubules are 
involved in cell division, organelle and protein transport, as well as cell migration 
72
, 





While actin and microtubules are well studied components of the cytoskeleton, the 
role of vimentin intermediate filaments (IFs) in MSC response to external stimuli still 
requires further clarification. Vimentin is a 57kDa type III intermediate filament 
primarily expressed in cells of the mesenchymal lineage 
77,78
. Structurally, vimentin is 
made up of a central alpha helical rod with head and tail domains 
79
. Together these 
monomers form coiled-coil dimers and then organize into staggered antiparallel 
tetramers (Figure 1.4). Groups of tetramers form unit-length filaments that join to 
form mature vimentin filaments that are involved in cellular function. Vimentin IFs 
connect the cell membrane with the nucleus, promoting transduction of information 






Figure 1.4 Vimentin intermediate filament formation and vimentin in mesenchymal 
stem cells imaged at low and high magnifications. Scale bars 20µm and 10µm, 
respectively. Vimentin = green, F-actin (phalloidin) = red, nucleus (DAPI) = blue. 








1.3.1 Vimentin Involvement in Disease 
Early research suggested that vimentin was not an essential protein; vimentin null 
mice appeared to survive normally without any obvious defects 
82
. However, later 
research found that a lack of vimentin in mice led to impaired wound healing and 
resistance to renal pathologies 
83,84
. Similarly, cerebellar defects, impaired 
equilibrium, altered action coordination, and impaired steroid production were 
observed 
85,86
. Further, vimentin appears to play a role in a variety of diseases. 
Upregulation of vimentin is established as a key marker in the epithelial to 
mesenchymal transition of tumor cells, leading to poor prognosis and metastasis 
78,87,88
. Mutations in vimentin appear to be linked to cataract formation 
89
 and 
antibodies against vimentin with altered post-translation modifications are measured 
to detect early rheumatoid arthritis 
90
. Interestingly, in giant axonal neuropathy, 
vimentin present in non-neural tissues has been found to be disrupted 
80,91
. Vimentin 
has also been found to be disrupted or dispersed in osteoarthritic chondrocytes 
92,93
.  
Damaged osteoarthritic chondrocytes were less stiff, and therefore their stiffness was 
less affected by vimentin disruption, compared to healthy chondrocytes, in which 
vimentin disruption led to a decrease in stiffness 
11
. In contrast, another study found 
that vimentin disruption caused a decrease in stiffness and viscoelastic parameters in 
both healthy and osteoarthritic chondrocytes 
94
. Notably, vimentin has also been 
found to be downregulated in MSCs isolated from osteoarthritic patients 
95
. Taken 
together, altered or absent vimentin is not as benign as originally observed and bears 
further study. Beyond involvement in disease, it has also been found to be involved in 
15 
 
a variety of cellular properties and functions including mechanical properties, cellular 
spreading, and chondrogenesis.  
1.3.2 Vimentin in Cellular Mechanosensitivity and Mechanical Properties 
Vimentin filaments are thought to maintain cellular integrity due to their intrinsic 
mechanical properties. They have actually been found to have a strain dependent 
response to load; at low strain vimentin networks remain less rigid, but then harden at 
high strains and resist breakage 
96,97
. Their properties make vimentin filaments a part 
of the cellular machinery that is involved in maintaining or adapting cellular 
mechanical properties in response to manipulation or loads. Correspondingly, 
vimentin has been tied to the ability of cells to transduce the effects of fluid shear 
stresses 
98
 and are physically displaced within endothelial cells in response to fluid 
shear in vitro 
99
. Similarly, they have been shown to be involved in the dilatory 
response to fluid shear flow in harvested arteries 
100
. There is evidence that vimentin 
responds to various mechanical loads through reorganization. This has been observed 
with changing environmental stiffness 
101





, compressive load 
102
, and single impact loads 
103
. There is still growing 
evidence as to how vimentin participates in mechanotransduction, but research 





Vimentin has also been found to be critically involved in the mechanical properties of 
cells 
97
. Well spread vimentin-null fibroblasts were found to have decreased 
cytoplasmic stiffness, but not cortical stiffness 
111
. In other studies, vimentin-null 
16 
 
fibroblasts, endothelial cells, and cancer cells were found in general to have decreased 
cellular stiffness 
38,88,112,113
. Similarly, vimentin-deficient fibroblasts exhibited 
impaired stiffening capacity, cellular mechanical stability at high strain, and 
decreased contractility
112,113
, but the effect on contractility may be substrate and cell 
density specific 
38
. Comparatively, increases in vimentin lead to increases in cellular 
stiffness 
114,115
. While these measurements were taken in cells that were spread on a 
substrate, suspended or semi-suspended cells demonstrated similar decreases in 
cellular mechanical properties in response to vimentin disruption. Vimentin network 
collapse due to pharmacological drug treatment led to a decrease in cellular stiffness 
in lymphocytes 
116
 and natural killer cells 
117
. Similarly, disruption of vimentin in 
chondrocytes or chondrocyte-like cells yielded a decrease in elastic moduli and 
viscoelasticity parameters 
11,94,118
. In contrast, other studies found that disruption of 
vimentin decreased compressibility of chondrocytes 
119
.   
1.3.3 Vimentin in Cellular Spreading and Adhesion 
Vimentin IFs have also been found to be involved in cellular adhesion and spreading 
in a variety of cell types. Vimentin deficiency been linked to slower adhesion by 
cancer cells 
87,120
, decreased adhesion strength when subjected to fluid flow 
105
, and 
altered adhesion structure formation (i.e. focal adhesions). Vimentin filament co-
localization with vinculin-positive focal adhesions has been long established 
121
 and 
vimentin deficiency has been linked to smaller and fewer vinculin-positive focal 
adhesions in cancer cells 
88
. Comparatively, in vimentin-null fibroblasts, focal 
adhesions were found to be irregular and did not organize into distinct and separate 
contacts as assessed through vinculin and talin visualization 
113
. Vimentin IFs have 
17 
 
also been shown to physically interact with a variety of integrin subunits including 
αVβ3, α2β1, α6β4, α5β1, as well as β3 and β1 integrin subunits 
104–110
. Vimentin 
deficiency yielded smaller αVβ3 integrin-positive focal adhesions in endothelial cells 
105
 and it was also shown to affect the expression of β1 integrin subunits. A decrease 
in vimentin has led to decreases in  β1 integrin subunit protein levels as well as cell 
surface β1 integrin subunits 
88,107
. Comparatively, overexpression of vimentin has 
been observed to lead to an increase in β1 integrin subunit levels 
88
. It has been 
suggested that these interactions between vimentin, focal adhesions, and integrin 
subunits may be tied to cytoskeletal linker proteins such as plectin and filamin A, 




Vimentin has also been implicated in maintenance of chondrocyte phenotype or early 
stage chondrogenesis of progenitor cells. However, studies evaluating vimentin-null 
mice did not assess deleterious effects of vimentin-deficiency on articular cartilage 
development 
82–84
. Studies disrupting vimentin or decreasing vimentin found 
decreased chondrogenic gene expression in chondrocytes and in chondrogenic MSCs 
123,124
. Disruption of vimentin in chondrocytes resulted in decreased aggrecan and 
collagen gene expression, sulfated glycosaminoglycan (sGAG) and collagen 
degradation, and collagen synthesis 
123
. A decrease of vimentin in progenitor cells 
similarly caused decreased aggrecan and type II collagen gene expression as well as 
sGAG and type II collagen deposition 
124
. However, these studies were conducted in 
the early stages of in vitro culture and it is not yet clear whether vimentin influences 
chondrogenesis over longer culture times. Studies have also suggested that vimentin 
18 
 
is involved in sensing hydrostatic pressure loading used for the stimulation of 
chondrogenic differentiation. The change from punctuated vimentin organization to 
diffuse organization was found to be associated with hydrostatic pressure stimulation 
of  chondrogenesis 
101
. Thus, it appears the vimentin may have some influence on the 
progression and stimulation of chondrogenesis. 
1.4 Methods for Manipulating Vimentin 
Studies evaluating vimentin use a variety of techniques to manipulate vimentin 
networks for study. Vimentin-null mice and the isolation of then vimentin-null cells 
has been used 
38,111,113,125
. However, simpler and more cost-effective techniques are 
also commonly implemented in research to approximate the effect of complete 
ablation of vimentin expression such as the use of pharmacological disrupters 
11,94,116–
118,126
, introduction of oncogenes 
127
 and mutated proteins 
128
, and RNA interference 
98,105,124
.   
1.4.1 Disruption of the Vimentin network 
Manipulation of the cytoskeleton is often achieved by using chemical disruptors. 
Specifically for vimentin, the most commonly used chemical disruptor is acrylamide 
11,94,112,118,119,123,126,129,130
, however withaferin A 
117
 and calyculin A 
116
 have also been 
used to similar effect. Withaferin A causes disruption and aggregation of vimentin 
while Calyculin A targets vimentin phosphatases inducing disruption of the vimentin 
network 
97
. Calyculin A however exhibits off target effects due to its impact on other 
cellular phosphatases 
97
. Acrylamide treatment has been seen to cause a perinuclear 
collapse and aggregation of vimentin 
112,123,126,129,130
 as well as diffuse vimentin 
19 
 
staining throughout the cell 
94
. Perinuclear collapse of the vimentin network has also 
been induced by the overexpression of the oncogene simian virus 40 large T antigen 
127
, and microinjection of vimentin mimetic/dominant-negative mutant peptides 
131,132
. 
Aggregation and elimination of vimentin has similarly been observed through 
overexpression of gigaxonin 
91
. Interestingly, treatment with platelet derived growth 




While acrylamide is the most widely used disruptor, in MSCs, we’ve observed off 
target effects on actin (Figure 1.5). This has also been seen in some other cell types, 
with the theory being that a minor disruption of vimentin yields an indirect effect on 
actin organization 
118,119
. After treatment with a variety of acrylamide concentrations 
(0.4mM, 2mM, 4mM, 15mM, and 40mM) and treatment durations (3hr, 4hr, and 9hr), 
vimentin network disruption was not observed in isolation from cytoplasmic collapse 
(Figure 1.5). Unfortunately, whenever cytoplasmic collapse was observed, F-actin 
organization was also completely disrupted (Figure1.5). As actin has been well 
established as being involved in cellular mechanical properties and behaviors such as 
cellular spreading and adhesion, using acrylamide to attempt to interrogate the role of 




Figure 1.5 Acrylamide disruption of vimentin in hMSCs. Vimentin=green, F-actin 
(Phalloidin)=red A. Disruption of vimentin in hMSCs (Lonza) using 15mM acrylamide 
for 4 hours. Scale Bar: 25µm. B.  Disruption of vimentin in hMSCs (RoosterBio) using 
40mM acrylamide for 3 hours. Lower cell density and shorter culture time used in B in 
comparison to A and C.  Scale Bar: 50µm. C. Concentration dependency of acrylamide-
based disruption of vimentin in hMSC (Lonza) after 9 hours. Scale Bar: 40µm. 
Disruption of actin seen as punctuated spots of staining instead of visible fibers. 
1.4.2 RNA Interference 
An alternative method for manipulating vimentin, which was used in this body of 
work, is RNA interference (RNAi). This is a commonly used technique to manipulate 
gene expression products and knock down the expression of a gene of interest. While 
it has been investigated for use in therapeutics, it is also being used extensively in the 
research sector. This technique uses an inherent cellular pathway and machinery that 
cells use to respond to the presence of foreign double-stranded RNA, as shown in 
Figure 1.6 
134
. In short, complementary double stranded short hairpin RNA (shRNA) 
21 
 
is introduced into cells and this is then cut by a ribonuclease, Dicer, into small 
interfering RNA (siRNA). siRNA can be directly introduced into cells, bypassing this 
step. Next, a protein complex, RISC, binds to these siRNA and separates the two 
strands. One strand is degraded and the other strand is used as a template to bind and 
degrade any sequences that are complementary to it. The shRNA can be designed to 
have strands that are complementary to the mRNA of the gene of interest. The RISC 
complex uses the siRNA template strand to find and bind to the mRNA of the gene of 
interest, in this case, vimentin, and then degrades it. Once the mRNA is degraded, the 
RISC complex bound to the siRNA template strand remains and continues to find and 
bind to more mRNA, thereby decreasing the vimentin available in the cell. This 
knockdown effect, however, is diluted by continued cell division. Regardless, siRNA 
has been used successfully to decrease vimentin expression in a number of cell types 






Figure 1.6 Schematic of shRNA-based RNAi 
 
However, to increase the knockdown effect duration, alternative shRNA delivery 
methods must be used, such as inducing the cells to express these shRNAs 
intracellularly long term. Viral delivery can be used to achieve this. Essentially, 
oligonucleotides containing the shRNA sequence are cloned into a viral vector. There 
are a variety of viral vectors that have been used with RNAi including adenovirus, 
adeno-associated virus, retrovirus, and a subset of retrovirus called lentivirus 
134
. 
However, only retroviruses and lentiviruses incorporate their DNA into the host 
genome, which allows for extended expression of the shRNA sequence. Further, 
lentiviruses can transduce both dividing and non-dividing cells increasing their utility 
23 
 
for research purposes. Lentiviruses can also be made replication incompetent, 
improving the safety of the virus for use.  
 
To increase the versatility of this technique, the shRNA viral vector can be further 
manipulated. In the case of this body of work, the viral vector chosen included the 
capacity to turn the shRNA expression on and off. The promoter for the shRNA 
expression is blocked by a repressor protein until doxycycline binds to it. In the 
presence of doxycycline, the promoter region is free to proceed with the transcription 
of the shRNA and the subsequent knockdown of vimentin. This system provides the 
ability to manipulate the timing of shRNA expression.  
1.5 Significance and Specific Aims 
MSCs demonstrate potential for use in cell therapies and in tissue engineering. 
Understanding of how MSCs sense and respond to their environment, whether it is 
responding to external load, sensing of extracellular matrix proteins, or differentiation 
cues, will help to clarify how therapeutic MSCs will react to different physical 
stimuli. Their ability to interact with and respond to their environment is tied to the 
cytoskeleton, of which vimentin’s contribution to MSC behavior is still being 
explored. Vimentin has been found to influence cellular mechanical properties, 
mechanosensitivity, and cellular adhesion. Further, as aberrant vimentin expression or 
organization has been found in osteoarthritic chondrocytes, MSCs from osteoarthritis 
patients, and in cancer cells, there is a clear need to understand how vimentin is 
influences cellular behavior. Specifically, as MSCs from osteoarthritic patients have 
been found to have altered expression of vimentin, the use of autologous MSCs from 
24 
 
this patient population for a therapeutic purpose could be influenced by changes in 
vimentin expression, motivating a need for a better understanding of vimentin’s role 
in MSC behavior. The global hypothesis of this set of studies is that vimentin 
intermediate filaments contribute significantly to how MSCs respond to different 
physical and micro-environments. To test this hypothesis, vimentin expression was 
decreased using lentiviral shRNA targeting vimentin in MSCs and these cells were 
then used to examine cellular response to varying physical stimuli through the 
following aims:  
1.5.1 Aim 1: Determine if vimentin contributes to mesenchymal stem cell 
deformability. 
The first objective of this project was to determine the relationship between the 
vimentin intermediate filament network and the deformability of the MSCs in 
response to the compression of their external environment. Further, it was to evaluate 
whether other cytoskeletal proteins play a compensatory role in this response. Our 
hypothesis was that decreasing the vimentin levels in MSCs would lead to an increase 
in deformability. 
1.5.2 Aim 2: Evaluate vimentin’s influence on mesenchymal stem cell spreading in 
response to different microenvironmental conditions. 
The second objective was to determine if vimentin intermediate filaments are 
involved MSC spreading and if their influence is dependent on environmental cues, 
such as different substrate protein coating, substrate stiffness, and low fluid shear 
stress. Further, it was to determine if adhesion proteins were affected by vimentin 
25 
 
deficiency. We hypothesized that a decrease in vimentin would lead to altered cell 
spreading due to interactions with focal adhesions in different microenvironments. 
1.5.3 Aim 3: Determine if an initially intact vimentin network is required for 
chondrogenic differentiation 
As vimentin is thought to be involved in short term chondrogenesis and chondrocyte 
phenotype maintenance, this final objective was to determine if vimentin intermediate 
filaments are involved in long term in vitro chondrogenesis up to 14 and 21 days in 
two different culture environments: pellet cultures and agarose hydrogel cultures.  
Our hypothesis was that the chondrogenesis of MSCs with an initially decreased 
vimentin level would ultimately lead decreased chondrogenic extracellular matrix 
deposition.   
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Chapter 2: Deformability of Human Mesenchymal Stem Cells Is 




Mesenchymal stem cells (MSCs) have recently shown promise as a therapeutic cell 
source for the treatment of many diseases, including osteoarthritis 
13,135
. However, 
osteoarthritic cartilage presents a challenging environment for therapeutic MSCs, 
injected systemically or implanted within a biomaterial scaffold, due to the abnormal 
biochemical and mechanical environment 
136,137
. One characteristic of this mechanical 
environment is regular compression that deforms the tissue and chondrocytes, 
eliciting extracellular matrix protein expression 
50,138–142
. Response to mechanical 
stresses is partially governed by cellular mechanical properties. Changes in MSC 
mechanical properties have been found to be related to both their physical 
environment and differentiation potential 
52–55
. Mechanical properties and 
mechanotransduction are in part regulated by the cytoskeleton, consisting primarily of 
actin microfilaments, microtubules, and vimentin intermediate filaments (IFs) for 
cells of mesenchymal lineage 
55,56,75,76,94,112,113,118,119
. While their role in the 
pathogenesis of OA is still unknown, vimentin IFs have recently been found to be 
disrupted or dispersed in osteoarthritic chondrocytes 
92,93
. Notably, vimentin has also 
been shown to be downregulated in MSCs of osteoarthritic patients 
95
, which raises 
                                                 
1
 This work has been published in the Annals of Biomedical Engineering and is 
reproduced here with permission from the publisher.  
Sharma, P., Bolten, Z.T., Wagner, D.R., Hsieh, A.H. Deformability of Human 
Mesenchymal Stem Cells Is Dependent on Vimentin Intermediate Filaments. Ann 




questions about the potential efficacy of autologous stem cell therapies for treatment 
of OA.  
 
The role of vimentin is  still being examined using a variety of techniques to decrease, 
disrupt, or collapse vimentin IFs, but it is clear that they are involved in modulating 
the mechanical properties of cells. In fibroblasts, mutations resulting in vimentin 
deficiency have been linked to not only impaired migration, but also reduction of 
mechanical stability and stiffness of the cytoplasm 
111,112
. Further, in these cells, 
decreases in vimentin led to compromised ability for fibroblasts to contract collagen 




Perinuclear collapse of vimentin networks in fibroblasts has also been induced using 
proteins, such as the oncogene simian virus 40 large T antigen 
127
 or one variant of 
mutated desmin 
128
. Oncogene expression-dependent collapse of the vimentin 
network in fibroblasts caused an increase in cellular stiffness, which supports 
vimentin IFs association with tumor invasion and tumor cell stiffness 
127
. IF collapse 
caused by mutated desmin revealed a complex distribution of cellular stiffness with 
increased cellular stiffness in regions of the collapsed vimentin and a decrease in 




Collapse of the vimentin network has also been induced by pharmacological 
inhibitors such as withaferin A 
117
, calyculin A 
116
, and acrylamide 
11,94,118,126
. Non-
adherent cell populations or cells suspended in hydrogels have revealed decreases in 
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cellular mechanical properties with the use of pharmacological inhibitors. 
Specifically, in chondrocytes and chondrocyte-like cells, disruption of vimentin 
networks using acrylamide resulted in decreased elastic moduli and viscoelasticity, as 
measured by atomic force microscopy and micropipette aspiration, as well as a 
decrease in deformability 
11,94,118,126
. Likewise, in T lymphocytes and natural killer 




Much of the research investigating how vimentin intermediate filaments contribute to 
cell mechanics and function has been conducted in fibroblasts by introducing the 
expression of abnormal proteins or pharmacological inhibitors, which may have off 
target effects that can influence the measurement of cellular stiffness. However, 
whether vimentin IFs similarly affect the biophysical properties of MSCs has not 
been established and an improved understanding of how IFs are involved in 
mechanosensing and mechanical properties of MSCs will be valuable for interpreting 
outcomes from stem cell therapies. In this study, we examine the relationship between 
MSCs’ capacity to deform under external compression and the involvement of 
vimentin IFs using shRNA mediated RNA interference (RNAi). The aim is to 
investigate the effect of a decreased vimentin IF network on MSC deformability 
independent of effects from cell-substrate adhesion and long culture times. Our 
results suggest that a decrease in vimentin IFs paradoxically reduces the 
deformability of MSCs, potentially due to changes in the manner by which actin 





2.2 Materials and Methods 
2.2.1 hMSC cell culture 
For initial lentiviral construct screening experiments, hMSCs from Lonza 
(Walkersville, MD) were expanded per manufacturer’s instructions and used at 
passage 5 (P.5). For subsequent experiments, population doubling level (PDL) 9 bone 
marrow derived human mesenchymal stem cells (hMSCs) (RoosterBio; Frederick, 
MD) were expanded using RoosterBio Enriched Basal media supplemented with 
GTX Booster (RoosterBio) per manufacturer instructions and used at PDL 13-18 
hMSCs (approximately 4-5 passages). All subsequent subculture for lentiviral 
transduction and experimentation was completed using hMSC growth media: high 
glucose DMEM containing 4mM L-Glutamine (Gibco) supplemented with 10% fetal 
bovine serum (FBS) (Gibco), 100 U/mL Penicillin Streptomycin (Gibco), 1% MEM 
non-essential amino acids (Gibco), and 4 mM L-Glutamine (Gibco). Complete media 
exchange was completed every 2-3 days and the cells were maintained at 5% CO2 and 
at 37ᵒC.  
2.2.2 Lentivirus design and generation 
52 nt shRNA sense-loop-antisense sequences were designed and selected from human 
vimentin [Gen Bank: NM_003380] mRNA using the shRNA Designer through 
Biosettia, Inc. Single strand oligonucleotides were annealed and these double 
stranded oligos were then ligated into an inducible lentiviral RNAi vector conveying 
resistance to blasticidin and a TetO -H1 promoter following manufacturer 
instructions. This inducible system only allows shRNA transcription to take place in 
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the presence of tetracycline antibiotics, specifically doxycycline. The pLV-RNAi kit 
and pLV-Pack Packaging mix (Biosettia) were used to generate the shRNA constructs 
and package into replication-deficient lentivirus using HEK 293FT cells and 
Lipofectamine 2000.  Two sequences were evaluated, listed in Table 2.1, and a 
control shRNA lentiviral vector targeting the LacZ gene was used (Biosettia). Virus-
containing supernatants were collected 72hr post transfection and stored at -80ᵒC until 
use.  
Table 2.1 shRNA sequences screened for effective vimentin knockdown in hMSCs. 
Grey indicates overhang or loop shRNA 
 
4.2.3 shRNA transduction 
We performed hMSC transduction with the shVim-vector for 24hrs at a multiplicity 
of infection (MOI) of 15. Cells transduced with a shLacZ-vector and non-transduced 
cells were used as controls. Transduction was completed in the presence of 6µg/ml 
hexadimethrine bromide (Polybrene) (Sigma) to assist with transduction efficiency. 
Titered viral concentrations for an MOI of 15 were determined through a Quanti-IT 
PicoGreen Assay (Invitrogen). Two days post-infection, pure populations were 
selected using 12µg/ml Blasticidin for 4 days. Both shVim-hMSCs and shLacZ-
hMSCs were cultured in the presence of 1µg/ml doxycycline to induce RNAi. Cells 
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were cultured for 7, 14, or 21 days on tissue culture plastic before being harvested to 
be assayed.  
2.2.4 Western blotting 
To quantify levels of vimentin protein translation, cells were transduced and 
induction carried out for 7, 14, and 21 days. Cells were harvested and resuspended in 
a lysis buffer (50mM HEPES, 150mM sodium chloride, 1% Triton X-100, 1mM 
EDTA, 10mM Na-pyrophosphate, 10% glycerin) supplemented with a 1:100 
concentration of protease inhibitor cocktail (Fisher Scientific). Protein concentrations 
were determined using a modified Lowry assay with a Folin-phenol color reaction 
detected by a ND-1000 spectophotometer (Nanodrop). After sample removal, the 
supernatant was mixed at a concentration of 1:1 with a loading buffer (13% (v/v) 
Tris-HCl, 20% (v/v) glycerol, 4.6% (w/v) SDS, 0.02% (w/v) bromophenol blue, 200 
mM dithiothreitol). Samples and a human vimentin protein positive control were 
subjected to SDS-PAGE using pre-cast Criterion Tris-HCl gels (BioRad). 293FT 
HEK cell lysate was used as a protein positive control for β-actin. Approximately 9µg 
of protein from each sample was loaded into the Criterion Tris-HCl gels. After SDS-
PAGE, proteins were electrophoretically transferred to a polyvinylidene fluoride 
membrane and detected using a rabbit IgG anti-human vimentin primary antibody 
(ThermoFisher) and Vectastain ABC-AmP for chromogenic detection. Detection of 
β-actin using a mouse IgG anti-human β-actin primary antibody was used as a loading 
control. Semi-quantitative analysis was completed using ImageJ (NIH) to determine 
band intensities and protein expression levels were determined relative to non-
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infected cells. For semi-quantitative analysis of vimentin protein expression levels, 
the top band of the cluster was used, as it aligns with the positive protein control.  
2.2.5 Immunofluorescence imaging 
To visualize decrease in translated vimentin protein in 2D cultures, vimentin RNAi 
was induced for 7 and 14 days. Sham control (shLacZ) samples were performed in 
parallel. As an additional control, non-transduced cells were subjected to the RNAi-
inducing agent (1µg/ml doxycycline) for 14 days to determine its potential effects on 
cytoskeletal organization. Cells were fixed with 4% paraformaldehyde and 
permeabilized using 0.1% Triton X-100.  Cells were labelled with either rabbit IgG 
anti-human vimentin primary antibody (ThermoFisher) or mouse IgG anti-human 
tubulin primary antibody (Santa Cruz) and visualized with biotinylated (anti-rabbit 
IgG or anti-mouse IgG) secondary antibodies (Vector) and fluorescein-labelled 
streptavidin (Vector). F-actin filaments were then stained with Alexafluor 594 
phalloidin (Invitrogen), and the nucleus labelled with DAPI (Invitrogen). 
Fluorescence images were taken at 100x magnification with an Olympus IX81 
microscope.   
To visualize the cytoskeleton in agarose gels, vimentin RNAi was induced for 14 
days before being harvested. Sham control (shLacZ) samples were performed in 
parallel. Cells were then resuspended in 4% (w/v) agarose and pipetted into a 6mm x 
3mm diameter mold, followed by overnight fixation in 4% paraformaldehyde. These 
were infiltrated with 30% sucrose, embedded in Tissue-Tek O.C.T compound 
(Sakura), and then stored at -80ᵒC until sectioning. Frozen sections (20µm) were 
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created using an HM550 series cryostat (Richard Allen Scientific). These sections 
were labelled with either rabbit IgG anti-human vimentin primary antibody 
(ThermoFisher) or rabbit IgG anti-human tubulin primary antibody (Abcam) and 
visualized with biotinylated anti-rabbit IgG secondary antibodies (Vector) and 
fluorescein-labelled streptavidin (Vector). In additional sections, F-actin filaments 
were stained with Alexafluor 488 Phalloidin (Invitrogen) and the nucleus stained 
using Slow Fade Gold anti-fade reagent with DAPI (Invitrogen). Confocal 
fluorescence images were taken at 600x magnification with a Nipkow (spinning) 
disk-equipped Olympus IX81 microscope. Confocal Z-stacks (1 µm slices) of the 
entire cells were taken and projected into a single image for analysis.  Fluorescence 
intensity of labelled proteins was quantified using Image J (NIH) 
143
. Cells were 
manually traced and corrected total cell fluorescence intensity measurements per cell 
area were calculated using the following equation: corrected total cellular 
fluorescence (CTCF) = (Integrated Density – (Area of selected cell x mean 
fluorescence of background reading)) / Cell Area (pixels). Data are shown as mean 
CTCF + s.e.m.  
2.2.6 Cell deformation 
To measure cell deformation, after 14 days of inducing vimentin (and LacZ) RNAi 
cells were incubated with Cell Tracker Green CMFDA (Invitrogen) to stain the cell 
cytoplasm. Subsequently, 300-400k cells were resuspended in 2% (w/v) or 4% (w/v) 
agarose and pipetted into a 6mm x 6mm x 10mm mold. After gels solidified, they 
were placed into a custom microscope-mounted micrometer-controlled deformation 
device 
126
. This process took at least two hours from time of trypsinization. Samples 
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were then subjected to 0, 10, and 20% uniaxial bulk compressive strain. Fluorescence 
images of cells were generated at 400x magnification and cell diameters in the 
loading direction and perpendicular to the loading direction were measured using 
ImageJ (NIH). Analysis was performed similar to a previously study 
126
. Aspect ratios 
(ARs) were calculated as cell diameter in the loading direction/ cell diameter 
perpendicular to load, and the deformed population ARs were then normalized to the 
undeformed population ARs. Data are shown as mean normalized aspect ratio ± 
standard deviation. 
2.2.7 Cytoskeletal disruption 
To determine the effect of microfilament and microtubule disruption on the shVim-
hMSC and shLacZ-hMSC deformability, after 14-15 days of RNAi induction cells 
were incubated with CMFDA live cell tracker (Invitrogen). Afterward 300-400k cells 
were resuspended in 4% (w/v) agarose and pipetted into a 6mm x 6mm x 10mm 
mold. Following encapsulation and prior to deformation, cell-agarose constructs were 
incubated with either 20µM colchicine or 9.85µM cytochalasin D for 3hr in 37ᵒC at 
5% CO2 to disrupt microtubules or actin microfilaments, respectively 
126
. Agarose 
blocks were subjected to strain and the images analyzed, as described above. Data are 
shown as mean aspect ratio + standard deviation.   
2.2.8 Statistical Analysis 
Statistical analyses for all studies were performed using non-parametric Kruskal-
Wallis tests followed by a Mann-Whitney post-hoc for pairwise analysis using the 




2.3.1 Inducible lentiviral shRNA mediated knockdown of vimentin expression in 
hMSCs 
Initially, two shRNA vectors (Table 2.1), designed using different locations within 
the gene, were assessed for effectiveness in decreasing vimentin expression over 14 
days in the presence of 1 µg/ml doxycycline, the highest recommended dose. Because 
shVim1 yielded greater RNAi than shVim2 (Figure 2.1A), it was used for all 
subsequent experiments and is henceforth referred to as shVim. Cultures of shVim-
transduced hMSCs exhibited approximately a 30% decrease in vimentin expression 
after 14 days of induction, as determined by Western blot in the initial screen and in 
experiments to further characterize the vimentin knockdown by shVim (Figure 2.1A, 
2.1B). A decrease in vimentin protein was visible as seen by immunofluorescence in 
cells seeded on tissue culture plastic and in agarose hydrogels (Figure 2.1C, 2.1D, 
Figure 2.2). Visually, we confirmed that 1 µg/ml doxycycline had negligible effect on 
the organization of vimentin, tubulin, and F-actin in 2-D culture (Figure 2.1E).  Based 
on these results, it was determined that inducing RNAi for at least 14 days 
sufficiently knocked down vimentin protein levels, and this minimum induction 




Figure 2.1 Characterization of vimentin knockdown in hMSCs. a. Two lentiviral vectors 
were screened using western blots and immunostaining on Day 14. In Western blots, 
‘+Cntl’ is a purified vimentin protein positive control for Vim and a 293FT HEK cell 
lysate for B-Act. Scale bar: 50µm. b. Characterization of knockdown by Western blot 
on days 7, 14, and 21 of shRNA induction. ‘+Cntl’ is purified vimentin protein for Vim 
and 293FT HEK cell lysate for B-Act. c. Observation of vimentin knockdown by 
immunostaining on days 3, 7, and 14 of shRNA induction; vimentin (green), F-actin 
(red), nucleus (blue). Scale bar: 50µm. d. Observation of vimentin knockdown in 
agarose hydrogel; vimentin (green), nucleus (blue). Scale bar: 50µm. e. Effect of 1µg/ml 
doxycycline treatment on cytoskeletal proteins of control, non-transduced, hMSCs. 




Figure 2.2 Characterization of vimentin knockdown at day 14. Representative 
fluorescence images of non-transduced, shLacZ-hMSCs, and shVim-hMSCs each 
labelled by immunostaining for vimentin (green) or phalloidin staining for F-actin (red). 
Scale Bar: 50µm.   
2.3.2. Vimentin knockdown reduces hMSC deformability  
Knockdown of vimentin expression over 14 days resulted in decreased deformability 
of cells compared to both non-transduced hMSCs and shLacZ hMSCs in 4% agarose 
hydrogels. Compression of shVim-hMSCs yielded significantly higher normalized 
aspect ratios (Figure 2.2A), or smaller deformations, compared to non-transduced 
hMSCs at 10% (p=0.003) and 20% (p<0.0005) strain (Figure 2.2B), as well as 
compared to shLacZ-hMSCs at 20% strain (p<0.0005). We found no significant 
difference between shLacZ-hMSCs and non-transduced hMSCs, indicating that 
lentiviral transduction did not significantly affect cellular deformability (10%, 
p=0.528; 20%, p=0.913; Figure 2.2B). Interestingly, no significant difference was 
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observed between any of the groups during deformation within the 2% agarose gels 
(10%, p=0.182; 20% p=0.093; Figure 2.2C). Further, it was found that doxycycline 
treatment itself did not convey any resistance to the hMSCs (Figure 2.2D). After 14 
days of 1 µg/ml doxycycline treatment, no significant difference in deformation was 
observed between untreated and treated hMSCs in 4% agarose gels in any strain 
group (10%, p=0.929; 20%, p=0.383).   
 
Figure 2.3 Cell Deformation of Vimentin-deficient hMSCs. Normalized aspect ratios of 
cells subjected to 0%, 10%, or 20% strain. a. Depiction of deformation and calculations. 
b. Deformation of control, non-transduced, hMSCs, shLacZ-hMSCs, shVim-hMSCs in 
4% agarose hydrogels. c. Deformation of control, non-transduced, hMSCs, shLacZ-
hMSCs, shVim-hMSCs in 2% agarose hydrogels. d. Deformation of control, non-
transduced, hMSCs with or without treatment with 1µg/ml doxycycline for 14 days. All 
data are expressed as mean aspect ratio ± SD. Asterisks represent statistically 




2.3.3. Functional role of actin filaments, but not microtubules, is altered by vimentin 
knockdown 
To determine whether the reduced deformability of shVim-hMSCs was caused by 
changes in the actin or microtubule network, we exposed transduced cells seeded in 
4% agarose to either cytochalasin D or colchicine, respectively. The non-transduced 
hMSCs sample group was not included in this experiment, because these cells were 
found to have no significant difference in deformability compared with shLacZ-
hMSCs (Figure 2.2). Comparisons in this experiment focused only on the effect of 
vimentin knockdown to the sham (shLacZ) control. After disruption of the 
microtubule network, shVim-hMSCs remained significantly less deformable at both 
10% (p=0.007) and 20% (p=0.001) strain compared to shLacZ-hMSCs (Figure 2.3A). 
In contrast, disrupting the actin microfilament network resulted in comparable cell 
deformations between shVim-hMSCs and shLacZ-hMSCs (Figure 2.3B). Normalized 
aspect ratios were still slightly higher for shVim-hMSCs compared to shLacZ-




Figure 2.4 Effect of Cytoskeletal Disruption on Cell Deformation. Normalized aspect 
ratios of shVim-hMSCs and shLacZ-hMSCs subjected to 0%, 10%, or 20% strain after 
chemical disruption of actin microfilaments or tubulin microtubules. a. Deformation of 
shLacZ-hMSCs and shVim-hMSCs after actin microfilament disruption b. Deformation 
of shLacZ-hMSCs and shVim-hMSCs after microtubule disruption All data are 
expressed as mean aspect ratio ± SD. Asterisks represent statistically significant 
differences (p< 0.05). 
2.3.4. Cytoskeletal organization and quantity in agarose embedded hMSCs 
To further investigate the involvement of the actin or tubulin networks in the 
deformation of shRNA transduced cell populations, cytoskeletal protein content was 
semi-quantitatively determined from fluorescence microscopy of non-deformed cells.  
It was found that shVim-hMSCs and shLacZ-hMSCs did not have statistically 
significant differences in fluorescence intensities of F-actin staining (p=0.267) 
(Figure 2.4). However, the microtubule network fluorescence intensity was 
significantly lower in the shVim-hMSCs compared to the shLacZ-hMSCs (p=0.01) 




Figure 2.5 F-actin microfilament and Tubulin microtubule fluorescence intensity in 
shVim-hMSCs and shLacZ-hMSCs. Fluorescent intensity measurements of shLacZ-
hMSCs and shVim-hMSCs stained for F-Actin  and tubulin. All data are expressed as 
CTCF ± s.e.m. Asterisks represent statistically significant differences (p < 0.05). Scale 
bar: 50µm. 
2.4 Discussion 
Recently, studies have found vimentin IFs to be disrupted in chondrocytes and even 
in MSCs harvested from osteoarthritic bone marrow 
92,93,95
.  Because mechanical 
loading is a strong regulator of cell behavior, we investigated how an altered vimentin 
network affects deformation of hMSCs during loading of agarose constructs. As a 
major component of the cytoskeleton, vimentin IFs are involved in the cellular 
response to mechanical loading and in modulating cellular mechanical properties. 
However, extracellular matrix and substrate stiffness also introduce changes in cell 
shape and cytoskeletal tension via adhesion complexes 
52
. Thus, the mechanical 
behavior of a cell is highly complex and context-dependent. 
 
In this study, we focused on the deformation of MSCs in an experimental system that 
minimizes the ability for cells to interact physically with their surrounding 
microenvironment. As MSCs are not habitually unattached to extracellular matrix, 
this study provides a snapshot of the intrinsic deformability of undifferentiated MSCs. 
To prevent cell-matrix interactions, which would confound measurements of intrinsic 
deformability, we examined deformation of cells embedded in agarose hydrogels 






Contrary to expectations, our experiments showed that in 4% agarose hydrogels 
MSCs with decreased vimentin expression are more resistant to deformation 
compared to control cells. In an attempt to elucidate the mechanism behind this 
phenomenon, we additionally disrupted either actin microfilaments or microtubules. 
Although cells were generally more deformable with either treatment, only disruption 
of actin microfilaments eliminated the difference in deformability between shLacZ 
and shVim cells. That vimentin-deficient MSCs maintained a significantly greater 
resistance to deformation with microtubule disruption suggests a less prominent role 
for microtubules. Semi-quantitative measurement of the fluorescence intensity of 
immunostaining for F-actin and tubulin yielded further insight. Since actin 
fluorescence was unchanged, microfilament organization rather than quantity may be 
involved in the decreased deformability. The lower fluorescence intensity of the 
tubulin in shVim-hMSCs implies that the decrease in microtubules and organization 
of the actin microfilaments may work cooperatively to enhance resistance to cell 
deformation. 
 
One obvious limitation of our RNAi approach is that vimentin IF expression is not 
completely ablated, unlike in fibroblasts isolated from vimentin null mice 
112,113
. On 
the other hand, our approach precludes any compensatory mechanisms that cells may 
develop physiologically in a knockout animal. Because vimentin continued to be 
expressed, albeit at a decreased level, we did not observe a complete collapse in the 




. It is possible that the remaining vimentin network consists primarily of larger 
filaments, rather than the more diverse network of larger and smaller filaments that 
might support that strain normally. While large filaments were not observed in the 
immunostaining, Western blots did show a decrease in the smaller fragments in the 
knockdown cells compared to the control cells (Figure 2.1B).  
 
The increased resistance to deformation that we observed in the MSCs with decreased 
vimentin appears to contradict much of the literature in this area. Whole cell 
deformation experiments using chondrocytes and immune cells with chemically 
disrupted vimentin networks have resulted in mechanically less stiff and more 
deformable cells 
11,94,116–118
, though it is questionable how specific these treatments 
are for a given cytoskeletal target. Likewise in anchored vimentin-deficient 
fibroblasts, torsional loads applied via cell adhesions resulted in decreased stiffening 
or cytoplasmic rupture, suggesting that without vimentin, cells are mechanically 
unstable and unable to stiffen in response to load 
112,113
. It is not clear at this time how 
much our unexpected findings might be explained by the lack of cell-matrix 
attachment and the 3D hydrogel microenvironment of our experimental system.  
 
Other studies, however, observed trends that are consistent with our results. One 
study reported a decrease in compressibility of acrylamide-treated chondrocytes 
119
. 
The authors postulated that vimentin IFs act as tensional elements preventing 
elongation orthogonal to the direction of compression, while microtubules prevent the 
compression of cells along the loading axis. Our data suggest that the actin 
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microfilaments may play a more significant role in the resistance to deformation in 
the presence of a diminished vimentin network. Interestingly, dose-dependency of 
acrylamide treatment can also affect mechanical properties, implying a nonlinear 
relationship between the organization of vimentin and any change in cellular 
mechanical properties 
94
. Disruption of vimentin in chondrocytes using acrylamide 
was found to affect mechanical properties measured by micropipette aspiration only 
at high concentrations 
94
. Further, we have shown previously that chondrogenic 
hMSCs treated with this same high concentration of acrylamide trended toward 
increased deformability, but without statistically significant results 
126
. In this study, 
we did not observe a complete collapse of the vimentin network, and this could be 
why we see a dissimilar response to deformation in vimentin-deficient MSCs.   
 
One critical parameter of this study is the choice of culture duration in the agarose 
hydrogel. Without significant culture time, cells would not be able to develop 
adhesion moieties that could subvert the deformation results. It has been observed 
that cytoskeletal proteins will undergo reorganization over chondrocyte culture time 
in agarose hydrogels over the timescale of days 
144
, implying that the cytoskeletal 
organization is dynamic over time. Here, we allowed a brief recovery after transfer to 
3D culture in an attempt to capture an environment that simulates how vimentin may 
be involved in mechanosensing when hMSCs are first placed into a carrier 
biomaterial for therapy just prior to implantation. However, observations of cellular 
deformability at different stages in culture could provide more information about cell 
deformability and how microtubules and actin microfilaments reorganize to 
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compensate for a less robust vimentin network over time. Further, longer culture 
periods would allow insight into changes in cellular phenotype due to 3-D culture, 
and changes in cellular behavior with the deposition of extracellular matrix. 
 
The mechanical loads experienced by hMSCs in our experimental system are 
analogous to inclusions that deform within a loaded bulk porous material, which 
compounds the complexity of factors – beyond those associated with the cytoskeleton 
– that contribute to the cell deformation results. On a superficial level, the 
measurements that were made using 2% and 4% agarose can provide some insight 
into the balance of stiffness between cells and their surrounding material. In 2% 
agarose, cells deformed less across all groups than in 4% agarose, whose modulus is 
roughly five times that of 2% 
145
. It is possible that, due to the lower modulus of 2% 
agarose, cells were not subjected to sufficiently high compressive loads to resolve 
differences between shVim- and shLacZ-hMSC deformabilities. Delving deeper, 
some studies have shown differences in cytoskeletal organization with different 
agarose concentrations 
101
.  Further, the non-linear mechanics of the cells might be 
distinct between shVim- and shLacZ-hMSCs, where deformation may be similar 
under low load, but distinct at high load. Our previous work on chondrogenic hMSCs 
deficient in type VI collagen 
146
 is one example of such behavior.  
 
Some important aspects of cell deformation that we were not able to explore in this 
study include potential anisotropy of cell deformation, which would require more 
time consuming confocal imaging and 3D strain analysis of cells, as well as the 
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possibility of discontinuities at the cell-gel interface due to differential stiffnesses that 
could interfere with analysis of cellular deformation. A more rigorous mechanical 
analysis of how cell deformability is governed in this complex system is certainly 
warranted. In this particular study, we chose a more straightforward approach to 
characterizing cell deformation in order to collect sufficient data for statistical 
comparisons between treatment groups. 
 
While deformability measured by whole cell compression in 3D and stiffness 
measurements of anchored cells on a planar substrate yield different mechanical 
property relationships, it may be possible to relate the two sets of characteristics with 
further investigation. It has been speculated that the reduced mechanical stability 
observed in vimentin negative fibroblasts may not necessarily be directly correlated 
with cellular flexibility, implying that their ability to withstand large deformations, 
e.g. migration through small pores, could be impaired 
113
. We have also observed 
impaired chemotactic migration in the vimentin knockdown MSCs and further found 
that robust vimentin networks may be required for migration through small pores 
(unpublished data). Further analysis of this phenomenon may shed light on the 
relationship between our observed deformation behavior in unanchored cells and cells 
experiencing mechanical stimuli due to adhesion and cytoskeletal remodeling during 
migration.  
 
One variable of this study that has not been systematically studied in stem cells is 
MOI used for lentiviral transduction and its potential effects on cellular physiology. 
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In order for us to achieve the desired knockdown of a gene as robustly expressed as 
vimentin, a relatively high MOI was required. Our previous studies using lentivirus-
mediated RNAi in hMSCs had shown no detrimental effects on differentiation 
146
, but 
those prior experiments had used lower MOI. Though we did not observe any overt 
differences in morphology in any cells used for this present study, it is possible that 
other aspects of stem cell function may have been affected, independent from 
decreased vimentin. There has been some anecdotal evidence that MOI-dependent 
effects may be important. 
 
This study reveals a unique relationship between vimentin IFs and MSCs’ capacity to 
deform due to external whole cell compression. Our observations suggest that 
deformability of MSCs is dependent on the robustness of the vimentin IF network in 
unanchored cells. Varying expression and organization of vimentin in healthy and 
diseased cells may affect the mechanical properties, and consequently the 
mechanotransduction, of these cells. Literature suggests that vimentin disruption or 
absence is present in osteoarthritic chondrocytes and even mesenchymal stem cells 
from osteoarthritic patients, but it is not yet clear if this change is a symptom of the 
developing disease environment or an early actor in disease progression. In addition 
to examining vimentin’s role in the intrinsic properties of MSCs in agarose hydrogels, 
this study sheds initial light onto changes to mechanical properties that may occur to 
hMSCs due to an abrogated vimentin network that may be relevant in a cell therapy 
environment. Our observations introduce another variable and piece of information in 




The objective of this first Aim was to determine whether vimentin IFs are involved in 
the capacity for MSCs to deform, and we found that they are, if in an unexpected 
way. As mentioned above, deformation of chondrocytes within the load bearing 
environment of articular cartilage occurs as a result of the regular tissue compression 
and such compression can have functional outcomes such as changes in extracellular 
matrix protein expression 
50,138–142
. Thus, it is valuable to understand how MSCs 
entering such as environment may be affected by the compression, and how vimentin 
may contribute. The findings in this Aim suggest that the effect of decreasing the 
amount of vimentin in hMSCs is not completely separate from the remainder of the 
cytoskeleton, which can compensate for the vimentin deficiency when subjected to 
compression caused by the deformation of the environment. Further, cell-ECM 
interactions are likely to affect deformability of MSCs, perhaps differently if the 
vimentin networks are decreased. Thus, we decided to move our focus away from 
examining cell deformability and instead evaluated the role of vimentin in MSC 
spreading in response to different microenvironments, such as surfaces coated with 




Chapter 3: Vimentin Intermediate filaments influence Mesenchymal 
Stem Cell Spreading on Fibronectin  
3.1 Introduction 
Mesenchymal stem cells (MSCs), increasingly being investigated for therapeutic use, 
respond to a variety of extracellular cues. External stimuli can include extracellular 
matrix (ECM) proteins available for adhesion 
32





, and other biochemical and physical cues. Understanding the 
mechanisms that drive cellular response to the environment can motivate further 
development of MSC-based therapies. Cells transduce external stimuli using a variety 
of mechanisms, including through cytoskeletal proteins, of which vimentin 
intermediate filaments (IFs) have recently gained notice for their involvement in 
sensing the extracellular environment. However, this role for vimentin IFs in the 
MSC response to different microenvironments remains to be clarified.   
 
A variety of environmental characteristics can modulate the spreading and adhesion 
of MSCs. These include changes to substrate composition (e.g. extracellular matrix 
(ECM) protein/binding moieties) 
28–32
, the density of ECM proteins on substrates 
33
, 
and substrate stiffness 
27–29
, with all of these cues also tuning MSC differentiation 
toward different lineages. Of the variety of ECM proteins that MSCs bind to, 
fibronectin and type I collagen are used frequently to promote MSC adhesion to 
surfaces due to MSCs’ high affinity for binding to these proteins compared to other 
ECM molecules like laminin 
28,29,31,32
. Differences in cell spreading and area, 
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especially on different stiffness environments, have been shown to correspond with 
changes in MSC function and characteristics as well, such as cellular stiffness and 
differentiation potential 
34,37
. Vimentin IFs potentially influence cellular spreading to 
these proteins through interactions with cell adhesion structures, specifically focal 
adhesions 
88,105,113,114,121
. They have also been found to directly interact with integrins 




In addition to the composition of the ECM environment, mechanical stimuli, such as 
variations in substrate stiffness and mechanical loading affect MSC behavior and 
function. For example, such stimuli have been shown to initiate or promote MSC 
differentiation along different lineages 
27–29,51,58
. Softer substrate stiffness, where cells 
are typically smaller, is correlated with adipogenic or neural differentiation, while 
stiffer substrate stiffness, where cells are typically more spread, is more associated 
with osteogenic or myogenic differentiation 
27,29,39,40
. A variety of mechanical loading 
regimens have been used to promote MSC differentiation including fluid flow, which 
typically promotes osteogenesis 
51,147
. However, perfusion bioreactors have had 
success with chondrogenesis 
58,148
. Aside from effects on differentiation, fluid shear 
stress has been shown to promote proliferation, migration, and activation of calcium 
and mitogen-activated protein kinase (MAPK) signaling pathways in MSCs 
65,67–69
. 
Further, low shear stresses have been found to promote fibrocartilaginous ECM 
deposition and gene expression 
66
 and MSC spreading on endothelial cell layers 
71
. 
Vimentin IFs may be involved in how MSCs respond to such physical stimuli as they 
have been found to be a mechanosensitive cellular element. Not only is vimentin 
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solubility affected by changes in substrate stiffness 
149
, but it has also been found to 
be involved in cellular spreading in a substrate specific manner 
38
. Further, vimentin 
IFs reorganize in response to mechanical loading in chondrogenic MSCs and 
chondrocytes 
101–103
 and also appears to be involved in the mechanotransduction of 




Altogether, while vimentin has been implicated in a variety of cellular response 
mechanisms in different cell populations, understanding of their influence on MSC 
behavior specifically is still lacking. In this study, we focused on vimentin IF’s 
influence on MSC spreading in response to different microenvironments, specifically 
ECM proteins, substrate stiffness, and low fluid shear stress. Vimentin appears to be 
involved in MSC spreading on fibronectin-coated stiff substrates. The observed 
behavior is potentially due to vimentin’s interaction with focal adhesion structures in 
MSCs when spreading on fibronectin. Further, vimentin may play a 
mechanoprotective role in resisting cell area changes in response to fluid shear stress. 
Altogether, vimentin appears to influence MSC spreading response to a variety of 
microenvironments.  
3.2 Materials and Methods 
3.2.1 hMSC Cell Culture 
Population doubling level (PDL) 9 bone marrow derived human mesenchymal stem 
cells (hMSCs) (RoosterBio; Frederick, MD) were expanded using RoosterBio 
Enriched Basal media containing GTX Booster (RoosterBio) per manufacturer 
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instructions. All subsequent subculture for lentiviral transduction and experimentation 
was completed using hMSC growth media: high glucose DMEM containing 4 mM L-
Glutamine (Gibco) supplemented with 10% fetal bovine serum (FBS) (Gibco), 100 
U/mL Penicillin-Streptomycin (Gibco), and 1% MEM non-essential amino acids 
(Gibco). All experimentation with hMSCs cultured in growth media was completed 
with PDL 13–18 hMSCs (approximately 4–5 passages). Complete media exchange 
was completed every 2–3 days and the cells were maintained at 5% CO2 and at 37ᵒC. 
3.2.2 shRNA Transduction 
hMSC transduction was performed with either the shVim lentiviral vector (5’-
AAAAGGCAGAAGAATGGTACAAATTGGATCCATTTGTACCATTCTTCTGC
C-3’) or the control, shLacZ lentiviral vector (5’-
GCAGTTATCTGGAAGATCAGGTTGGATCCAACCTGATCTTCCAGATAACT
GC-3’), for 24hr at a multiplicity of infection (MOI) of 15, as previously described 
150
. Transduction was completed with 6 µg/ml hexadimethrine bromide (Polybrene) 
(Sigma) supplemented in the media to assist with transduction efficiency. Titered 
viral concentrations for an MOI of 15 were determined through a Quanti-IT 
PicoGreen Assay (Invitrogen). Two days after infection, pure populations were 
selected using 12µg/ml Blasticidin for 4 days. Both shVim-hMSCs and shLacZ-
hMSCs were cultured in the presence of 1µg/ml doxycycline to induce RNAi for 14 
days on tissue culture plastic before being harvested to be assayed in all of the 
following experiments. All subsequent culture of the shLacZ- and shVim-hMSCs was 
also conducted in the presence of 1µg/mL doxycycline.  
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3.2.3 Cellular Spreading  
To determine the effect of substrate protein on cellular spreading, 25mm diameter 
glass coverslips were corona-treated for approximately 20s to make the surface more 
hydrophilic (Electro-Technic Products). After UV sterilization, coverslips were 
coated with 10µg/ml human fibronectin (FN), 50µg/ml FN, 10µg/ml Type I rat tail 
collagen (COL I), or 50µg/ml COL I overnight at 4ᵒC. shLacZ- and shVim-hMSCs 
were then seeded onto the coverslips and allowed to spread for approximately 2hrs or 
24hrs. At these times, cells were fixed with 4% paraformaldehyde and stored in 
phosphate buffered saline (PBS) at 4ᵒC until imaging.  
To determine the effect of surface stiffness on cellular spreading, 25mm diameter 
glass coverslips were amine-activated using 3-aminopropyltrimethoxysilane. 5kPa 
(8% Acrylamide, 0.07%  N,N’-Methylene bisacrylamide) and 13kPa (8% 
Acrylamide, 0.2% N,N’-Methylene bisacrylamide) polyacrylamide gels were formed 
onto these coverslips 
151
. These gels were then activated with Sulfo-SANPAH and 
coated with 10µg/ml FN overnight at 4ᵒC. shLacZ- and shVim-hMSCs were seeded 
onto the gels and allowed to spread for 24hr. Cells were then fixed with 4% 
paraformaldehyde and stored in PBS at 4ᵒC until imaging.  
To determine the effect of fluid shear stress on cellular spreading, after 14-19 days of 
shRNA induction, shLacZ- and shVim-hMSCs were seeded into Ibidi µ-Slide I 0.2 
chamber slides that had been coated with 10µg/ml FN for 1hr at room temperature 
and allowed to spread overnight. Reciprocal fluid shear at 1dyne/cm
2
 was then 
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applied for 4hr with 30min periods of alternating flow direction. After 4hr, cells were 
fixed with 4% paraformaldehyde and stored in PBS at 4ᵒC until imaging.  
For all samples, phase contrast images were taken at ×100 magnification with an 
Olympus IX81 microscope and ImageJ was used to determine the cellular areas 
and/or cell circularity.  
3.2.4 Gene Expression 
Gene expression was assessed using quantitative reverse transcription polymerase 
chain reaction (qRT-PCR) as previously described 
146
. On day 14 of shRNA 
induction, cells cultured on tissue culture polystyrene were resuspended in TRIzol 
and RNA was isolated per manufacturer’s instructions through chloroform separation 
and isopropanol precipitation. Total RNA was then reverse transcribed. Gene 
expression was analyzed using qRT-PCR (MyiQ System, BioRad, CA) with primers 
designed for human genes (Table 3.1). Expression levels for ITGAV, ITGA2, ITGB1, 
and ITGB3 and the housekeeping gene 18S were determined using the ΔΔCt method. 
Cycle threshold (Ct) values were averaged and the ΔCt was calculated by subtracting 
the average 18S Ct values from the average Ct values for the genes of interest. ΔΔCt 
values for genes of interest were calculated by subtracting the shLacZ-hMSC ΔCt 
values from the shVim-hMSC ΔCt values. Relative gene expression levels (fold 
difference) were calculated using the exponential relationship of 2
-ΔΔCt
. Data are 









Table 3.1 Sequences of primers used for qRT-PCR 
Gene Forward and Reverse Sequences GenBank accession no. 
18S 
5'- AAACGGCTACCACATCCAAG -3' 
NR_003286 
5'- CCTCCAATGGATCCTCGTTA -3' 
ITGA2 
5'- AGTGGCTTTCCTGAGAACCG -3' 
NM_002203.3 
5'- GATCAAGCCGAGGCTCATGT -3' 
ITGAV 
5'- TTTCGGATCAAGTGGCAGAA -3' 
NM_002210.4 
5'- TCCTTGCTGCTCTTGGAACTC -3' 
ITGB1 
5'- ATCTGCGAGTGTGGTGTCTG -3' 
NM_002211.3 
5'- AAGGCTCTGCACTGAACACA -3' 
ITGB3 
5'- TGCGAGTGTGACGACTTCTC -3' 
NM_000212.2 
5'- GTCCAGTCGGAGTCACACAG -3' 
3.2.5 Western Blotting 
On day 14 of induction, cells cultured on tissue culture polystyrene were harvested 
and resuspended in a lysis buffer (50 mM HEPES, 150 mM sodium chloride, 1% 
Triton X-100, 1 mM EDTA, 10 mM Na-pyrophosphate, 10% glycerin) containing a 
1:100 concentration of a protease inhibitor cocktail (Fisher Scientific). Protein 
concentrations were determined through a modified Lowry assay with a Folin-phenol 
color reaction detected by an ND-1000 spectophotometer (Nanodrop). The protein 
solution was mixed at a concentration of 1:1 with a loading buffer [13% (v/v) Tris–
HCl, 20% (v/v) glycerol, 4.6% (w/v) SDS, 0.02% (w/v) bromophenol blue, 200 mM 
dithiothreitol]. Samples were subjected to SDS-PAGE using pre-cast Criterion Tris–
HCl gels (BioRad). Approximately 3 µg of protein from each sample was loaded into 
gels. After SDS-PAGE, proteins were transferred electrophoretically to a 
polyvinylidene fluoride membrane and the vinculin content labelled using a mouse 
IgG anti-human vinculin primary antibody (ThermoFisher). Vinculin content was 
visualized using a Vectastain ABC-AmP kit for chromogenic detection. GAPDH 
visualization using a rabbit IgG anti-human GAPDH primary antibody was used as a 
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loading control. Semi-quantitative analysis was completed using ImageJ (NIH) to 
determine band intensities. 
3.2.6 Immunofluorescence and focal adhesion analysis 
To visualize changes to focal adhesions, 25mm diameter glass coverslips were 
corona-treated for approximately 20s to make the surface more hydrophilic. After UV 
sterilization, coverslips were coated with 10µg/ml human fibronectin (FN) overnight 
at 4ᵒC. shLacZ- and shVim-hMSCs were then seeded onto the coverslips and allowed 
to spread for 24hrs. Cells were fixed with 4% paraformaldehyde and stored in 
phosphate buffered saline (PBS) at 4ᵒC until staining. Cells were then permeabilized 
using 0.1% Triton X-100 and blocked with 1.5% normal goat serum. Cells were 
labelled with a mouse IgG anti-human vinculin primary antibody (Thermo Fisher) 
and visualized with biotinylated AlexaFluor594-tagged anti-mouse IgG secondary 
antibody (Invitrogen). The nucleus was stained with DAPI (Invitrogen). Fluorescence 
images were taken at ×600 magnification with an Olympus IX81 microscope. The 
areas of focal adhesions in cells were determined using ImageJ’s particle analyzer 
feature. 
3.2.7 Statistical Analysis 
Statistical differences in cellular spreading and focal adhesion areas were analyzed by 
first comparing among the groups using the non-parametric Kruskal-Wallis test. Pair-
wise analyses were conducted using Mann-Whitney test; Cell area, α = 0.01; Focal 
adhesion area, α = 0.05. Differences in gene expression and western blotting, were 




3.3.1 Vimentin influences cell spreading on fibronectin coated surfaces 
To evaluate the role of vimentin in sensing different extracellular matrices, hMSCs 
were seeded onto glass coverslips coated with low and high concentrations of FN or 
COL I and allowed to attach for either 2hr or 24hr. After 2hr, shVim-hMSC areas 
were significantly smaller on FN regardless of concentration, while shLacZ-hMSC 
areas were not (Figure 3.1). No significant differences between shLacZ- and shVim-
hMSC areas were found on COL I regardless of concentration. After 2hr of spreading 
time, no significant differences in the circularity of shLacZ– or shVim-hMSCs were 
measured when spread on any of the surfaces. However, both shLacZ- and shVim-
hMSCs were the least rounded on the higher concentration of COL I. Interestingly, 
with both cell populations, an increase in COL I concentration resulted in a decrease 
in circularity, whereas an increase in FN concentration resulted in an increase in 
circularity. Both cell populations were more rounded on the higher concentration of 
FN than COL I, but behaved similarly on the lower concentrations of the two 




Figure 3.1 shLacZ- and shVim-hMSCs spreading and circularity after 2hrs. A. Area 
measurement of cells seeded on type I collagen and fibronectin. *p<0.01 between 
shLacZ- and shVim-hMSCs seeded on the same surface. A,B,D p<0.01 between shLacZ-
hMSCs seeded on different surfaces. x,y,z, p<0.01 between shVim-hMSCs seeded on 
different surfaces. n=140-280 cells. B. Measurement of circularity of cells seeded on type 
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I collagen and fibronectin. A,B,C p<0.01 between shLacZ-hMSCs seeded on different 
surfaces. x,y,z p<0.01 between shVim-hMSCs seeded on different surfaces. n=140-280 
cells.  
 
After 24hrs, shVim-hMSC areas were also significantly smaller than shLacZ-hMSCs 
on FN regardless of concentration (Figure 3.2). However, compared to the cell 
spreading measured at 2hr, shVim-hMSCs were smaller than the shLacZ-hMSCs on 
the higher concentration of COL I as well. No differences were observed on the lower 
concentration of COL I. Both shLacZ- and shVim-hMSCs also has larger cell areas 
with increasing FN concentration, but not on COL I.  Circularity was not measured as 
the cells were highly spread by this point. As the spreading was similarly affected on 
the FN coated surfaces at both 2hr and 24hr, we chose to focus on the relationship 






Figure 3.2 Cell spreading of shLacZ- and shVim-hMSCs after 24hrs. Area measurement 
of cells seeded on type I collagen and fibronectin. *p<0.01 between shLacZ- and shVim-
hMSCs seeded on the same surface. A,B p<0.01 between shLacZ-hMSCs seeded on 
different surfaces. x,y p<0.01 between shVim-hMSCs seeded on different surfaces. 
n=70-155 cells.  
3.3.2 Vimentin may preferentially influence cell spreading on fibronectin-coated stiff 
substrates   
Next, we examined how this relationship between vimentin and MSC spreading on 
fibronectin coated substrate is affected by substrate stiffness. Both shLacZ- and 
shVim-hMSCs had larger areas on 13kPa stiffness polyacrylamide gels compared to 
the 5kPa stiffness gels (Figure 3.3). shVim-hMSCs were significantly smaller on the 
13kPa gels compared to the shLacZ-hMSCs (Figure3.3). However, the cell areas were 




Figure 3.3 Effect of varying substrate stiffness on cell spreading of shLacZ- and shVim-
hMSCs. Top: Representative images of cells visualized using phase contrast microscopy. 
Scale bar 50µm. Bottom: Cell area measurement of shLacZ- and shVim-hMSCs seeded 
on fibronectin (10µg/ml) coated substrates of varying (5kPa vs. 13kPa) stiffness. 
*p<0.01, n=185-230 cells. 
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3.3.3 Vimentin may provide resistance to cell area changes in response to fluid shear 
stress   
Next, we examined the effect of low fluid shear stress on MSCs spreading on 
fibronectin. shLacZ-hMSCs subjected to fluid shear did not have different cell areas 
from those subjected to static conditions. Comparatively, shVim-hMSCs subjected to 
fluid shear stress were significantly smaller than those subjected to static conditions 
(Figure 3.4). shVim-hMSCs were also smaller than the shLacZ-hMSCs when 
comparing populations that were subjected to fluid shear stress (Figure 3.4).   
 
Figure 3.4 Cell spreading of shLacZ- and shVim-hMSCs in response to fluid shear 
stress. shLacZ- and shVim-hMSCs were seeded in 10ug/ml fibronectin-coated Ibidi µ-
Slide I 0.2 chamber slides subjected to reciprocal fluid flow for 4 hours at 1dyne/cm
2
 
fluid shear stress with change in direction every 30min. *p<0.01, n=125-280 cells.  
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3.3.4 Vimentin deficiency does not impact hMSC integrin gene expression and 
vinculin quantity 
To examine the relationship between vimentin deficiency and cell spreading related 
molecules, integrin subunit gene expression of cells cultured on tissue culture 
polystyrene was assessed, but no significant differences were observed in the gene 
expression of αV, β3, α2, or β1 integrin subunits between shLacZ- and shVim-
hMSCs (Figure 3.5A). As gene expression of these adhesion proteins appeared to be 
unaffected by vimentin deficiency, the quantity of the focal adhesion protein vinculin 
in cells cultured on tissue culture polystyrene was analyzed through western blotting, 
but again no significant differences in vinculin levels were observed between shLacZ- 




Figure 3.5 Gene expression and western blotting of shLacZ- and shVim-hMSCs 
cultured on tissue culture polystyrene. A. Relative gene expression levels (fold 
difference) were calculated using the exponential relationship of 2
-ΔΔCt
. Data are shown 





range and shVim-hMSC gene expression relative to shLacZ-hMSC gene expression.  
p<0.05, n=3. B. Vinculin protein levels as measured by western blotting. Relative 
percent change of vinculin expression of the shVim-hMSCs relative to the shLacZ-
hMSCs, both normalized to the GAPDH expression, mean. p<0.05, n=3. 
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3.3.5 Vimentin deficiency limits focal adhesion size in MSCs spread on fibronectin 
Based on the gene expression and western blotting results, a more direct effect of 
vimentin deficiency on adhesion structures when the cells were spread on fibronectin 
was analyzed. Specifically, the size of focal adhesions in cells seeded on fibronectin-
coated cover glass was assessed. Focal adhesions measured through quantitation of 
vinculin fluorescence intensity were found to be smaller in shVim-hMSCs compared 
to shLacZ-hMSCs (Figure 3.6). 
 
Figure 3.6 Vinculin focal adhesion areas. Areas of focal adhesions were quantified by 
ImageJ measurements of vinculin immunostaining fluorescence intensity in selected 
areas of shLacZ- and shVim-hMSCs seeded on fibronectin-coated glass coverslips.  





The extracellular environment has been shown to strongly influence MSC behavior. 
The mechanisms by which MSCs respond to external cues are complex and use a 
variety of cellular systems, including the cytoskeleton, working together to respond to 
changes in the environment. Vimentin IFs are increasingly being shown to be 





. Therefore, in this study, we chose to explore the influence of 
vimentin IFs on cellular spreading in response to different microenvironmental cues.   
 
Initially, cell spreading on substrates coated with type I collagen and fibronectin was 
analyzed. Vimentin appears to be necessary for unimpaired hMSC spreading on 
fibronectin from an early stage of spreading onward (Figure 3.1, 3.2), as the 
vimentin-deficient cells were smaller than control cells on fibronectin, but not on type 
I collagen, except at the highest concentration of collagen at 24hr. Further, this study 
suggests that the vimentin-dependent spreading response to fibronectin may be 
specific to stiff environments, rather than soft (Figure 3.3), as a difference in cell area 
was only apparent on the stiff polyacrylamide gels and not the soft gels. Previously, 
the influence of vimentin on cell spreading has primarily been assessed in vimentin-
null mouse embryonic fibroblasts (mEFs) and the opposite has been observed 
38
. Not 
only were vimentin-null mEFs found to spread faster on both fibronectin and collagen 
compared to control cells, but were also smaller on softer fibronectin-coated 
polyacrylamide gels compared to stiff gels. These discrepancies are likely due to the 




In addition to ECM proteins and environmental stiffness, MSCs are also responsive to 
fluid shear stresses 
51,66,71,147
. Thus, the relationship between vimentin, hMSC 
spreading, and low fluid shear stress was analyzed. Specifically, the shear stress of 
1dyne/cm
2
 was assessed, as this low level of shear stress has been shown to promote 
MSC fibro-cartilaginous ECM deposition, especially type II collagen, and 





 is in the physiological range of leukocyte 
recruitment in low shear areas of arterial circulation and postcapillary venules 
71
, 
which can be potentially applied to MSCs traversing the same areas. In fact, 
1dyne/cm
2
 has been shown to promote MSC spreading on tumor necrosis factor α-




Our results suggest that vimentin may be necessary to resist cell area changes in 
response to this low fluid shear stress, as the control cells did not exhibit any area 
changes between fluid shear and static conditions, while the vimentin-deficient cells 
were smaller in response to fluid flow compared to their static controls (Figure 3.4). 
This is supported by previous work where vimentin, along with α-actinin and filamin 
A, content increased in osteoblasts in response to fluid flow, exhibiting a proposed 
mechanoprotective role 
152
. Interestingly, higher shear stresses have resulted in the 
inability for vimentin-deficient endothelial cells to remain attached and these cells 
have also been found to have impaired focal adhesion formation 
105
. It is possible that 
vimentin-deficient hMSCs would behave similarly when exposed to higher shear 
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stresses. Previous research also suggests that our results may be explained by 
impaired recruitment of integrin subunits. β1 integrin subunit recruitment to focal 
contacts has been observed in osteoblasts stimulated by fluid shear stress 
153
. 
However, vimentin-deficient cells have been found to have fewer β1 integrins at the 
cell surface as well as lower β1 integrin protein levels 
88,107
. This lack of β1 integrins 
could potentially impair normal mechanotransduction of fluid shear stress. While 
changes to cell area were the main focus of this study, future analysis of integrin 
subunit recruitment to cell surface and signaling through proteins such as IL-1β or 
those in the MAPK family 
69
 would serve to enhance understanding of how vimentin 
transduces the effects of this low shear stress.   
 
As spreading of hMSCs on fibronectin, on stiffer surfaces, and in response to fluid 
shear stress appears to be influenced by vimentin IFs, the effect of vimentin 
deficiency on adhesion proteins was examined. However, decreasing vimentin levels 
in hMSCs did not yield any effect at the transcriptional or translational level on the 
integrin subunit gene expression and vinculin protein levels that were examined in 
vimentin-deficient and control cells cultured on tissue culture polystyrene (Figure 
3.5). Contrary to our gene expression and western blotting findings, in cancer cells, 
complete vimentin knockdown has been found to result in decreased protein levels of 
vinculin, β1 integrin, and the cytoskeletal linker filamin A 
88
. However, as vimentin 
deficiency in hMSCs led to a decrease in vinculin-positive focal adhesion size (Figure 
3.6), it is possible that vimentin primarily influences MSC behavior at a localized, 




Previous work has found similar results, with vimentin expression inhibition leading 
to smaller vinculin-positive 
88
 and αVβ3-positive 
105
 focal adhesions. Vimentin has 
also been found to interact with αV, β3, and α2 integrin subunits as well as with α2β1 
integrins in endothelial cells and with αVβ3 integrins associated with vinculin-
positive focal contacts 
104,106
. In fact, it was observed that vimentin filaments were 
unable to interact with focal adhesion kinase-positive focal adhesions in the absence 
of β3 integrins 
109
. Vimentin has also been found to interact with β1 integrins, in 
conjunction with focal adhesion protein talin, to modulate binding of Chinese hamster 
ovary (CHO) cells to fibronectin 
154
. Further, knockdown of vimentin in human 
embryonic kidney (HEK) cells resulted in not only fewer β1 cell surface integrins, but 
also impaired cell spreading on collagen as measured by a decreased number of 




αVβ3 integrins are known to bind to fibronectin and β1 integrin subunits are part of 
integrins that bind to both collagen and fibronectin 
155
. These binding partners 
coupled with the previous research suggest that vimentin’s influence on cellular 
spreading on fibronectin observed here may also involve vimentin-integrin 
interactions. Interestingly, previous work has shown that hMSCs internalize activated 
β1 integrins from the cell surface on collagen-coated soft (0.1-1kPa) substrates 
compared to stiff (50-100kPa) substrates 
156
. This internalization may occur on both 
fibronectin and collagen as β1 integrin subunits are part of integrins that bind to both 
155
. If so, this internalization may indicate a mechanism to explain our findings that on 
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a soft substrate vimentin-deficiency did not significantly alter cell spreading, 
implying that vimentin does not play a strong role in cell spreading on soft surfaces. 
Especially as vimentin appears to interact with β1 integrin subunits 
88,107,154
. It also 
implies a relationship between β1 integrin subunits and vimentin-dependent spreading 
on stiff substrates and potentially specifically on fibronectin.    
 
 Cytoskeletal linkers such as filamin A and plectin have both been associated with 
vimentin IFs and focal adhesions. Filamin A not only associates with vimentin during 
cell spreading, but also binds to vimentin directly and serves to regulate β1 dependent 
adhesion to collagen in conjunction with vimentin 
107
. Similarly, recruitment of 
vimentin IFs to focal adhesions has been shown to involve plectin isoforms 
109,122
. A 
better understanding of vimentin’s interactions with different focal adhesion proteins, 
integrins, and cytoskeletal linkers will help expand understanding of how vimentin 
influences cellular spreading.  
 
This study is primarily limited by the use of a RNA interference system to decrease 
the quantity of vimentin rather than ablate it completely, as has been previously used 
in vimentin-deficient mice 
113
. The use of an RNAi system, however, prevents any 
unforeseen compensation that might occur in knockout conditions. As demonstrated 
by the discrepancy in the gene expression and western blotting data with literature, 
more complete knockdown of vimentin may change the effects that we have 
observed. Alternatively, the culture of these cells on fibronectin or collagen could 
also affect our gene expression and western blotting observations. Similarly, the use 
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of a high multiplicity of infection and doxycycline for shRNA induction may affect 
our findings. Another interesting observation was that the control cells and vimentin-
deficient cells did not exhibit differences in cell area in the static controls during the 
fluid shear study, as was expected based on spreading on the fibronectin-coated glass 
coverslips and the polyacrylamide gels. This is attributed to the fibronectin adsorption 
time: overnight at 4°C for the coverslips and gels and 1hr at room temperature for the 
microfluidics chambers. We presume differences in adsorption time affected 
fibronectin deposition, either by configuration or quantity. 
 
This study reveals a new relationship between MSC spreading, fibronectin, and 
vimentin IFs. Our observations suggest that a complete vimentin IF network is 
needed for unimpaired spreading of MSCs on fibronectin in stiff environments. 
Further, vimentin may be needed for resisting cell area changes in response to low 
fluid shear stresses. It appears that these changes in cell spreading may be tied to how 
an intact vimentin network affects focal adhesions and their formation, potentially 
with a dependence on integrins. These interactions clearly suggest that continued 
research into the role of vimentin intermediate filaments within MSCs will be 
necessary to better understand MSC behavior in differing microenvironments.   
 
3.5 Conclusion 
The objective of this second Aim was to examine if vimentin IFs influence cellular 
spreading in a variety of microenvironments, and they do appear to, based on our 
findings. MSC area has been correlated with functional changes, such as changes to 
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cell stiffness and differentiation potential 
34,37
. Understanding how vimentin 
influences cell area can help to clarify how it might be involved in the MSC 
functional response to their physical environment. Our findings appear to show that 
vimentin is involved in changes to MSC in multiple microenvironments with different 
cues such as varying stiffness or low fluid shear stress. Different microenvironmental 
cues appear to affect the level of vimentin’s involvement in cell area, i.e. soft vs. stiff 
environments. While our data suggests that vimentin is involved in resisting low fluid 
shear stress, higher fluid shear stress responses may be less dependent on vimentin. 
Altogether this suggests a complex cellular response mechanism that also involves 
other cytoskeletal proteins working in concert with vimentin. However, it does appear 
that vimentin’s involvement may require interaction with adhesive structures as both 
our findings and literature suggests. It is likely that vimentin intermediate filaments 
work in support of actin microfilaments in regulating cell area in different 
environments. Further, vimentin may have more influence on particular adhesive 
structures than others, either directly or indirectly through supporting proteins. In the 
next area of this work, we sought to determine how the influence of vimentin on 
individual cells might affect MSC differentiation and subsequent extracellular matrix 
deposition in a cell population study, using two different culture environments with 




Chapter 4: Vimentin intermediate filaments may have a limited 




Mesenchymal stem cells are increasingly being investigated for the treatment of 
orthopaedic diseases such as osteoarthritis 
13
. Tissue engineering strategies combine 
cells and biomaterials, and research suggests that pre-conditioning (e.g. mechanical 
stimulation) of biomaterial constructs can help improve mechanical properties and 
extracellular matrix (ECM) deposition 
43,47,49
. Understanding the effects of 
chondrogenic culture environment itself on these properties prior to pre-conditioning 
can help improve understanding of the effects such treatments.  
 
The matrix environment surrounding chondrocytes and chondrogenically committed 
MSCs is immediately comprised of a pericellular matrix (PCM) surrounded by an 
ECM. The PCM consists primarily of type VI collagen and hyaluronan 
7
 while the 
surrounding ECM is made up of a variety of collagens and proteoglycans, including 
type II collagen and aggrecan, but not type VI collagen 
5,7
. Research in MSC 
chondrogenic differentiation is often conducted using pellet cultures to recapitulate 
and better understand condensation-like cartilage formation with MSCs undergoing 
terminal differentiation 
41,42,157
. In early chondrogenesis and endochondral 
ossification, cell-to-cell contacts through N-cadherin and neural cell adhesion 
molecule (N-CAM) are prominent 
158
 and their loss is concomitant with a 
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commitment to the chondrogenic lineage 
158,159
. Comparatively, biomaterials, 
including hydrogels such as agarose or alginate, are frequently used for evaluating 
MSC chondrogenesis for tissue engineering cartilage. While cells within these 
materials often lack the cell-to-cell contacts present in the pellet cultures 
157,160
, such 
culture systems are often used because they are permissive for studying 
chondrogenesis 
48,49,157,161,162
 and the effects of mechanical loading on cell growth, 
ECM deposition, and mechanical properties 
48,49,101,162,163
.   
 
Regardless of culture conditions, MSCs sense and respond to their environment using 
the cytoskeleton, consisting of actin microfilaments, tubulin microtubules, and 
vimentin intermediate filaments (IFs). While the role of microtubules in 
chondrogenesis appears to be limited or not well studied 
52
, the influence of actin 
microfilaments has been evaluated. Both disruption of actin and negatively 
modulating the RhoA/ROCK pathway promote chondrogenesis 
52,73,74
. The effect of 
vimentin IF deficiency on cartilage development has not been specifically 
investigated, but vimentin-null mice appear to exhibit normal skeletal development 
82
, 
albeit with impaired wound healing 
83
, altered physical coordination potentially due to 
cerebral defects 
85
, and reduced response to renal injury 
84
. Additionally, disruption or 
decrease of vimentin in chondrocytes or progenitor cells negatively influenced 
chondrogenic gene expression and extracellular matrix deposition, synthesis and 
degradation 
123,124
. Further, an increase in vimentin has been observed in MSCs 
undergoing chondrogenesis 
124,164
 and changes in the scaffold environment have been 
shown to cause variations in vimentin 
101,165
. There is also evidence for vimentin’s 
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involvement in disease, as dysregulated expression or organization of vimentin is 
apparent in osteoarthritic chondrocytes 
92,93
 and in MSCs isolated from bone marrow 




As vimentin IFs are known to have some influence in early chondrogenesis and 
exhibit abnormalities in degeneration, we sought to evaluate its influence on the 
capacity for MSCs to undergo chondrogenic differentiation in two different culture 
environments: agarose hydrogel cultures and pellet cultures. After determining that 
vimentin may be slightly involved in the deposition of an organized ECM, we next 
examined the expression of genes related to matrix degradation, cellular adhesion to 
the surrounding matrix, and chondrogenesis. While a decrease in vimentin at the 
beginning of chondrogenesis did not affect gene expression compared directly to the 
control cell population, variations appeared when examining the behavior of MSCs 
over culture time and when comparing culture conditions.  
4.2 Materials and Methods 
4.2.1 hMSC Cell Culture 
Population doubling level (PDL) 9 bone marrow derived human mesenchymal stem 
cells (hMSCs) (RoosterBio; Frederick, MD) were expanded using RoosterBio 
Enriched Basal media with the GTX Booster (RoosterBio) per manufacturer 
instructions. All subsequent subculture for lentiviral transduction and experimentation 
was completed using hMSC growth media: high glucose Dulbecco Modified Eagle 
Medium (DMEM (containing 4mM L-Glutamine (Gibco) supplemented with 10% 
fetal bovine serum (FBS) (Gibco), 100 U/mL Penicillin-Streptomycin (Gibco), and 
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1% Minimal Essential Medium non-essential amino acids (Gibco). hMSCs were used 
for transduction and experimentation at PDL 13–18 (approximately 4–5 passages). 
Complete media exchange was completed every 2–3 days and cells were maintained 
at 5% CO2 and at 37ᵒC. 
4.2.2 shRNA Transduction 
hMSC transduction with the vimentin targeting lentiviral vector (shVim) (5’-
AAAAGGCAGAAGAATGGTACAAATTGGATCCATTTGTACCATTCTTCTGC
C-3’) or the control vector targeting LacZ (shLacZ) (5’-
GCAGTTATCTGGAAGATCAGGTTGGATCCAACCTGATCTTCCAGATAACT
GC-3’) was completed for 24 h at a multiplicity of infection (MOI) of 15, as 
previously described 
150
. Transduction efficiency was assisted by the presence of 
6 µg/ml hexadimethrine bromide (Polybrene) (Sigma). Titered viral concentrations 
were determined through a Quanti-IT PicoGreen Assay (Invitrogen). Two days post-
infection, pure populations were selected using 12µg/ml Blasticidin for 4 days. Both 
shVim-hMSCs and shLacZ-hMSCs were cultured in the presence of 
1µg/ml doxycycline to induce RNAi. All subsequent cultures of shVim-hMSCs and 
shLacZ-hMSCs were conducted in the presence of 1µg/mL doxycycline. Cells were 
cultured for 14 days on tissue culture plastic before being harvested to undergo 
differentiation. 
4.2.3 Chondrogenic Differentiation 
After 14 days of shRNA induction, shVim- and shLacZ-hMSCs were seeded in two 





 cells were centrifuged and resuspended in incomplete chondrogenic media 
(high glucose DMEM with 4mM L-glutamine supplemented with 10% FBS, 
50μg/mL L-ascorbic acid, 40μg/mL L-proline, 1mg/mL insulin, 0.55mg/mL 
transferrin, 0.5μg/mL sodium selenite, 50mg/mL bovine serum albumin, 470μg/mL 
linoleic acid, 100 U/ml penicillin/streptomycin) before being centrifuged again. 
Complete media (incomplete media with 10ng/mL TGFB3) supplemented with 
1µg/ml doxycycline was added to the pelleted cells and they were cultured for 14 and 
21 days. To form agarose cultures, cells were resuspended in 4% (w/v) agarose at a 
cell density of 1x10
6
 cells/ml and pipetted into an Ø6mm x 3mm mold to form 
agarose discs. Discs were cultured in complete chondrogenic media supplemented 
with 1µg/ml doxycycline for 14 and 21 days. 
4.2.4 Histology and Immunohistochemistry 
Chondrogenic agarose discs were sliced in half and then chondrogenic pellets and 
half agarose discs were fixed with 4% paraformaldehyde. Pellets were then infiltrated 
with 30% sucrose, embedded in Tissue-Tek O.C.T compound (Sakura), and stored 
−80 °C until cryosectioning (8µm) using an HM550 series cryostat (Richard Allen 
Scientific). Agarose samples were dehydrated using sequential ethanol washes and 
xylene before being embedded in paraffin. 5µm paraffin sections were created using a 
HM355S microtome (Microm). Paraffin sections were warmed for 2hr and then 
rehydrated with xylene and sequential ethanol washes. Some sections (OCT or 
paraffin) were histologically stained for visualizing sGAGs with 0.1% Safranin-O. 
Additional sections were used for immunohistochemical detection of type II collagen, 
type VI collagen, or aggrecan. These sections were blocked with 0.3% hydrogen 
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peroxide and then with 1% bovine serum albumin (BSA). Sections were labeled with 
either rabbit IgG anti-human type II collagen primary antibody, rabbit IgG anti-
human type VI collagen (Col6a1) primary antibody, or mouse IgG anti-human 
aggrecan primary antibody. For visualization, biotinylated secondary antibodies were 
used with a horseradish peroxidase-conjugated streptavidin (Vectastain ABC; Vector 
Laboratories), followed by a 3, 3 –diaminobenzidine substrate color reaction. All 
sections were then dehydrated through sequential ethanol washes. Chondrogenic 
pellets were mounted with Cytoseal XYL and agarose culture sections were mounted 
with Permount. All histology and immunohistochemistry samples were imaged using 
bright field microscopy at × 100 magnifications with an Olympus IX81 microscope 
and a Qcolor3 camera. Sections of the images are presented in Figures 4.1 and 4.2.  
4.2.5 Gene expression  
Gene expression was assessed using quantitative reverse transcription polymerase 
chain reaction (qRT-PCR). To isolate RNA, after 14 and 21 days of chondrogenesis, 
chondrogenic pellets and agarose discs were homogenized in TRIzol 
(Ambion/ThermoFisher). For the chondrogenic pellets, RNA was isolated per 
manufacturer’s instructions. Briefly, RNA was isolated using chloroform phase 
separation and isopropanol precipitation. For the agarose discs, RNA was isolated by 
modifying a previously presented method for RNA isolation from agarose 
166
. Ethanol 
(100%) was added to create the final ratio of 2:1 Trizol:100% ethanol. That solution 
was then was used to isolate RNA using the RNeasy Micro kit (Qiagen). Total RNA 
was then reverse transcribed, amplified, and analyzed using qRT-PCR (MyiQ 
System, BioRad, CA) with primers designed for human genes (Table 4.1). 
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Specifically, the expression of transcription factor sex determining region Y-box 9 
(SOX9), type VI collagen (COL6A1), matrix metalloprotease 13 (MMP13), 
aggrecanases “A disintegrin and metalloproteinase with thrombospondin motifs” 4 
and 5 (ADAMTS4 and ADAMTS5), N-cadherin (CDH2), αV (ITGAV) integrin 
subunit, and β1 (ITGB1) integrin subunit and the housekeeping gene 18S were 
analyzed using the ΔΔCt method.  
Table 4.1 Sequences of primers used for qRT-PCR 
Gene Forward and Reverse Sequences GenBank accession no. 
18SR5 
5'- AAACGGCTACCACATCCAAG -3' 
NR_003286 
5'- CCTCCAATGGATCCTCGTTA -3' 
SOX9 
5'- AGTACCCGCACTTGCACAAC -3' 
NM_000346 
5'- CGTTCTTCACCGACTTCCTC -3' 
COL6A1 
5'- CTACACCGACTGCGCTATCA -3' 
NM_001848 
5'- GCCACCGAGAAGACTTTGAC -3' 
MMP13 
5'- AAGGAGCATGGCGACTTCTA -3' 
NM_002427.3 
5'- GGTCCTTGGAGTGGTCAAGA -3' 
ADAMTS4 
5'- AGGCACTGGGCTACTAC -3' 
NM_005099.5  
5'- GGGATAGTGACCACATTGTT -3' 
ADAMTS5 
5'- TCTAAGCCCTGGTCCAAATG -3' 
NM_007038.4 
5'- TCGTGGTAGGTCCAGCAAA -3' 
CDH2 
5'- AGGGGACCTTTTCCTCAAGA -3' 
NM_001792.4 
5'- TCAAATGAAACCGGGCTATC -3' 
ITGAV 
5'- TTTCGGATCAAGTGGCAGAA -3' 
NM_002210.4  
5'- TCCTTGCTGCTCTTGGAACTC -3' 
ITGB1 
5'- ATCTGCGAGTGTGGTGTCTG -3' 
NM_002211.3  
5'- AAGGCTCTGCACTGAACACA -3' 
 
Cycle threshold (Ct) values were averaged and the ΔCt was determined by 
subtracting the average 18S Ct values from those of the gene of interest. ΔΔCt values 
for each gene were calculated by subtracting the ΔCt values for the reference sample 
from the corresponding ΔCt values for the sample of interest at each time point, 
depending on the relationship being examined. Relative gene expression levels (fold 
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difference) were calculated using the exponential relationship 2
-ΔΔCt
. Data are shown 





range. Three to five biological replicates were evaluated for each gene.  
4.2.6 Statistical Analysis 
Statistical differences in gene expression were determined using Student’s t-test to 
compare ΔCt values. Statistical significance was set to α=0.05. 
4.3 Results and Discussion 
In this study, we sought to determine the effects of vimentin knockdown on 
chondrogenic extracellular matrix deposition and gene expression using two different 
culture environments: pellets and agarose hydrogels. In short term cultures, vimentin 
has been found to be involved in chondrogenesis 
123,124
, however extended culture 
times have not been evaluated. We sought to address this gap in knowledge by 
examining its potential involvement in longer chondrogenic culture times, 14 and 21 
days, using shRNA lentiviral particles that we previously showed could achieve 
approximately 30% vimentin knockdown at day 14 of induction 
150
. At this point, the 
cells were placed in the two chondrogenic culture environments and subsequently 
induced to undergo chondrogenesis for a further 14 and 21 days.   
 
For pellet cultures, immunohistochemical (IHC) and histological staining revealed 
robust, but varied, matrix deposition by both shLacZ- and shVim-hMSCs (Figure 
4.1). Overall, the type II collagen structure appeared to become more densely 
organized from day 14 to day 21. shLacZ- and shVim-hMSC pellets had similar type 
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II collagen, type VI collagen and aggrecan organization; however, an apparent 
decrease in aggrecan intensity was observed from day 14 to 21. Safranin O staining 
for sulfated glycosaminoglycans (sGAGs) possessed greater definition of structural 
features in shLacZ-hMSC pellets from day 14 to day 21, while the shVim-hMSC 
pellets appeared to retain more disordered, amorphous, with possible less intensity, 




Figure 4.1 IHC and Histology of Pellet Cultures. shLacZ- and shVim-hMSC pellet 
cultures stained using IHC for type II collagen, type VI collagen, and aggrecan and 




Comparatively, the agarose hydrogels showed limited ECM deposition (Figure 4.2). 
Both shlacZ- and shVim-hMSC hydrogels had similar type II collagen staining 
patterns, with slightly less deposition in the shVim-hMSCs culture. Type VI collagen, 
aggrecan, and safranin O staining was primarily localized in circular pockets, 
presumably around individual cells. The low ECM deposition in the agarose 
hydrogels is likely due to the low cell density 
167
. While low cell densities in 
hydrogels have been successfully used to evaluate chondrogenesis 
44,161
, higher cell 
densities typically yield more ECM deposition 
49,167,168
. The slight variation in 
staining in the shVim-hMSC cultures compared to the shLacZ-hMSC cultures 
suggests that the loss of vimentin could have some effect on ECM deposition or 
organization. 
 
Figure 4.2 IHC and Histology of Agarose Cultures. shLacZ- and shVim-hMSC agarose 
cultures stained using IHC for type II collagen, type VI collagen, and aggrecan and 
stained with safranin O for sGAGs on day 14 and day 21 of culture. Scale bar: 50µm. 
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To further interrogate the potential variation in ECM deposition, gene expression was 
evaluated. In general, no significant differences were observed in the gene expression 
between chondrogenic shLacZ- and shVim-hMSCs at Day 14 or Day 21 (Figure 
4.3A). These results imply that vimentin’s involvement could be in organizing the 
ECM, rather than upstream at the transcriptional level, during these stages of 
chondrogenesis. For example, chondrogenesis has previously been shown to be 
impaired by interfering with arginine-glycine-aspartic acid (RGD)-dependent ECM 
binding sites, which also caused vimentin reorganization 
101
. Similarly, calcium 
mediated signaling was involved in vimentin reorganization that occurred in response 
to hydrostatic pressure loading in chondrogenic cultures 
101,169
. Part of our previous 
work evaluated cytoskeletal changes of shVim-hMSCs, where we found that the 
functional role of actin may be altered with vimentin knockdown. Therefore, it is 
possible that vimentin has a functional effect on interactions among different 
cytoskeletal elements in depositing and organizing ECM. 
 
Despite the lack of difference between shLacZ- and shVim-hMSCs, some distinctions 
in gene expression were observed when comparing the cell populations at day 14 and 
day 21 (Figure 4.3B) as well as between the two culturing conditions (Figure 4.3C). 
In pellet cultures, gene expression of MMP13 increased and ADAMTS5 decreased 
from day 14 to day 21, but only in pellet cultures, not agarose hydrogels (Figure 
4.3B). Similarly, when evaluating the effects of culture condition at day 21, shLacZ- 
and shVim-hMSCs both exhibited significantly less degradative enzyme (MMP13, 
ADAMTS5, ADAMTS4) expression in agarose gels compared to pellet cultures 
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(Figure 4.3C). As high expression of these enzymes is related to hypertrophy and 
degeneration 
170–172
, these results suggest that by day 21 the chondrogenic cells in 
pellet cultures may have become hypertrophic, as has been previously reported for 
pellet cultures
41
. Alternatively, the limited ECM deposition in agarose hydrogels 
compared to pellet cultures may not elicit any remodeling response to hypertrophy. 
One exception is that in shVim-hMSCs at day 14, we did not observe any difference 
in expression of MMP13 and ADAMTS4 between the agarose and the pellet cultures, 
suggesting aberrant expression in response to culture environment at this stage of 
chondrogenesis (Figure 4.3C). 
 
In terms of cell adhesion receptors, we found higher expression of αV integrin in the 
agarose cultures compared to the pellet cultures (Figure 4.3C). This could be 
indicative of a bias toward cell-PCM or cell-ECM adhesion in the agarose, whereas in 
pellet cultures the comparatively high cell density would involve greater cell-to-cell 
adhesion. In pellet cultures, however, we did not see greater expression of N-
cadherin, which is involved in cell-to-cell adhesion. But its expression is typically 
upregulated during early chondrogenesis and cells might not exhibit elevated 
expression levels at later stages, especially if cells are hypertrophic 
173
. More likely, 
the expression of αV integrin is related to its specific binding moieties in the PCM 
and ECM that might be different between the two culture environments. Specifically, 
αV subunit containing integrins are known to bind to RGD-specific binding sites 
174
 
and they have been found to facilitate chondrocyte binding to cartilage, type II 
collagen, type VI collagen, and fibronectin 
175,176
. When examining the expression of 
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matrix proteins, we observed lower type VI collagen levels in the shVim-hMSCs in 
the day 21 agarose hydrogels compared to the pellet culture (Figure 4.3C), suggesting 
that type VI collagen expression may be negatively affected by vimentin knockdown 
in a culture condition-dependent manner. Determining differences in the PCM 
composition or analyzing multiple αV subunit-containing integrins in these 









Figure 4.3 Gene expression of Pellet and Agarose Cultures. shLacZ- and shVim-hMSC 
pellet and agarose culture assayed for gene expression at day 14 and day 21 (n = 3-5). A. 
shVim-hMSC samples relative to shLacZ-hMSC samples for all both culture conditions 
and time points. B. Day 21 samples relative to Day 14 samples for both cell populations 
and culture conditions. C. Agarose culture samples relative to pellet culture samples for 
both cell populations and time points. *p<0.05, #p<0.01 compared to stated relevant 





) ± range. 
 
This study is primarily limited by the knockdown of vimentin expression rather than 
the ablation found in cells isolated from vimentin null mice. Thus, it is possible that 
our observations may be underrepresenting vimentin’s involvement in these 
processes. However, this study better recapitulates a situation in which MSCs from 
osteoarthritic patients would be isolated for cell therapy, where the MSC function 
may be impaired 
95,177
. Regardless, it is possible that over the course of 
chondrogenesis that the cells were able to overcome the moderate decrease in 
vimentin. This then focuses our findings specifically on the influence of vimentin 
decrease at the initiation of chondrogenesis on long term chondrogenic cultures. 
Further, while we did not observe a deficiency in chondrogenic differentiation, the 
use of the high MOI for lentiviral transduction and the doxycycline for the shRNA 





This study provides new insight into the involvement of vimentin in the 
chondrogenesis of MSCs. Namely, vimentin deficiency, at least at the start of 
chondrogenesis, does not appear to affect gene expression in longer chondrogenic 
cultures when compared to a control cell population. Variations in ECM deposition, 
coupled with the gene expression, imply a need for further examination of vimentin’s 
role in interacting with the PCM and whether that interaction truly affects ECM 
organization and deposition. Differential gene expression of degradative enzymes and 
the αV integrin subunit in different culture conditions further opens new avenues for 
this area of research. As MSCs are increasingly being evaluated for cell therapy, 
understanding how culture environment can affect their behavior and what cellular 
elements regulate that response will be critical.  
4.4 Conclusion 
The first two Aims of this work were focused on the effect of physical compression, 
i.e. cell deformability of MSCs, and then the response to microenvironmental 
changes, i.e. changes in cell area of MSCs. In contrast, the objective of this final Aim 
was to determine how vimentin influences the start of chondrogenesis, which 
ultimately may result in changes in longer in vitro culture, and also to determine how 
that influence would be altered by changes in environmental conditions. With this 
third aim, we wanted expand our understanding of vimentin’s influence from effects 
on individual cells to its impact on a population of MSCs.   
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Chapter 5: Conclusions and Future Work   
The aim of this work was to examine how mesenchymal stem cells respond to 
different environments. As MSCs are increasingly being investigated for therapeutic 
use 
1,3
, a fundamental understanding of how these cells will behave in different 
environments is critical for the success and evaluation of MSC therapies. In this 
work, we focused on the influence of vimentin intermediate filaments on MSC 
response to varying physical stimuli as vimentin is increasingly gaining notice as 
being involved in many cell characteristics and functions. Further, its expression has 
been found to be aberrant in MSCs isolated from osteoarthritic patients, which 
suggests that understanding vimentin’s influence on MSC behavior could impact 
autologous cell therapies from this patient population. By decreasing vimentin protein 
levels in MSCs using a lentiviral shRNA-based system, we were able to examine the 








Overall, the primary finding from these studies is that vimentin intermediate filaments 
influence physical changes in MSCs in response to external cues such as mechanical 
load, different ECM proteins, and environmental stiffness. Vimentin’s influence on 
the regulation of these physical changes in MSCs is likely to be at a localized, direct 
interaction level, rather than having much control over regulating gene expression and 
protein translation. While vimentin IFs do not appear to be critical for chondrogenic 
differentiation, based on these three studies, it is instead likely that they have more of 
an influence over the mechanical regulation of chondrogenesis. In Chapters 2 and 3, 
we described how vimentin IFs influenced physical changes, deformability and cell 
size, in MSCs in response to external stimuli. And in Chapters 3 and 4, we described 
a potential lack of influence over gene and protein expression.  
 
The objective of the first aim (Chapter 2) was to examine the influence of vimentin 
intermediate filaments on MSC deformability. MSCs entering a load bearing 
environment, such as articular cartilage, would be subjected to compression due to 
tissue deformation caused by normal or abnormal use, and vimentin networks have 
been shown to  influence cellular stiffness and the capacity to resist such compression 
11,52,94,112,113,118,139–141
. As mentioned, deformation of cells, such as chondrocytes 
within this environment are known to be deformed and  this compression can result in 
functional outcomes such as changes in extracellular matrix protein expression 
50,138–
142
. Thus, it is important to understand how MSCs entering such as environment may 
be affected by this compression, and vimentin’s role in response. In this study, we 
embedded the cells in agarose hydrogels and subjected them to deformation, finding 
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that vimentin-deficient hMSCs were actually less deformable than the control cells, 
supporting that vimentin must have a role in controlling the mechanical properties 
and physical structure of MSCs. Subsequent disruption of actin and microtubules and 
quantification of the immunofluorescent intensity of these proteins in vimentin-
deficient cells relative to control cells revealed that actin may be compensating for the 
decrease in vimentin, thereby decreasing the deformability of the cells. These results 
suggest a complex relationship between cytoskeletal proteins in responding to 
extracellular compression that needs to be further investigated.  
 
Future work into this area would involve incorporating more realistic cell-ECM 
adhesions that are absent in the current experiments. Our focus was on the intrinsic 
cell response, however a more relevant environment would include cell-ECM 
contacts as these would necessarily complicate cellular deformation in response to 
external compression of the cellular environment. Based on our findings in Chapter 3, 
vimentin would also likely play a complex role in influencing cell-ECM contacts 
dependent on the ECM proteins available for adhesion and this would affect the 
subsequent deformation of the cells. 
 
The objective of the second aim (Chapter 3) was to determine how vimentin 
intermediate filaments would influence cellular spreading in various 
microenvironments, rather than the large physical compression of the agarose gel 
examined in Aim 1 (Chapter 2). MSC behavior and function are affected by a variety 





. Further, the area of MSCs has been associated 
with functional changes (e.g. cell stiffness, differentiation potential) 
34,37
. Clarity of 
how vimentin influences cell area can lend insight into how IFs are involved in 
functional changes in response to their physical environment. When we first 
measured cell spreading on fibronectin- or collagen-coated glass coverslips, the 
vimentin-deficient cells were found to be smaller than the control cells on fibronectin. 
Comparatively, this was not the case with the cells on the collagen-coated surfaces, 
except on the highest concentration at 24hr. Next, we exposed the cells to surfaces of 
varying stiffness and found that the cell areas were larger on the stiffer substrates in 
both cell populations. However, while the vimentin-deficient cells were smaller than 
the control cells on the stiff substrate, no difference was observed on the soft 
substrate. This suggests that vimentin may only be involved in cellular spreading in 
stiff environments when adhered to fibronectin. Finally, the cells were exposed to low 
fluid shear stress and the control cell populations did not respond to the fluid flow by 
changing cell area. Comparatively, the vimentin-deficient cells were smaller when 
exposed to fluid flow, suggesting that vimentin may be involved in resisting low fluid 
shear stress-induced cell area changes. These findings implicate vimentin in the 
response of MSCs in different microenvironments, specifically a physical change in 
cell size due to interactions with fibronectin-coated stiff surfaces and in response to 
low fluid shear stress on a fibronectin-coated surface. Further, instead of affecting 
expression in MSCs, vimentin IFs appear to affect MSC adhesion structures, which 
regulate the cell spreading. While gene expression of integrin subunits and the 
quantity of vinculin protein did not appear to be altered by vimentin deficiency, we 
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found that when seeded on fibronectin, vimentin-deficient cells had smaller focal 
adhesion areas. Overall, these studies together indicate a complex role for vimentin in 
cellular spreading as we’ve shown that it influences spreading, specifically on 
fibronectin, in a variety of microenvironments.  
 
There are many directions for future work in this area. First, examining the substrate-
stiffness responses using a variety of ECM proteins would expand this work. It would 
also be valuable to extend the focal adhesion work and delve into the different focal 
adhesion proteins and integrin subunits that vimentin may interact with to better 
examine how they affect cell spreading in conjunction with vimentin. Further, cell 
spreading in 2D environments will necessarily be different than cell spreading in 3D 
conditions in all types of biomaterial scaffolds. Examining if these findings hold true 
in three dimensions would be critical for expanding this knowledge to a more in vivo-
like environment. Finally, our findings with fluid shear stimulation only touch upon 
how vimentin and cellular response to fluid shear stress may be related. Moving 
beyond the physical effects to the changes in signaling and relationships with integrin 
subunits would allow more clarity into this area of research. Ultimately, in practice, 
this work indicates a need for examining cell behavior in 2D using multiple substrate 
proteins for cellular adhesion, as this can clearly impact the outcome of research.  
 
The objective of the third aim (Chapter 4) was to move away from analyzing effects 
of vimentin deficiency on a cell by cell basis, and instead examine the effects on 
chondrogenesis of the MSC populations.  As previous studies had found that vimentin 
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affects chondrogenic extracellular matrix deposition and chondrocyte phenotype 
maintenance in short term studies 
123,124
, we decided to extend this research further 
and analyze in vitro chondrogenesis at 14 and 21 days. In this study, cells with 
limited vimentin, at least at the start of chondrogenesis, were cultured in two different 
environments: as pellet cultures and in agarose hydrogels. Ultimately, however, we 
found that a decrease in vimentin at the start of chondrogenesis had a limited effect 
on extracellular matrix deposition in both culture environments. In the pellet cultures, 
histology suggested that the sGAGs may be decreased or less organized in the 
vimentin-deficient cultures. Comparatively, in the agarose, it seemed that only type II 
collagen deposition might be decreased with decreased vimentin. However, gene 
expression for chondrogenic, degradative, and adhesion proteins between the two cell 
populations did not reveal any differences. By delving further into the gene 
expression and comparing the culture time and condition, we found, in general, a 
higher presence of degradative enzymes in the pellet cultures compared to the agarose 
cultures, suggesting that the MSCs were hypertrophic within the pellet cultures at 
these time points. However, the higher expression of αV integrin subunits in the 
agarose culture compared to the pellet culture suggests that pericellular matrix 
deposition may be different between the two culture conditions possibly due to cell 
density or cell shape. Ultimately, this work indicates that decreasing the levels of 
vimentin protein at the start of chondrogenesis may have a limited role in 




Future studies in this area could take three directions. First, stepping away from 
studying the role of vimentin in chondrogenesis, better understanding of the effect of 
culture condition on the pericellular matrix would clarify and expand our findings. 
Second, instead of focusing on the inherent role of vimentin in chondrogenesis, 
examining how vimentin is involved in mechanical stimulation of chondrogenesis 
could be more valuable as vimentin has been shown to be involved in 
mechanosensing of hydrostatic pressure-based stimulation of chondrogenesis 
101
. 
We’ve shown that vimentin is involved in physical changes in MSCs in response to 
external stimuli in Chapters 2 and 3, and thus coupled with previous literature, it 
appears that vimentin may have a greater role in the mechanical regulation of 
chondrogenesis. Third, as vimentin has been found to be disorganized, disrupted, 
downregulated, or absent in osteoarthritic chondrocytes and even MSCs, the focus 
could be shifted to vimentin’s role in osteoarthritis pathology in chondrocytes and 
MSCs. Vimentin may have a more clear effect on cellular behavior in an 
osteoarthritic environment as these cells must respond to deteriorating changes in 
their physical surroundings.   
 
Altogether these studies clearly indicate a role for vimentin in how MSCs interact 
with their physical and micro-environments, if not during chondrogenesis. Decreasing 
the amount of vimentin in MSCs had a limited effect on cells at the transcription or 
translational level as seen in both Chapters 3 and 4. Coupled with the results from 
Chapter 2, vimentin appears to instead have a more physical, and likely direct, 
interaction with the rest of the cytoskeleton or other structures and proteins that 
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typically allow the cells to interact with the environment in an unimpaired manner. 
Further, decreasing the quantity of vimentin likely affects the internal mechanical 
balance of the cell as well as signaling cascades which together may contribute to the 
observed changes in MSCs’ physical response to their environment.  
 
In this work, we did not emphasize the relationship between the three cytoskeletal 
proteins, in an attempt to isolate the role of vimentin. Functionally, however, it is 
known that actin microfilaments, microtubules, and vimentin intermediate filaments 
as well as other supporting proteins are interconnected and do not have an isolated 
effect on cellular behavior. And thus, the changes in the physical behavior of MSCs 
are likely caused by alterations of the mechanical equilibrium, the subsequent 
compensation by the other cytoskeletal proteins, and altered signaling cascades in 
response to the environment when vimentin is decreased. It is largely accepted that 
actin microfilaments and vimentin intermediate filament act as tensional elements in 
the cell, while microtubules serve to resist compression. In the first aim, with a 
decrease in vimentin, we observed a decrease in deformability. The resistance to 
compression is likely due to the remaining vimentin network and reorganization and 
compensation by the remaining cytoskeleton. This decrease in deformability may or 
may not be present when cell adhesions are introduced, as in Aim 2. This ambiguity 
is related to how actin microfilaments’ role in cellular stiffness changes through the 
formation of actin stress fibers and increased cellular contractility when the cells are 
no longer rounded and from adhesions to their environment. Vimentin’s related role 
must also change with cellular spreading and attachment and we observed that 
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vimentin may specifically be involved in adhesion to fibronectin in stiff 
environments, likely in support of the actin microfilaments’ function. However, it is 
certainly possible that the decrease in deformability is still present with the addition 
of cell adhesions, opening up the question of whether vimentin-dependent cellular 
deformability itself could contribute to the observed changes in adhesions and cell 
areas. The interaction of cellular deformability and cellular adhesion could again play 
a role in chondrogenesis. While vimentin-deficient cells, at least at the initiation, were 
used for chondrogenesis, it is not clear if the expression of vimentin over the culture 
period was recovered. However, this early limited vimentin expression does not 
appear to impact chondrogenesis in longer term culture. This suggests that 
chondrogenic induction and the related signaling cascades may occur independent of 
the effects of the deformability and area changes that might be caused by vimentin 
deficiency. It is known that a disrupted actin network is often associated with 
chondrogenic differentiation and microtubules appear to have a limited role in 
chondrogenesis. Our findings indicate a limited role for vimentin as well. Altogether 
it appears that vimentin’s primarily influence is in affecting MSCs’ physical response 
to different environments, i.e. deformability and maintaining cell area. 
 
These findings also indicate that while vimentin may not be a regulator of 
chondrogenesis of MSCs, physical responses to external cues such as different ECM 
proteins and stiffness or mechanical loads are influenced by vimentin IFs. Thus, 
further studies are needed to determine how this role for vimentin in the MSC 
response will affect cell signaling in different environments and subsequently MSCs’ 
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trophic and immunomodulatory roles for therapeutic purposes. Similarly, further 
studies are needed to examine how vimentin’s involvement in MSC interaction with 
different ECM environments can affect mechanical preconditioning of chondrogenic 
MSCs prior to the implementation as a therapeutic.  
 
One challenge facing allogenic cell therapies is the donor-to-donor variability among 
isolated cell populations. This is also a challenge in the research sector, where human 
MSCs from different donors can be purchased. While we did not examine the donor-
to-donor variability in expression of vimentin, it is unlikely that there are large 
variations in its expression in healthy MSC populations as it appears to be a robustly 
expressed protein. In fact, changes in culture environment and culture time are more 
likely to impact changes in cytoskeletal structure 
144
. However, it is possible that 
donor variability could impact the chondrogenic potential of the populations of MSCs 
as well as affecting chondrogenesis-dependent increases in vimentin 
124,164
. These 
variations could potentially impact our findings from Aim 3 (Chapter 4). 
 
This work contributes to the current scientific body of knowledge in a multiple ways. 
We are the first to show that a lentiviral RNAi platform can be used to elicit a 
decrease in vimentin in human MSCs. Most of the previously reported studies rely on 
non-specific chemical disruption of intermediate filaments, which in our experience 
can have important off-target effects on the actin cytoskeleton. Other studies use short 
term RNAi interference, rather than relying on a lentiviral approach for an extended 
effect. Further, we showed that vimentin is involved in the cell deformability of 
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MSCs in an unexpected way. Specifically, a moderate decrease in vimentin did not 
increase deformability, as one might expect, but instead decreased deformability. 
Moreover, our results suggest one potentially novel mechanism of this phenomenon 
might be a shift in the resistance to deformation from the vimentin network to the 
actin network, potentially in combination with the remaining vimentin filament 
network. Most critically, we show for the first time that vimentin is involved in 
maintaining MSC area in response to different microenvironments, specifically when 
adhered to fibronectin and on stiff substrates. Practically, this emphasizes the need for 
evaluating cellular behavior on substrates coated with different ECM proteins as it 
can clearly affect research outcomes. We further found that vimentin may be involved 
in resisting call area changes in MSCs in response to low fluid shear stress. Finally, 
we found that an initial deficiency in vimentin is not sufficient to impact 
chondrogenesis of MSCs during long term culture regardless of culture condition, 
which corroborates normal overall joint development that has been observed in 
vimentin knock-out mice.  
 
MSCs’ popularity as a therapeutic cell population has necessitated further study into 
how these cells behave fundamentally. With an understanding of the factors that 
affect MSC behavior, researchers will not only be able to better design therapies, but 
evaluate their success as well. As the cytoskeleton is involved in functional cell 
behaviors, vimentin intermediate filaments will likely influence cell behavior in many 
of the latest technologies that are being developed using MSCs, especially as cell 
microenvironment has such a large influence on behavior. Success of technologies 
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such as MSC-derived extracellular vesicles and incorporation of MSCs into 3D 
printed scaffolds will ultimately be affected by MSCs’ response to physical stimuli 
and different microenvironments. The responses to these stimuli will be controlled by 
a variety of cellular structures, such as focal adhesions and other cytoskeletal 
elements that vimentin may directly influence as demonstrated by the work in this 
dissertation; these studies demonstrate that vimentin is involved in the physical MSC 
response to a variety of microenvironments. Ultimately, these studies serve to extend 
the discussion regarding how MSCs interact with different environments, the 
understanding of which will be critical for the development and evaluation of 
mesenchymal stem cell therapies.   
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Appendix A: Downregulation of Vimentin Intermediate Filaments 




This work was collaboratively completed with my contributions being toward the 
generation of the lentiviruses and the cell culture of the transduced cell populations. 
Additionally, I was involved in manuscript preparation as I authored most of the   
introduction, methods, and discussion sections. As this work relates to the findings in 




Mesenchymal stem cells (MSCs) are increasingly being investigated for a variety of 
therapeutic applications, including musculoskeletal disorders such as osteoarthritis 
13
 
and degenerative disc disease 
178
.  The use of MSCs as a therapeutic cell source for 
these conditions, among others, can be attributed to the combined advantages of 
diverse differentiation potential, immunomodulation properties, paracrine effects, and 
their homing capability 
1
. Migration and adhesion of MSCs to a damaged tissue’s 
extracellular matrix are essential for MSCs to carry out their therapeutic function. 
Their capacity to migrate to diseased or damaged tissues has been investigated in a 
number of models 
24–26
, and further understanding of their homing potential has come 
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from studies focusing on MSCs’ chemotactic response to chemokines or growth 
factors 
24,26,179,180
. In addition to migration, MSC adhesion and spreading have been 





, substrate stiffness 
27
, and composition 
30,31
 have been shown to 
be capable of tuning MSC differentiation. 
 
As with most other cell types, migration and adhesion of MSCs are largely governed 
by the cytoskeleton, which consists of actin microfilaments, microtubules, and 
intermediate filaments (IFs), primarily vimentin. The roles of actin and microtubules 
in migration and adhesion, in concert with a complex collection of supporting 
proteins, have been well described. Actin microfilaments form multiple structures 
required for migration at the leading edge of the cell.  Lamellipodia are made up of 
branched microfilaments while filopodia are formed from microfilament bundles 
181,182
. The development and stability of these structures is mediated by the formation 
and separation of focal adhesions or integrin clustering at the leading and trailing 
edges of the cells 
182
. It is thought that microtubules help to polarize cells for 
migration through extension into the lamellopodia and trafficking of vesicles 
containing adhesion molecules to the leading edge of the cell 
182
. Similarly, actin has 
also been found to be required for the formation of cellular projections for migration 
while microtubules are needed for cellular cytoplasmic projection elongation 
181
. 
Comparatively, significantly less is known about the related function of vimentin IFs 




There is increasing evidence that vimentin IFs are involved in cellular adhesion and 
spreading. Vimentin deficiency results in slower adhesion by cancer cells
87,120
. 
Further, vimentin IFs are known to interact with, and potentially regulate, focal 
adhesions 
88,105,113,114,120,121
 and interact with numerous integrin subunits 
104–110
.  
These interactions with adhesion proteins appear to be associated with the activity of 
cytoskeletal linkers plectin and filamin A 
107–109,122
.  However, the relationship 
between cellular adhesion, spreading, and vimentin IFs in MSCs has not been fully 
explored.  
 
Vimentin IFs also appear to be involved in cellular migration. While changes in 
vimentin IFs have been found to correlate with changes in the migration of MSCs 
183
, 
vimentin’s involvement in migration has been more extensively investigated in cancer 
cells and fibroblasts. Increased vimentin expression has been designated as a key 
marker in the epithelial to mesenchymal transition and is associated with increased 
tumor cell migration, metastasis, and poor prognosis 
78,87,88,114
. Down regulation or 
absence of vimentin in carcinoma cells, fibroblasts, and epithelial has been shown to 
impair cell migration 
87,113,114,132,184,185
 and alter the migration of lymphocytes and 
leukocytes through endothelial cells 
186,187
.  Vimentin IFs further appear to be 
involved in modulating cellular structures involved in migration. Long cellular 
cytoplasmic projections during migration through matrix pores have been found to 
require vimentin IFs for elongation 
181
.  Similarly, pseudopodia of leukocytes 





. While it is apparent that vimentin IFs are involved in cellular 
migration, the mechanism by which they act in MSCs remains to be clarified.  
 
In this study we sought to investigate the role of vimentin IFs in adhesion and 
protrusion formation during MSC migration. Specifically, we examined the 
relationship among MSC adhesion, cellular projection formation, and vimentin IFs 
using lentiviral shRNA-mediated RNA interference (RNAi) to determine the effect of 
decreased vimentin expression on these behaviors. Our results indicate that vimentin 
IFs are necessary for the cellular structural integrity required for forming cellular 
protrusions and normal cell-substrate adhesion. 
A.2 Materials and Methods 
A.2.1 Human Mesenchymal Stem Cell Culture 
Population doubling level (PDL) 9 bone marrow derived human mesenchymal stem 
cells (hMSCs) (RoosterBio; Frederick, MD) were expanded using RoosterBio 
Enriched Basal media supplemented with GTX Booster (RoosterBio) per 
manufacturer instructions. PDL 13-18 hMSCs were used for all experiments. 
Subsequent subculture for lentiviral transduction and experimentation was completed 
using hMSC growth media: high glucose DMEM containing 4mM L-Glutamine 
(Gibco) supplemented with 10% fetal bovine serum (FBS) (Gibco), 100 U/mL 
Penicillin Streptomycin (Gibco), 1% MEM non-essential amino acids (Gibco), and 
4mM L-Glutamine (Gibco). Complete media exchange was completed every 2-3 days 
and the cells were maintained at 5% CO2 and at 37ᵒC.  
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A.2.2 shRNA Lentivirus Generation 
shRNA lentivirus was designed and generated as previously described
150
.  Briefly, a 
52 nucleotide shRNA sense-loop-antisense (5'- 
AAAAGGCAGAAGAATGGTACAAATTGGATCCAATTTGTACCATTCTTCTG
CC-3') sequence was designed and selected from human vimentin [Gen Bank: 
NM_003380] mRNA using the shRNA Designer through Biosettia, Inc. After 
annealing, double stranded oligonucleotides were ligated per manufacturer 
instructions into an inducible lentiviral RNAi vector conveying resistance to 
blasticidin and containing a TetO-H1 promoter. RNA interference in this inducible 
system occurs only in the presence of doxycycline. The pLV-RNAi kit and pLV-Pack 
Packaging mix (Biosettia) were used to generate the shRNA constructs and package 
into replication-deficient lentivirus using HEK 293FT cells and Lipofectamine 2000. 
A shRNA lentiviral vector targeting the LacZ gene (5’-
GCAGTTATCTGGAAGATCAGGTTGGATCCAACCTGATCTTCCAGATAACT
GC-3’) was used as a control (Biosettia). Three days post-transfection, virus-
containing supernatants were collected and stored at -80ᵒC until use. 
A.2.3 shRNA Transduction  
hMSCs were transduced with the shVim- or shLacZ- lentiviral particles for 24hrs at 
an multiplicity of infection (MOI) of 15. The shLacZ-transduced hMSCs served as 
our non-targeting control for all experiments, as previously described 
150
. 
Transduction was completed in the presence of 6µg/ml hexadimethrine bromide 
(Polybrene) (Sigma) to assist with transduction efficiency. Titered viral 
concentrations for an MOI of 15 were determined using a Quanti-IT PicoGreen Assay 
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(Invitrogen). Two days after transduction, 12µg/ml Blasticidin was used to select for 
pure populations for 4 days. Subsequently, shVim-hMSCs and shLacZ-hMSCs were 
cultured in the presence of 1µg/ml doxycycline to induce RNA interference (RNAi). 
Cells were cultured for 14-18 days on tissue culture polystyrene before being 




A.2.4 GFP-Vimentin Transfection 
5 x 10
5
 PDL ~15-17 hMSCs (RoosterBio) were transfected with 6µg EGFP-
Vimentin-7 DNA plasmid according to the Amaxa™ Optimized Protocol provided by 
the LONZA Nucleofector Kit for hMSCs (Lonza).  EGFP-Vimentin-7 (subsequently 
GFP-Vimentin) was a gift from Michael Davidson (Addgene plasmid # 56439). On 
day 3, pure populations were selected using 500µg/mL geneticin for 1 day. On Day 7, 
cells were harvested to be assayed. 
A.2.5 Surface Reflective Interference Contrast Microscopy and Immunofluorescence 
Surface reflective interference contrast microscopy (SRIC) was used to detect 
surface-to-surface interference between light rays reflected from the 
substrate/medium interface and those from the medium/cell membrane interface. The 
intensity of the light is a measure of the proximity of the cell membrane to the glass 
surface, so the membrane closest to the surface appears darker and those further away 
appear brighter. Therefore, SRIC is an optimal method when evaluating cellular 
attachment, adhesion, and spreading behavior. Cells were fixed in 4% 
paraformaldehyde prior to imaging and stained for vimentin. To visualize vimentin, 
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cells were labelled with a rabbit IgG anti-human vimentin primary antibody 
(ThermoFisher) followed by a biotinylated (anti-rabbit IgG) secondary antibody 
(Vector) and fluorescein-labelled streptavidin (Vector). For image capture using 
SRIC and to visualize vimentin, we used a Nikon Eclipse TE2000-E microscope. 
A.2.6 Immunofluorescence for F-Actin and Focal Adhesion Analysis 
To visualize vimentin and analyze focal adhesion staining, cells seeded on glass 
coverslips coated with 100µg/ml human fibronectin for 30min (Corning) were fixed 
with 4% paraformaldehyde were then permeabilized using 0.1% Triton-X-100. Cells 
were then labelled with a rabbit IgG anti-human vimentin primary antibody 
(ThermoFisher) followed by a biotinylated (anti-rabbit IgG) secondary antibody 
(Vector) and fluorescein-labelled streptavidin (Vector). To dual stain for vimentin 
and vinculin, after vimentin staining, cells were then labelled with a mouse IgG anti-
human vinculin primary antibody followed by an Alexafluor 594-labelled goat anti-
mouse IgG secondary antibody.  To dual stain for vimentin and F-actin, after 
vimentin staining, Alexa Fluor 594 Phalloidin was used to label F-actin. DAPI was 
used to stain cellular nuclei. Fluorescent imaging was completed using a Nikon 
Eclipse TE2000-E microscope. ImageJ was used for the quantification of the average 
vinculin adhesion area. All images were converted to binary images to isolate 
individual vinculin adhesions, and the particle analyzer in ImageJ was used to detect 
all adhesions greater than 0.5 µm
2
 to prevent the quantification of background noise. 





A.2.7 Cytoskeletal Disruption and Visualization 
25mm diameter glass coverslips (VWR) or 35mm diameter (14mm diameter glass) 
glass bottomed dishes (Matek) were sterilized using UV light for 30 min and then 
coated with 100µg/ml human fibronectin for 30min (Corning). GFP-vimentin hMSCs 
were seeded onto glass-bottomed dishes while shVim- and shLacZ- hMSCs were 
seeded onto the glass coverslips.  Chemical disruption of actin microfilaments and 
inhibition of cellular contractility was completed using 0.4µM cytochalasin-D 
(Sigma) and 50µM blebbistatin treatment, respectively. Chemical treatments were 
conducted at 37°C and 5% CO2. After the designated treatment time, the cells were 
fixed with 4% paraformaldehyde. To visualize vimentin with disrupted cytoskeletal 
elements in shVim- and shLacZ-hMSCs were then permeabilized using 0.1% Triton-
X-100. Subsequently, cells were labelled with a rabbit IgG anti-human vimentin 
primary antibody (ThermoFisher) followed by a biotinylated (anti-rabbit IgG) 
secondary antibody (Vector) and fluorescein-labelled streptavidin (Vector). 
Fluorescent imaging was completed using a Nikon Eclipse TE2000-E microscope. 
 
Chemical disruption of cytoskeletal elements and time lapse microscopy of GFP-
vimentin hMSCs was completed after 4 days of nucleofection. After adding the 
chemicals directly to the cells, fluorescence images were taken every 2 min for 1.5hr 
using an Olympus IX81 microscope with an environmental chamber to maintain the 





A.2.8 Cellular Cytoplasmic Projection Formation Assay and Analysis 
Tissue culture treated polyester transwell inserts with 3.0 µm pores were coated with 
100µg/mL fibronectin for 30 min at room temperature. shVim- and shLacZ-hMSCs 
were seeded onto transwell inserts for 20 min. The bottom chamber was filled growth 
media containing SDF-1 (ThermoFisher) (200 ng/ml) Cells were incubated at 37°C 
and 5% CO2 for 24hr, after which the cells were fixed with 4% paraformaldehyde and 
permeabilized using 0.1% Triton-X-100. To visualize protrusion formation, cells 
were then labelled with a rabbit IgG anti-human vimentin primary antibody 
(ThermoFisher) followed by a biotinylated (anti-rabbit IgG) secondary antibody 
(Vector) and fluorescein-labelled streptavidin (Vector). Alexafluor 594-labelled 
Phalloidin was used to stain F-Actin. Fluorescence images were taken of the 
protrusions using a Nikon Eclipse TE2000-E microscope. 15-30 fields of view were 
taken for the bottom face of each transwell insert only and the number, length, and 
average area of protrusions were analyzed on ImageJ or Fiji software. 
A.2.9 Statistical Analysis 
To determine significant differences in focal adhesion area between shVim- and 
shLacZ-hMSCs, Student’s T-test (α=0.05) was used.  To determine significant 
differences between the average number, length, and area of protrusions on by 






A.3.1 Vimentin is involved in cell-substrate contact and might be involved in 
pseudopodia-substrate interactions in hMSCs 
First, we evaluated the relationship between the cell-substrate contact and the 
vimentin network (Figure A.1). We used surface reflective interference contrast 
microscopy (SRIC) to evaluate the contacts between the cell membrane and the 
underlying substrate. In the same cells, we used immunofluorescence of vimentin 
filaments to analyze the relationship between cell contacts and vimentin expression. 
Throughout this paper, we used shLacZ-transduced human mesenchymal stem cells 
as a control, as previously described 
150
. We used darker areas in micrographs to 
characterize cell-substrate adhesion (Figure A.1B, dark color). These dark contrast 
areas indicate a closer contact distance between the cell membrane and the glass 
substrate, whereas white/gray areas indicate that the cell membrane and the glass 
substrate are farther apart. 
 
We observed that for vimentin knockdown cells (shVim-hMSCs), the fluorescence 
intensity of vimentin was diminished in certain areas of the cell, especially at the 
edges (Figure A.1D, G). More importantly, the areas that lacked vimentin 
fluorescence intensity (Figure A.1F, I) also corresponded to darkened areas using the 
SRIC filter. This effect is due to the enhanced contact between the cell membrane and 
the substrate, which causes an increased in interference and therefore, darker areas in 
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the resulting micrograph. These results clearly indicate that the absence of vimentin 
network is directly correlated to areas of increased cell-substrate contacts.  
 
Our observation of shLacZ-hMSCs indicated that the organization of the vimentin 
network varied at the cell edge depending on the presence of pseudopodia 
(cytoplasmic projections). For example, cells with no evident projections at the edge 
have vimentin filaments that point outwards toward the membrane in addition to the 
curved filaments oriented in the same direction as the cell membrane (Figure A.1J). 
When projections were present at the edge, we found more vimentin filaments 
pointed outwards in the direction of the projection than those oriented along the cell 
body (Figure A.1K, L). shVim-hMSCs lacked vimentin staining at these surface 
projections (Figure A.1N, O). We found that vimentin-absent projections had an 
increased cell-substrate contact, as indicate by the dark contrast areas in shVim-
hMSC samples (Figure A.1 Q, R). These results seemed to indicate that the vimentin 
network plays a key role at modulating cell projections and cell-substrate adhesion at 








Figure A.1 Vimentin is involved in cell-substrate contact and might be involved in 
pseudopodia-substrate interactions in hMSCs. (A-C) Vimentin and cell-substrate 
adhesion in shLacZ cell. (A) Vimentin staining in shLacZ cell.  (B) SRIC image in 
shLacZ cell. (C) Vimentin and SRIC overlay of shLacZ cell. (D-I) Vimentin and cell-
substrate adhesion for shVim cells.  (D,G) Vimentin staining in shVim cells. (E,H) SRIC 
image of shVim cells. (F,I) Vimentin and SRIC overlay shVim cells.  (I) Zoom panel 
shows vimentin and SRIC overlay at cellular protrusion in shVim cell.  (J-L) Vimentin 
at the cell edges in shLacZ cells. (M-O) Vimentin staining at the cell edges in shVim 
cells. (P-R) Vimentin and SRIC overlay.  (R) White arrow points to lack of vimentin 
staining in the cell protrusion. 
 
A.3.2 Increased actin expression and vinculin focal adhesion area play a role in 
increased cell-substrate contacts in shVim cells 
We next focused on the organization of actin microfilaments in shVim- and shLacZ-
hMSCs. In shLacZ-hMSCs, both vimentin and actin filaments were observed along 
the cell edge as well as actin stress fibers (Figure A.2A).  When comparing the actin 
staining with the SRIC images, it appears that the darker areas contain actin. In 
shVim-hMSCs, the protrusions and edges of the cell were largely absent of vimentin, 
but appeared to have increased actin filaments, especially compared to the shLacZ-
hMSCs (Figure A.2B, C). When we compared the ratio of actin fluorescence between 
shlacZ and shVim-hMSCs we found that at the cell edges shVim-hMSCs expressed 
more vimentin (Figure A.2D). The ratio of actin to vimentin was significantly 
increased in shVim-hMSCs compared to shLacZ-hMSCs (Figure A.2D), due to both 
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the reduction in vimentin expression and the increase in actin fluorescence intensity at 
the cell edges.  
 
To gain a better understanding of the relationship between cell-contacts and vimentin, 
we examined vinculin staining. We noticed that shLacZ-hMSCs appeared to have a 
smaller focal adhesion area compared to shVim-hMSCs (Figure A.2G, H, I). We 
calculated the average area of the focal adhesions by taking a binary image of the 
fluorescent images and using ImageJ throughout the cell (Figure A.2 E, F, G).  We 
found that, indeed, shVim-hMSCs had larger areas of vinculin expression compared 
to shLacZ-hMSCs (Figure A.2G), with a large variation in the data due to the many 
different sizes of focal adhesions. In the case of shLacZ-hMSCs, the darkened areas 
correspond almost precisely to vinculin fluorescence expression (Figure A.2H), 
indicating that SRIC correctly represents focal adhesions. In the case of shVim-
hMSCs, upon looking at co-localized images of vinculin and SRIC, we observed that 
vinculin staining did not always line up with the darkened cell membrane areas that 
are closest to the substrate (Figure A.2I). The darkened areas are in fact much larger 
compared to the vinculin-positive areas. This data seems to indicate that although 
changes in vinculin may play a role shVim-hMSC adhesion, there are other factors 
that are involved. Together with our actin images, this data seems to suggest that 
increased amounts of actin and stress fiber formation at the cell edges, coupled with 
the increase in vinculin focal adhesion area, may account for the increase in cell-






Figure A.2 Increased actin expression and vinculin focal adhesion area play a role in 
increased cell-substrate contacts in shVim cells. (A) shLacZ cell showing vimentin, 
actin, and SRIC images. Vimentin is located on the periphery of the cell and actin does 
not form defined stress fibers. (B-C) shVim cell showing actin, vimentin, and SRIC 
images.  Yellow arrows indicate where vimentin expression does not extend into cellular 
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projections, but where actin expression is increased with stress fiber formation. (D) 
Ratio of actin and vimentin fluorescence expression at the cell edge. Ashvim is actin 
fluorescence in shVim cells, AshlacZ is the actin expression in shLacZ, Vshvim is 
vimentin expression in shVim and VshlacZ is vimentin expression in shLacZ cells. (E) 
ShLacZ vinculin immunofluorescence staining. (F) Binary image of shLacZ vinculin. 
(G) Vinculin adhesions in shLacZ hMSC and shVim hMSC (H) shLacZ cell showing 
vimentin, vinculin and SRIC. (I) shVim cell showing vimentin, vinculin and SRIC.  
A.3.3 Vimentin-rich cell protrusions resist cell retraction 
Due to actin’s apparent role in the adhesion of shVim-hMSCs to the substrate, we 
decided to inhibit actin polymerization using cytochalasin D (Figure A.3). In shLacZ-
hMSCs, upon treatment of cytochalasin D, the cell body retracted, but did not 
completely round up (Figure A.3A,B,C,D,E,G). As the cell body retracted, some 
small cytoplasmic protrusions remained in place (Figure A.3B,D,E,G). Using live-cell 
imaging of GFP-Vimentin expressing cells, we observed that these cytoplasmic 
protrusions contained vimentin (Figure A.3 C,D). When we treated shVim-hMSCs 
with cytochalasin D, the cell bodies retracted into a rounded morphology and no 
cytoplasmic protrusions were left remaining in place (Figure A.3F,H), compared to 
the shLacZ-hMSCs where these projections were still observed. These results indicate 






Figure A.3 Vimentin projections resist cell retraction.  (A)  Live cell imaging of shLacZ 
cells treated with 0.4µm cytochalasin D at T=0 and T=1:15hr. (B) Live cell imaging of 
shLacZ GFP-vimentin cells treated with 0.4um cytochalasin D at T=0 and T=1:15hr.  
(C) Immunofluorescence images of vimentin staining in shLacZ cells and shVim cells 
untreated (top panel) and cytochalasin (D) (bottom panel).   
A.3.4 Vimentin plays a key role in the formation of cell protrusions 
Thus far, we observed the role of vimentin in cell adhesion on 2D substrates. Next, we 
wished to gain a better understanding of the role of vimentin in protrusion formation.  To do 
this, we used a transwell migration assay to evaluate the differences between the control 
(shLacZ-hMSCs) and vimentin knockdown (shVim-hMSCs) hMSCs (Figure A.4A). SDF-1 
was used as a chemoattractant to stimulate migration to the bottom portion of the transwell 
insert (Figure A.4A). One major difference between shVim- and shLacZ-hMSCs was the lack 
of protrusions visibly extending from the bottom of the transwell insert in vimentin 
knockdown cells. In shVim-hMSCs short, actin-rich, cytoplasmic extensions could be 
observed having migrated shortly beyond the transwell pores (Figure A.4B).  shVim-hMSCs 
did not form the long cellular projections (or protrusions) rich in vimentin that were observed 
in the shLacZ-hMSCs (Figure A.4C). In shLacZ cells, z-projections revealed that these 
protrusions extending from the shLacZ-hMSCs contained both actin and vimentin (Figure 
A.4 D-F).  Vimentin appeared to be centrally located within the cells, and was surrounded by 
cortical actin on the outside. Furthermore, when shLacZ-hMSCs migrated through the 
transwell to the bottom well, they maintained a similar cytoskeletal organization, with actin 





To quantify the differences in protrusion formation between shLacZ- and shVim-hMSCs, we 
determined the average number of protrusions per viewing frame (Figure A.4J,K, L).  
Significantly more shLacZ-hMSCs formed long cellular projections compared to shVim-
hMSCs.  However, because we knocked down the expression of vimentin rather than ablated 
it, vimentin positive projections could still be observed in shVim-hMSCs. There was no 
difference observed in the normalized length of each protrusion (data not shown), 
demonstrating that vimentin knockdown cells can still grow cell projections if they retain 
enough vimentin to form vimentin positive protrusions.   
 
Figure A.4. Vimentin plays a key role in the formation of cell projections (A) Migration 
of hMSCs were monitored through 3µm transwell pores using fluorescent microscopy.  
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Transwells were coated in fibronectin and SDF-1 was included in the bottom well to 
stimulate cell migration through the pores. (B)-C Fluorescent images showing 
projection formation through transwell pores of shLacZ and shVim cells.  (D-F) Z plane 
projections of shLacZ cells stained with actin and vimentin migrating through transwell 
pores. (G-I) Vimentin and actin staining of a shLacZ hMSC adhered to the bottom side 
of a transwell. Green arrow (H) points to vimentin staining in the central area of the 
cell.  Red arrow (I) points to actin stress fibers on the periphery of the cell (J-K) 
Vimentin staining of shLacZ and shVim transmigrating through transwell pores. This 
panel depicts vimentin staining of protrusion formation through the pores to the bottom 




In this study, we sought to clarify vimentin’s role in MSCs by using lentiviral-based RNAi to 
decrease expression of vimentin IFs in the cells, and then examining the interplay between 
vimentin networks and MSC adhesion and migration. Our results reveal that intact vimentin 
networks are needed for retaining organized substrate adhesions. Immunofluorescence shows 
that the control shLacZ-hMSCs have vimentin IFs present throughout the cell. Further, SRIC 
micrographs show interspersed adhesion-like areas within the shLacZ-hMSCs. 
Comparatively, in the SRIC micrographs, shVim-hMSCs have larger areas of dark contrast, 
indicating the cell membrane is closer to the substrate surface. These dark regions correspond 
to areas of the cell without vimentin, suggesting that with decreased vimentin the MSC cell 
surface is closer to the substrate surface and may have increased regions of surface adhesion. 
Interestingly, the immunofluorescence for focal adhesions, as visualized through vinculin, 
does not show co-localization with these SRIC-based adhesions or regions of dark contrast. 
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However, we observed increased staining for actin in these areas, suggesting a role for actin. 
Perhaps evaluation of other focal adhesion components may help clarify this finding. 
Previously vimentin decrease has been be shown to cause decreases in focal adhesion size as 
measured through αVβ3 integrin staining 
105
. Similarly, investigation of alternative focal 
adhesion proteins, such as paxillin, may help to clarify this further 
185
. However, it is certainly 
possible that a decrease in vimentin IFs may cause a decrease in the distance between the cell 
membrane and substrate surface that is independent of cellular adhesive structures. In either 
case, our study implies a complex relationship between vimentin, focal adhesion contacts, 
SIRC-based surface closeness that must be further clarified in the future.  
 
The disruption of F-actin in GFP-vimentin hMSCs and shLacZ-hMSCs revealed vimentin-
positive extensions remaining when the cell body retracted. The cellular extensions were not 
active pseudopodia, but remnants after the cell body retracted. As the shVim-hMSCs lacked 
these vimentin-positive extensions after actin disruption, we postulate that vimentin might be 
necessary for retaining cellular morphology in adhered hMSCs, while active pseudopodia 
enable the cell to spread further. However, in the transwell assay in which MSCs extend 
projections through narrow pores, we observed a similar result; shvim-hMSCs lacked 
vimentin-positive cellular projections, which shows that vimentin was also necessary to 
actively form cell projections.  
 
It is well established that vimentin deficiency impairs cellular migration in a variety of cell 
types
87,113,114,120,132,184,185
. Increasingly, studies have shown that vimentin is necessary for the 
formation of filopodial structures during adhesion and early spreading on 2D surfaces
107
. 
Similarly, vimentin has been found to be needed for other types of cellular extensions as well 
such as for early neurite extension in hippocampal neurons
188





. Our results support this assertion and demonstrate that vimentin IFs 
may be necessary for the formation of these long protrusions in MSCs.  
 
While migration of cancer cells is likely aberrant and involving other factors, there is 
increasing evidence in this research area supporting vimentin’s involvement in the formation 
of lengthy cellular extensions as we observed. Invadopodia formation and extension in breast 
cancer and colorectal cancer cells lines both required vimentin for elongation
181
. Similarly, 
actin-independent tubulin microtentacles on detached breast carcinoma cells were found to 
contain vimentin
189
. Disruption of vimentin with phosphatase inhibitors in these cells as well 
as the use of vimentin negative cancer cells resulted in a decrease in the number of 
microtentacles. It has been proposed that vimentin provides stability for the formation of 
longer microtentacles, or cellular extensions, compared to the shorter, less stable vimentin-
negative microtentacles of less invasive cancer cells
189
.   
 
Our study is primarily limited by the use of RNAi to decrease vimentin networks rather than 
to ablate all vimentin expression. Specifically, MSCs completely lacking a vimentin network 
may yield larger effects in protrusion formation and extension
189
.  In addition, we chose to 
examine the formation of cellular protrusions using small pored transwell inserts. Examining 
transmigration through a variety of pore sizes as well as alternative culture and test conditions 
such as confined migration scenarios 
190
, gel degradation experiments 
181
, and transmigration 
through cell layers 
191
 may reveal more intricacies about vimentin IF’s role in protrusive 
structures for MSC migration. Further investigation into the relationship between vimentin, 
F-actin, and microtubules will help to clarify the formation, extension, and maintenance of 
these protrusive structures. Our results showed that shLacZ-hMSCs’ extensions contained 
both vimentin and F-Actin. Closer to the transwell pore and the origin of the extension, 
vimentin appears to be located in the interior of these protrusions with actin primarily located 
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in the outer regions. Closer to the protrusion end, vimentin and actin appear more 
interspersed. It is possible that in addition to potentially playing a structural role, vimentin 
may be involved in initial contact and adhesion. Comparatively, microtubules have been 
found to be needed for protrusion elongation 
181
 and microtentacles are dependent on a 
microtubule network 
189
. However, the study of microtubules and other cytoskeletal structures 
are outside of the scope of this paper.   
 
This study primarily demonstrates that vimentin IFs are needed for the formation and 
maintenance of protrusive structures in hMSCs. Further, our observations also suggest that 
vimentin IFs are involved in the organization of cellular adhesions and proximity to substrate 
surfaces. Both the capacities to adhere and form pseudopodia are critical cellular functions, 
and greater understanding of the mechanisms involved in these behaviors in MSCs is 





Appendix B: Layered Alginate Constructs: A Platform for Co-
culture of Heterogeneous Cell Populations
4
 
In addition to work described above, a dual-layered alginate hydrogel system was 
developed for potential co-culture, however, it was ultimately not implemented for 
studying the role of vimentin in MSCs. Included in this appendix is the written 
portion of the published Journal of Visualized Experiments article describing the 
method developed.   
B.1 Introduction 
Compressive load bearing tissues such as articular cartilage or intervertebral discs 
consist of heterogeneous tissue regions that are critical for both biomechanical 
function and appropriate mechano-transduction in the tissue. Not only is cellular 
organization and function distinct in different regions, but the extracellular matrices 
(ECM) are also varied in composition and orientation. For example, articular cartilage 
consists of three primary zones with varying cell morphology, mechanical function, 
and ECM. Differences in their ECM lead to differential load bearing responsibilities; 
the superficial layer is primarily involved in tensile response to load, while the middle 
and deep zones are mainly accountable for response to compression 
192
. Similarly, in 
the intervertebral disc, a gel-like nucleus pulposus is surrounded by a lamellar 
annulus fibrosis and the cells within these two distinct areas experience different 
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types of biophysical stimuli 
193
. In these types of tissues, cells and the extracellular 
matrices within the tissue layers interact with each other as the tissue undergoes and 
responds to mechanical forces.  
 
Recapitulation of such heterogeneous tissue structures remains a challenge in tissue 
engineering and regenerative medicine, and our understanding of their biological 
significance is limited. There is a need for culturing platforms for analyzing stratified 
tissues as well as co-cultures of different populations of cells within one construct. In 
articular cartilage tissue engineering, scaffold-less layered constructs have been 
constructed by harnessing the ability of zonal chondrocytes to deposit varied ECM to 
mimic the different layers of this tissue 
194,195
. However, layered hydrogel constructs 
provide an opportunity for investigating the interaction of diverse types of cell 
populations that lack the ability to form a robust tissue independently. For example, 
different populations of mesenchymal stem cells can be co-cultured within layered 
constructs. Such layered scaffolds have been used with both chondrocytes and 
differentiating mesenchymal stem cells for improved tissue engineering 
196
. Not only 
can different cell populations be co-cultured in similar hydrogel layers, but single cell 
type can also be cultured within layers that have been manipulated to have varying 




Many different biomaterial hydrogels have been used to layer cell populations for 
cartilage tissue engineering such as those using polyethylene glycol or poly vinyl 
alcohol bases 
198–200
. However, alginate hydrogels are one of the simplest biomaterials 
127 
 
from which to create layered scaffolds for studying heterogeneous cell populations in 
co-culture. While agarose hydrogels are also easily formed, alginate hydrogels have 
the added benefit of allowing easy isolation of cells from the 3-D construct for 
analysis of individual cells as has been described previously 
126
. In previous studies, 
bi-layered alginate hydrogels have been formed in thin sheets and from these sheets, 
sections were sliced (e.g. using a biopsy punch) for particular applications such as for 
analysis of biochemical content or interfacial shear properties 
201,202
. Another method 
for forming thin alginate sheets has been described with the potential for stratification 





Here, we present a method for reproducibly creating bi-layered alginate hydrogel 
discs for use in co-culturing different populations of cells. This alginate disc platform 
possesses several advantages. Primarily, the reproducible shape and small size is 
conducive for mechanical stimulation of the embedded cells without requiring a 
biopsy punch or other physical alteration to the hydrogel for many applications. 
Additionally, cell viability remains high during the layering process and after gel 
formation a clear separation of the two cell populations within the gel is visible with 
no initial overlapping region.  
B.2 Protocol 
B.2.1. Preparation for Formation of Alginate discs 
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B.2.1.1 Prepare a 4% (w/v) alginate solution in 1x Dulbecco’s Phosphate Buffered 
Saline without added calcium chloride or magnesium chloride and place in a 37ᵒC 
water bath. Concentrations of the alginate solution can vary, but 1-4% (w/v) alginate 
solutions are recommended.  
B.2.1.2  Mix the alginate solution at a ratio of 1:1 with warm cell culture media base 
(e.g. Dulbecco’s Modified Eagle Medium) for the desired cell type. The alginate 
concentration is now half of the original concentration, i.e. 2% (w/v). Sterilize 
alginate/media solution using sterile 0.2 µm nylon syringe filters.  
B.2.1.3 Prepare a bath of sterile 102 mM calcium chloride dihydrate in sterile water 
with enough solution to submerge molds (~ 200-300 mL). 
B.2.1.4 Collect the sterile “gel formation mold” (6 mm diameter x 3 mm tall 
cylindrical wells in a 3 in x 3 in aluminum plate, see Figure 1) and endplates (Bottom: 
one 3 in x 3 in aluminum plate, Top: one 1.5 in x 3 in aluminum plate) and prepare 
molds as follows: 
B.2.1.4.1 Cut thick filter paper (blotter filter paper) and the cell microsieve membrane 
(10 µm pore size) to the sizes of the top and bottom endplates and place them in the 
calcium chloride bath until saturated, approximately 1 min. If desired, sterilize the 
thick filter paper and the microsieve membrane via autoclave or ultraviolet light for 
30 min prior to use.  
B.2.1.4.2 Set-up one half (the bottom half) of the mold construct. 
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B.2.1.4.2.1 Place the following items atop one another in the following order and 
smoothen using a sterile spatula: large endplate (3 in x 3 in), thick filter paper, and 
then the microsieve membrane.  
B.2.1.4.2.2  Invert and press the mold onto a stack of paper towels to ensure loss of 
excess calcium chloride solution.  
B.2.1.4.2.3  Place the “gel formation mold” with the cylindrical wells on top of the 
cell microsieve membrane and gently fasten the mold together on two sides using 
binder clips on the left and right sides. Make sure to leave enough room for the top 
endplate (1.5 in x 3 in) to cover the wells completely later. 
B.2.1.4.3 Set-up the second half (the top half) of the mold construct. 
B.2.1.4.3.1) Place the following items atop one another in the following order and 
smoothen: small endplate, thick filter paper, microsieve membrane.  
B.2.1.4.3.2) Invert and press this half of the mold onto a stack of paper towels to 
ensure loss of excess calcium chloride solution. Do not fasten this half of the mold 
using binder clips at this time. 
B.2.1.5) Culture cells as recommended per manufacturer’s instructions. Harvest the 
desired cells to embed in the layered alginate hydrogels. The recommended cell 
density is 1-2 x 10
6
 cells/ml, but this can be varied depending on desired experiments.  
Note: When using this method for making layers with different cell types, make sure 
to culture two cell types in parallel for layering. Mesenchymal stem cells (MSCs) 
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seeded at a cell density of 1 x 10
6
 cells/ml in six discs will be used as an example for 
the following protocol. Cell number and disc number can be scaled for experiments as 
needed.  
B.2.1.5.1) Two to three weeks prior to embedding, seed  mesenchymal stem cells at a 
cell density of 3000-5000 cells/cm
2
 in 10 ml of basal growth media (Dulbecco’s 
Modified Eagle Medium, 10% Fetal Bovine Serum, 2% L-Glutamine, 1% Non-
essential Amino Acids, 1% Penicillin/Streptomycin) in T-75 flasks.  
B.2.1.5.2) Remove spent media every 2-3 days and replace with 10 ml of basal 
growth media until the cells are 80-90% confluent.  
B.2.1.5.3) To harvest cells, remove spent media, and pipette 3 ml of 1x Dulbecco’s 
Phosphate Buffered Saline without added calcium chloride or magnesium chloride to 
rinse cells. Remove this solution, pipette 3 ml of 0.25% Trypsin-EDTA onto cells 
growing in T-75 flasks, and incubate for 5 min at 37 ᵒC. After cells have lifted from 
the adherent surface, add 6-9 ml of basal growth media.  
B.2.1.5.4) Centrifuge MSCs at 600 x g for 5 min at room temperature, aspirate the 
supernatant, and re-suspend in 1-5 ml of basal growth media. Count the cells using a 
hemocytometer using device instructions.   
B.2.1.5.5) Remove 1 x 10
6
 cells from the total cell resuspension, centrifuge using the 
same conditions, and aspirate the supernatant.  
B.2.2. Formation of Cell Seeded Alginate Discs 
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B.2.2.1) Re-suspend the cell pellet with 1 ml of the sterile alginate/media solution to 
achieve a cell density of 1 x 10
6
 cells/ml. The cell-alginate mixture will be 
homogenously cloudy in appearance when cells are mixed in appropriately.  
B.2.2.2) Pipette 130 µl of the cell-alginate mixture into six 6 mm diameter x 3 mm 
tall wells in the bottom half of the mold construct dropwise, so as not to create any 
bubbles. A slight convex meniscus should be visible above the edge of each well. 
B.2.2.3) Carefully smoothen the top half of the mold construct using a sterile spatula 
and turn it over, so that the cell microsieve membrane is on top of the wells. Place the 
mold construct on top of the wells, making sure to cover the wells containing the cell 
and alginate mixture completely.  
B.2.2.4) Lift the loaded mold construct and, while pressing down firmly on the center, 
binder clip the remaining two sides (top and bottom) to fasten the top and bottom 
halves of the mold construct. The cell-alginate solutions should be securely nestled in 
the wells at this time.  
B.2.2.5) Immerse fastened mold construct in the 102 mM calcium chloride bath, 
making sure that the entire construct is submerged. Incubate in the cell culture hood 
at room temperature for 90 min.  
B.2.2.6) At the end of the 90 min, remove the mold construct from the 102 mM 
calcium chloride bath and place on a stack of paper towels in the cell culture hood.  
Remove all four binder clips and separate the two halves of the mold construct. 
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Hydrogels formed in the wells should not have any bubbles and should fill the wells 
completely.  
B.2.2.7) Using a spatula, carefully trace the edge of the wells containing the 
hydrogels to carefully loosen and wedge out the hydrogels. After removing the 
hydrogels from the mold construct, drop the hydrogels directly into a bath of 1x 
Dulbecco’s Phosphate Buffered Saline with calcium chloride and magnesium 
chloride. Cover the gels completely to wash off the excess calcium chloride solution 
for 1-5 min.  
B.2.2.8) Transfer the hydrogels into basal growth media solution in desired dish (e.g. 
6 well plates) that completely covers the hydrogels. Incubate for at least 1 hr in the 
cell culture incubator at 37 ᵒC and 5% CO2 before continuing to the layering step.  
Note: Hydrogels containing cells can be kept in the cell culture incubator indefinitely 
at this time until layering of gels with another cell population is desired, provided that 
media changes are completed every 2-3 days.  
B.2.3. Layering of alginate discs 
B.2.3.1) During the last half hour of the 1 hr incubation, collect and prepare sterile 
molds and solution for annealing the gels. 
B.2.3.1.1) Prepare the “cutting mold” by fastening a mold that has wells half of the 
height of the “gel formation mold” (6 mm diameter x 1.5 mm tall wells in a 3 in x 3 
in aluminum plate) to an endplate (3 in x 3 in aluminum plate) using binder clips on 
the left and right sides.  
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B.2.3.1.2) Prepare the “annealing mold” by fastening a mold that is 3 mm larger in 
diameter than the “gel formation mold” (9 mm diameter x 3 mm tall wells in a 3 in x 
3 in aluminum plate) to an endplate (3 in x 3 in aluminum plate) using binder clips on 
the left and right sides.  
B.2.3.1.3) Prepare a solution of 100 mM sodium citrate/30 mM EDTA (Sodium 
citrate dihydrate, Ethylenediaminetetraacetic acid tetrasodium salt dihydrate) in 
sterile water. 
B.2.3.2) Remove gels of desired cell populations (in this example, two discs with 
hMSCs) from the media in the dish, and place into the “cutting mold” wells. Each gel 
should fit snugly into the wells with half of the gel protruding above the mold.  
B.2.3.3) Using a scalpel, slice the gel along the surface of the mold (this will cut the 
hydrogel in half). Flip the top half of the gel and place it into an open mold well. The 
half of the gel should also fit snugly into the mold well, but now both half gels should 
be the height of the mold with the cut inner surface visible. Repeat with second gel.  
Note: Warning: Only the inner cut surfaces will form layered discs. Using the outer 
surfaces will result in the halves separating. It is suspected that texture from the 
microsieve membrane transferred onto the gel surface prevents success of the 
annealing process.  
B.2.3.4) Place a piece of dry cell microsieve membrane on top of the wells, making 
sure that the microsieve membrane is in contact with all of the gel halves to be 
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annealed and covering them entirely. Place thick filter paper on top of the microsieve 
membrane, making sure to cover the gels completely. 
B.2.3.5) Pipette a solution of 100 mM sodium citrate/30 mM EDTA (Sodium citrate 
dihydrate, Ethylenediaminetetraacetic acid tetrasodium salt dihydrate) onto the thick 
filter paper until it is saturated. Approximately 750 µl is sufficient for four wells.  
B.2.3.6) Incubate the gels for 1 min at room temperature. Then, remove the cell 
microsieve membrane and thick filter paper and discard them. Remove the binder 
clips and open the mold.  
B.2.3.7) For each annealed gel, transfer one sodium citrate/EDTA-treated half of the 
hydrogel to the prepared “annealing mold” with the cut surface facing upwards. This 
will be one half of the annealed construct. 
B.2.3.8) Using a spatula, lift and place a second sodium citrate/EDTA-treated half-gel 
(may contain a different cell type) onto the gel already in the “annealing mold”, 
flipping this second half-gel so that the cut surface is in contact with the cut surface of 
the gel already in the “annealing mold”.  
B.2.3.9) Press gently down on the two gels using a spatula to remove any bubbles 
between to the two gels. Also, reposition the gels as needed to make sure that they are 
directly on top of one another.  
B.2.3.10) Gently lift the “annealing mold” and submerge it in the 102 mM calcium 
chloride bath for 30 min. Do not cover the wells with an endplate.  
135 
 
B.2.3.11) After the 30min incubation, remove the “annealing mold” and place it onto 
paper towels. Remove the binder clips and separate the mold from the endplate.  
B.2.3.12) Using a spatula, collect the annealed gels and place them into a 1x 
Dulbecco’s Phosphate Buffered Saline with calcium chloride and magnesium 
chloride bath to wash the gels. Subsequently, transfer annealed hydrogels to cell 
culture media in a desired dish (e.g. 6-well plate) for culture.  
B.3 Representative Results: 
Figure B.1 depicts the formation and layering of the alginate hydrogels. Completed 
bi-layered gels exhibit a complete initial separation of cell populations as shown in 
Figure B.2. Cell viability of human mesenchymal stem cells embedded within these 
hydrogels and layered remains high and comparable to the bulk hydrogels as shown 
in Figure B.3. Viability was assessed after annealing, slicing the gels vertically to 
access the center and then staining the live cells in the annealed gels with a live cell 
tracker, CMFDA (green) and the dead cells (red) with Ethidium homodimer-1 using 
the manufacturer’s instructions. Confocal Z-stacks were taken of the cut surface using 
a fluorescence microscope approximately 100µm into the gel. These images were 
projected into one 2D image. Live and dead cells were then quantified using the 
particle analyzer feature in the ImageJ software.   
We wanted to verify that these layered hydrogels, lacking cells, would be able to 
withstand cyclic compression, similar to that needed to induce a chondrogenic 
response. We found that the hydrogels do remain intact after seven days in culture 
and subsequent unconfined cyclic compression for 4 hr at 1 Hz from 0-10% strain. 
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However, after isolating the peak stress from each cycle and analyzing the trends over 
the four hour stimulation, the trends indicate that the layered hydrogels have a 
different response to the cyclic compression compared to the bulk, non-layered, 
hydrogels. Cyclic compression over four hours resulted in significantly different (p = 
0.03) peak stress trends between layered and non-layered gels (Figure B.4). Statistics 
were completed using the Student’s T-test (α = 0.05).  
 
Figure B.1 Schematic of layered hydrogel formation. A. Image of the stacked mold for 
the addition of 2% alginate+cell mixture with a depiction of the stacking order for the 







Figure B.2 Representative separation of cell populations in layered hydrogel. Model cell 
line 293FT HEK cells were either stained with live cell tracker CMFDA (green) or 
CMTPX (red). Each of these cell groups were embedded in 2% (w/v) alginate discs, and 
then halves of these discs were layered together. A piece was cut from the CMTPX side 
to identify it during imaging. Scale bar = 100μm. 
 
 
Figure B.3 High cell viability within layered hydrogel after layering process is complete. 
Human mesenchymal stem cells embedded in bulk and bi-layered hydrogels were 
stained with live cell (green) tracker CMFDA and dead cells (red) were stained with 
Ethidium homodimer-1. Viability remained high for both hydrogel groups after the 





Figure B.4 Significantly different trends of layered hydrogel cyclic compression 
response to cyclic compression. Hydrogels were incubated in a cell culture incubator for 
seven days and subsequently subjected to 0-10% unconfined cyclic compression for four 
hours at 1Hz. Peak stresses (± SEM) for each cycle were isolated and the trends over the 
loading period analyzed. Trends under unconfined cyclic compression from 0-10% 
strain for layered (n = 9) and bulk (n = 8) gels are significantly different (p = 0.03).  
 
B.4 Discussion 
Here, we describe a protocol for the formation of layered alginate hydrogel discs for 
studying co-cultures of multiple cell populations, such as those in physiologically 
layered tissues, e.g. cartilage. Layered structures, such as the described culture 
platform, can be used to examine the interplay between two distinct cell populations 
subjected to the same culture environment or under load.  
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Alginate is an anionic linear polysaccharide that has been found to be biocompatible 
and has been successfully used for cartilage biology and tissue engineering research 
44,202
. Alginate hydrogels are formed using divalent cations for crosslinking, e.g. 
calcium ions. These crosslinks can be undone by removing the cations using a 
chelator such as sodium citrate and this process has been used previously to isolate 
chondrocytes that have been cultured in the gels 
194,195,202
. Similarly, the same 
principle has also been successfully applied for adhering alginate sheets in bilayers or 
even clusters of alginate beads together 
201,202,204
. The platform described here relies 
on this same process, but is used to form small disc-shaped layered hydrogels. This is 
a two-step process in which first, alginate discs are formed using molds submerged in 
a calcium-rich bath. These are then sliced in half and treated with a calcium chelating 
solution to locally release the calcium ions from the crosslinked alginate. By placing 
these treated surfaces together and re-immersing the discs in a calcium-rich solution, 
crosslinks are reformed, making bi-layered constructs. These small layered gels 
eliminate the need for biopsy punches to generate easy-to-culture samples compatible 
with assays and experiments such as mechanical testing, as shown in Figure B.4, 
thereby minimizing waste of oftentimes precious cells as well as fabrication 
materials.  
As shown in Figure B.3, this process of forming and layering the hydrogels resulted 
in similarly high viability as the control or bulk hydrogels indicating that this 
procedure is not overly taxing to the cell population despite the length and absence of 
replenishing nutrients. The lack of an initial overlapping region in the gel allows 
physical separation during initial co-culture and the ability to observe changes to that 
140 
 
interface over time. Studies have shown that over long culture periods this interface 
may lose definition due to cellular cross-infiltration and extracellular matrix 
deposition 
201
. While the initial layered disc does not contain any adhesion molecules, 
as extracellular matrix is deposited, there is also a potential for investigating the 
merging of cell populations and the changing interface between the layers.   
These bi-layer discs can be used easily for dynamic compression stimulation. We 
were able to confirm that these hydrogels withstand dynamic compression without 
separation of the halves. However, during this process, peak load exhibited by the 
layered hydrogels during the four hour cyclic compression were found to be 
significantly different from the non-layered, bulk, hydrogels. This result suggests 
complex, non-linear strain transfer between the layers and reveals a need for a 
physically layered control gel, e.g. bi-layered hydrogel with the same cell 
population/condition in each layer, an important detail to note when planning the 
experimental design for studies involving mechanical loading. Better understanding 
of the observed differences could be achieved through computational modeling of 
spatial mechanics within these gels. Not only would such analyses help clarify the 
strain distribution and transfer between the layers, but it would also be instrumental 
for interpreting cellular behavior in these layered gels, especially with layers of 
varying mechanical properties. 
This is a versatile culture system that can be used for physical separation of cell 
populations during co-culture as described. Additionally, it can also be used as a base 
structure for further development. Changes to the existing structure could include 
increasing the number of layers, changing the sizes or the relative stiffness of the 
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layers, and incorporating additional extracellular matrix components into one or more 
of the layers. However, these expansions will require careful evaluation. In addition 
to changes in the distribution of forces throughout the discs, increasing the size and 
number of layers could lead to decreases in cell viability in the center of the gels and 
physical instability during mechanical stimulation. Further, large additions of 
extracellular matrix and stimulating proteins or alterations to the alginate to provide 
adhesion moieties may interfere with gel formation and annealing processes. 
This culture platform was developed for research applications for investigating the 
relationships between different cell populations in 3D culture. Thus, it is limited by 
its lack of scalability for clinical applications. Alternative methods for creating 
layered hydrogels, such as 3D printing, may ultimately be more clinically relevant 
due to anticipated future scalability advances, control over microstructure in the disc 
interior, and customizability of macroscale geometric features. For research 
applications, as presented here, the alginate discs do not independently provide 
adhesion moieties for cells, which could limit its application to other cells types. The 
comparable alternative to alginate when considering ease of use is agarose, which 
suffers from similar limitations. Further, it requires the use of enzymes to release cells 
for downstream analysis, while alginate crosslinks can be safely removed using 
calcium chelating agents. Primarily, this culture platform will help with improving 
the understanding of relationships between cell populations in hydrogels and 
potentially the effects of mechanical stimulation of these co-cultures. This 
understanding will then inform the development of therapies for heterogeneous 
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